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GENERAL INTRODUCTION AND OUTLINE
Cardiovascular disease (CVD) is the leading cause of mortality worldwide [1]. The main 
contributor to CVD is the formation of atherosclerotic plaques in the vessel wall, a process 
largely driven by hypercholesterolemia [2]. Indeed, cholesterol-lowering drugs such as 
statins have substantially lowered CVD related mortality [3]. In spite of this success, the 
incidence of CVD has continued to rise, prompting the search for additional modifiable risk 
factors. Perturbation of our biological clock has recently been recognized as a potential 
modifiable risk factor for metabolic diseases [4]. Epidemiological studies demonstrated an 
association between disturbed day-night rhythms, such as due to shift work [5], short sleep 
[6] and light at night [7-9], and several metabolic disturbances, such as obesity, dyslipidemia, 
insulin resistance and coronary heart disease. The overall aim of the projects described in 
this thesis is to investigate the mechanisms by which the biological clock contributes to 
lipid metabolism and how derangement of the biological clock may contribute to metabolic 
disorders. I will therefore provide an overview of the basic aspects of lipid metabolism and 
mammalian chronobiology, and the interplay between these two fields.
Within the topic of lipid metabolism, I will focus on lipoprotein metabolism and the role 
of brown adipose tissue (BAT) in lipoprotein metabolism. I will discuss the pathophysiology 
of atherosclerosis with a focus on dyslipidemia and obesity as risk factors. Within the topic 
of chronobiology, I will briefly address the basic organization of the mammalian biological 
clock, as this thesis describes studies performed in mice and humans. In this thesis, I will 
also explore the role of the hypothalamus-pituitary-adrenal (HPA)-axis in circadian rhythms. 
Therefore, the HPA-axis will be addressed in more detail. Next, since in humans short 
sleep duration is a common behavioral disruption of physiological day-night rhythms, I will 
briefly introduce human sleep physiology with a focus on short sleep duration and energy 
metabolism. Finally, I will combine these two fields and discuss circadian rhythmicity in lipid 




Lipids are hydrophobic molecules which encompass different molecular substances. For 
this thesis, I will focus on triglycerides (TG) and cholesterol, since these lipids are most 
involved in metabolic health and development of CVD. TGs are the most abundant lipids in 
human diet and their function for metabolism is to deliver energy in the form of fatty acids 
(FAs). TG consists of three FA chains esterified to a glycerol backbone. Cholesterol is an 
abundant dietary lipid in a typical Western type diet, with an entirely different structure and 
function. Cholesterol serves to build membranes, and serves as a precursor molecule for 
synthesis of bile acids and steroid hormones. Due to their hydrophobic nature, both TGs 
and cholesteryl esters, the storage form of cholesterol, have to be properly packaged into 
lipoprotein particles to be transported in the circulation. Lipoproteins are large spherical 
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macromolecular complexes, with a lipid rich core consisting of TGs and cholesteryl esters 
and an outer layer composed of proteins, free cholesterol and phospholipids. They are 
classified based on their diameter and density: very low density lipoproteins (VLDL), low 
density lipoproteins (LDL), intermediate density lipoproteins (IDL), high density lipoproteins 
(HDL), and chylomicrons (CM) (chyle refers to lymph).
Since TGs either derive either from the diet or from de novo synthesis in the liver, 
the latter predominating during fasting, there are two lipoprotein synthesis routes: the 
endogenous and exogenous pathway [10]. After feeding, dietary TGs within the intestinal 
lumen are hydrolyzed into FAs and 2-monoacylglycerol, both of which are taken up by 
enterocytes and re-esterified into TGs. Likewise, cholesteryl esters are hydrolyzed an 
cholesterol is taken up by enterocytes and re-esterified. In the enterocytes, apolipoprotein 
B (apoB48 in humans, apoB100 in rodents) is added onto droplets consisting of TGs and 
cholesteryl esters by the enzyme microsomal triglyceride transfer protein (MTP), eventually 
producing chylomicrons during exit of enterocytes by coating with a shell composed of 
phospholipids, cholesterol and additional apolipoproteins. These particles are secreted 
into the lymphatic fluid, and eventually reaches metabolically active cells via the circulation. 
In case of fasting, this role is taken over by the liver, which continuously produces VLDL 
particles according to intracellular mechanisms similar to chylomicrons, although they 
are built from apoB100 in both humans and rodents [11-13]. In the circulation, these large 
TG-rich VLDLs or CM are trapped onto the endothelium by proteoglycans in metabolically 
Figure 1. Overview of lipoprotein metabolism. ATP = adenosine triphosphate, BAT = brown adipose 
tissue, LDLr = LDL receptor, LPL = lipoprotein lipase, LRP = LDL-receptor related protein, TG = triglyceride, 
WAT = white adipose tissue. See text for explanation.
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active tissues where TGs are hydrolyzed by lipoprotein lipase (LPL) [14]. The liberated FA 
can then be taken up by parenchymal cells via FA transporters such as CD36 and FA acid 
transport protein (FATP). Over time, VLDL and CM are delipidated; they decrease in size 
and increase in relative density, turning into remnant particles, namely VLDL remnants, 
or IDL, and CM remnants. In the blood stream, they acquire additional apolipoproteins, 
importantly ApoE. ApoE can bind to both the LDL-receptor (LDLr) and LDLr-related protein 
(LRP) on hepatocytes, mediating their uptake [15]. Further delipidation of IDL results in 
LDL, which have lost all apolipoproteins except for ApoB100 that induces uptake by the 
LDLr only. HDL is a separately synthesized particle within the liver and intestine uniquely 
containing ApoA1 and/or ApoA2. HDL is secreted as a cholesterol-poor discoid particle, 
which has the capacity to take up cholesterol from various peripheral tissues, including 
macrophages. Also, in humans, HDL can take up cholesteryl esters from LDL particles, 
in exchange for TG via cholesteryl ester transfer protein (CETP). While ApoB-containing 
lipoproteins are associated with increased risk for CVD, ApoA-containing HDL is associated 
with a decreased risk for CVD [10] (Figure 1).
Dyslipidemia and the development of atherosclerosis
The major part of CVD is attributable to atherosclerotic disease [16]. Atherosclerosis 
is a chronic and active pathological process within the vessel wall, consisting of an 
inflammatory and a lipid-driven component. The lipid-component is driven by elevated 
circulating concentrations of LDL particles. LDL particles can enter the vessel wall, where 
they are prone to modification by e.g. oxidation and aggregation. Macrophages take up 
these modified LDL particles via SRA and CD36, resulting in ‘foam cells’: large cholesterol-
rich macrophages. Eventually, foam cells die and attract more immune cells, precipitating 
a pro-inflammatory cascade. On the other hand, HDL is described as anti-atherogenic, not 
only because of its anti-oxidative and anti-inflammatory properties, but mainly by its ability 
to extract cholesterol from macrophages via ABCA1 and ABCG1 for transport to the liver 
for excretion into the feces, a process that is termed reverse cholesterol transport [17]. 
Atherosclerotic plaques occlude the vascular lumen, diminishing laminar blood flow, without 
prominent clinical symptoms. However, upon plaque rupture, rapid platelet aggregation 
results in formation of thrombi that can completely occlude the lumen of a blood vessel, 
resulting in hypoxia and death of tissues downstream of the occlusion. Occlusion of the 
carotid artery results in a stroke, while in the coronary artery this results in a myocardial 
infarction.
White adipose tissue and its role in obesity
The prevalence of overweight and obesity has reached epidemic numbers worldwide. 
According to the World Health Organization, in 2014 1.9 billion people were overweight 
and 600 million were obese [18]. Obesity is a major risk factor for dyslipidemia and 
cardiovascular disease, but also for development of a myriad of other diseases, such as 
type 2 diabetes (T2D) and cancer [19, 20]. Although obesity is classified most commonly 
according to the body mass index (BMI, in kg/m2), this poorly reflects the underlying 
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pathophysiology, since it ignores body composition. The body composition plays an 
important role in the predisposition to metabolic disease, where the accumulation of white 
adipose tissue (WAT) is pivotal. Upon a positive energy balance, i.e. a surplus of energy 
intake over energy expenditure, excess energy is stored in WAT in the form of TGs. When 
a critical level of TGs in WAT is reached, the white adipocytes produce pro-inflammatory 
mediators, initiating a pro-inflammatory state within the WAT which perpetuates itself. 
This low-grade inflammatory status induces insulin resistance and leads to steatosis of 
other organs including skeletal muscles and the liver by ‘lipid overflow’, causing insulin 
resistance in those tissues. Prolonged insulin resistance may result in the development of 
T2D where insulin sensitizers and eventually insulin is administered to control pathological 
consequences to high blood glucose levels. Insulin resistance of the liver results in a higher 
VLDL particle output, which increases circulating TG levels, thus aggravating dyslipidemia 
[21]. Therefore, promoting weight loss and preventing obesity are key strategies to prevent 
CVD.
Brown adipose tissue: a target to promote metabolic health
Besides the white fat depots which have an important role in obesity, both humans and 
rodents also possess brown fat depots. In contrast to WAT, BAT burns energy to produce 
heat. Cold is the most important physiological stimulus to activate BAT. Cold signals from 
the skin are processed by the anterior hypothalamus, which increases the sympathetic 
outflow towards the densely innervated BAT. Upon release of noradrenalin, the β3-
adrenergic receptor on brown adipocytes is activated, leading to a downstream signaling 
cascade, ultimately resulting in increased hydrolysis of intracellular TG stores and increased 
FA oxidation by mitochondria. The mitochondria-dense brown adipocytes uniquely express 
uncoupling protein 1 (UCP1), which allows dissipation of the proton gradient generated by 
the electron transport chain into heat instead of ATP production. To replenish intracellular 
lipid stores, brown adipocytes increase the uptake of TG-derived FA as well as glucose from 
the circulation (Figure 2) [22].
In rodents, increasing BAT activity, either by physiological or pharmacological stimuli, 
has been proven to prevent and diminish diet-induced obesity and to lower dyslipidemia 
and atherosclerosis development [24-26]. In recent years, efforts have been made to 
translate these results to humans. In healthy young volunteers, a 3 week mild cold exposure 
intervention increased BAT volume (as detected by [18F]fluorodeoxyglucose uptake by 
PET-CT) and decreased fat mass by approx. 800 g [27]. Additionally, BAT activation by cold 
acclimation improved insulin sensitivity in individuals with T2D [28]. South Asians, an ethnic 
group with a predisposition for dyslipidemia, obesity and CVD, have lower BAT detectability 
accompanied by lower resting energy expenditure [29]. Therefore, the activation of BAT 
in humans is a viable therapeutic strategy to combat cardiometabolic diseases including 
adiposity, dyslipidemia and CVD. Current treatment strategies aim to recruit more BAT 




Organization of the mammalian biological clock
The earth turns around its axis, resulting in the daily rhythm of light and dark, while the 
rotation of the earth around the sun results in a yearly rhythm of different day length. These 
‘circadian’ (from Latin circa= about; dies=day) and seasonal rhythms have resulted in the 
evolution of biological clock systems throughout living organisms on earth (see box for 
more circadian terminology). Biological clocks are ubiquitous; they are present in bacteria, 
fungi, plants and animals. Presumably, the DNA damaging effects of ultraviolet radiation 
during the day has been one of the first triggers for a compartmentalization of cellular 
processes. DNA has to be unfolded for replication which renders it more susceptible to 
breaks. Darkness is therefore a more favorable period for DNA replication and repair. 
Furthermore, during the light period, energy from sunlight is available for photosynthesis, 
giving rise to a natural circadian rhythm in energy availability. Seasonal rhythms are 
represented by changing light exposure duration and are highly associated with changes 
in temperature. Rather than reacting to these changing environmental circumstances, the 
biological clock system evolved to anticipate to these recurrent events [31].
Figure 2. Brown adipocyte physiology. DG = diglyceride, FA = fatty acid, FATP = fatty acid transport 
protein, LPL = lipoprotein lipase, MG = monoglyceride, TG= triglyceride, TRL = triglyceride-rich lipoprotein, 
UCP-1 = uncoupling protein-1 . See text for explanation. From Hoeke et al. [23]
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The light-dark cycle is the most 
important cue for the mammalian biological 
clock. The biological clock system 
is hierarchy organized, with a central 
clock, located in the suprachiasmatic 
nuclei (SCN) of the hypothalamus, which 
governs peripheral clocks throughout 
the body. Light is perceived by the eye 
and information about the intensity and 
wavelength of light is transferred directly to 
the SCN via the retino-hypothalamic tract 
[32]. The SCN, consisting of approx. 20,000 
individual neurons, has the unique capacity 
to produce a rhythmic electrical firing rate, 
which is sustained ex vivo. The individual 
neurons synchronize each other through 
neuropeptide coupling, synaptic signaling 
and gap junctions [33]. The output of the 
SCN consists of this rhythmic electrical 
signal as well as an endocrine output, 
most importantly vasoactive intestinal 
polypeptide and arginine vasopressin 
[34, 35]. The SCN is the only part of the 
biological clock which allows entrainment 
of our biological clocks to light. However, 
light is not the only environmental cue 
conferring information on 24h rhythms 
and indeed the SCN can be synchronized 
by other “Zeitgebers” (German for ‘time 
givers’). These Zeitgebers include food 
intake and physical activity [36] (Figure 3).
The SCN orchestrates 24h rhythms in physiological processes and behavior to align 
them to the environment. The SCN synchronizes peripheral tissues both directly via 
hormonal and neuronal output originating from the SCN and indirectly, via regulating brain 
areas and dictating rhythmicity in hormonal output that is generated outside the SCN. The 
SCN has many direct neuronal connections to other brain regions, e.g. nuclei that control 
food intake behavior (e.g. the arcuate nucleus), body temperature (the pre-optic area) and 
hormonal output (e.g. pineal gland and paraventricular nucleus (PVN)) [37]. In addition, 
direct neuronal connections exist with peripheral tissues, including metabolic organs such 
as liver, adipose tissue and muscle. Likely, this holds true for additional metabolic organs 
which have not been investigated up to now [38-40].
BOX: RELEVANT CIRCADIAN TERMINOLOGY
Amplitude: the distance between the peak or 
trough and the mean value of an oscillatory 
function
Chronobiology: the scientific field that studies 
biological rhythms
Chronotherapy: treatment based on knowledge of 
chronobiology. May be used for different aspects, 
such as timing of drug administration, using of 
light as treatment or treatments aimed to improve 
sleep-wake rhythms.
Circadian: taking place or functioning in cycles 
of approximately 24 hours. Conventionally, 
circadian rhythms are required to be endogenously 
generated and therefore must be determined 
under constant conditions (such as in mice under 
constant darkness).
Daily: taking placing every 24 hours
Diurnal: for this thesis same as daily. Can also refer 
to species which have their habitual activity period 
during the light phase (contrary to nocturnal) 
Free-running period: the period of an oscillation 
(rhythm) in the freerun state
Jet lag: adverse health effects associated with the 
disruption of circadian rhythms, typically caused by 
time zone travel
Peak: highest value within a cycle
Period: the amount of time between the comple-
tion of one cycle
Trough: lowest value within a cycle
Zeitgebers: synchronizing environmental signals 
Zeitgeber time: convention to display time where 
onset of light is defined as ZT0. Measured in hours
15
1
Peripheral tissues exhibit rhythmicity 
in their tissue-specific function. While not 
every cell of the mammalian body has been 
studied, for now it seems safe to state that 
all tissues display a degree of rhythmicity. 
Estimates of the extent of rhythmicity in 
peripheral tissues are often derived from 
microarray studies, which report that 
5-10% of the transcriptome displays a 
circadian rhythm [41, 42]. Data derived 
from transcriptome analysis are probably 
an underestimation of the cellular circadian 
processes, since besides transcription, 
also histone modification, translation, 
post-translational modification and protein 
degradation display a circadian rhythm, 
[43, 44]. All mammalian cells that have been 
studied so far contain a molecular clock, 
driven by a transcriptional-translational 
feedback loop. In the past decade, the most 
important proteins of the molecular clock 
have been elucidated. Upon dimerization 
of core clock proteins BMAL1 and CLOCK 
(or within the same tissues their analogues 
BMAL2 and NPAS2), they form an active 
transcription factor. They bind to the 
promotor element E-Box, which promotes 
the transcription of downstream genes. 
Among these genes are both clock gene repressors and the ‘clock controlled genes’ (ccgs), 
which exert their tissue-specific functions. The clock gene repressor genes encode for 
proteins, namely PERIOD (PER1, PER2), CRYPTOCHROME (CRY1, CRY2) and NR1D1 (better 
known as REV-ERBα), which translocate back to the nucleus and inhibit the BMAL1-CLOCK 
dimer, thereby forming the negative arm of the transcription-translation feedback loop. 
This molecular clock system is equal amongst different cell types, also within the SCN 
(Figure 4) [45, 46].
HPA-axis physiology and its role in chronobiology
The SCN function and the molecular clock in peripheral tissues are well-described. 
Nevertheless, the exact signals that transfer the timing signal of the SCN to peripheral 
tissues are still largely unknown. There is some evidence for glucocorticoids to confer timing 
signal to peripheral tissues [47, 48]. Glucocorticoids are able to synchronize the circadian 
rhythm in clock gene expression in vitro [49, 50]. Also, complete absence of endogenous 
Figure 3. Organization of mammalian circadian 
clock system. SCN = suprachiasmatic nuclei; 




glucocorticoids by adrenalectomy shifts the circadian rhythm in clock genes in peripheral 
tissues [51]. In humans subjected to a constant food, sleep and activity protocol, an oral 
dose of glucocorticoids also shifted clock gene expression pattern in peripheral blood 
mononuclear cells [52].
Glucocorticoid secretion is regulated via the HPA-axis, which is the endocrine system 
that is best known for its response to stress. Upon a physiological or psychological stressor, 
the PVN secretes corticotrophin-releasing hormone (CRH). CRH stimulates the pituitary 
to secrete adrenocorticotropic hormone (ACTH) into the circulation, which stimulates 
the adrenals to secrete glucocorticoid hormones (cortisol in humans, corticosterone 
in rodents). ACTH and glucocorticoids exert a negative feedback on the hypothalamus 
and on the pituitary which dampen the response. Interestingly, in absence of stress, 
plasma glucocorticoid concentrations are highly rhythmic. In both humans and rodents, 
glucocorticoids reach a peak concentration before waking up (‘arousal’) and decrease 
throughout the wakeful period reaching the trough before sleep [53].
Glucocorticoids are steroid hormones which travel to the cell nucleus where they bind 
to their receptors: the mineralocorticoid receptor (MR) and the glucocorticoid receptor 
(GR). Since the MR has a higher binding affinity than the GR, the MR is bound throughout 
the 24h period, while the GR is only bound during the peak concentrations, such as during 
stress or the circadian peak [54]. MR and GR are present throughout the body, including 
the brain and metabolic organs such as liver, adipose tissue and muscle. In metabolism, 
glucocorticoids act as catabolic hormones, i.e. to increase available energy. GR agonism 
Figure 4. Cell autonomous clock. Every mammalian cell contains a core clock machinery which controls 




increases glucose release, gluconeogenesis, and lipolysis while inhibiting glucose uptake 
by muscle and adipose tissue. The circadian peak of glucocorticoids thereby increases 
energy availability before waking up.
Human sleep physiology and sleep insufficiency
Humans have a well-defined circadian sleep-wake rhythm. Sleep takes place during the 
night, while during the day we are awake and active. It is important to note that sleep 
physiology is not solely an output of the biological clock, but two processes: sleep timing 
and sleep pressure. Therefore, sleep insufficiency is not synonymous to a disturbance of 
the biological clock, but also affects the sleep pressure physiology. Sleep timing is the 
process determined by the biological clock. The SCN determines a circadian rhythm in 
wakefulness which is aligned with the light-dark cycle. Furthermore, sleep timing ensures 
that sleep-wake cycles are synchronized to circadian rhythms in other bodily functions [55]. 
This is relevant to energy metabolism, as sleep coincides with fasting and a nearly absent 
physical activity levels. Sleep pressure is a direct function of wakefulness. Upon wakening, 
sleep pressure builds up and upon sleep, sleep pressure decreases. The regulation of onset 
of sleep and maintaining sleep is a delicate interplay of brain areas promoting wakefulness, 
suppressing wakefulness and promoting sleep. For the regulation of sleep timing, it is clear 
that melatonin plays an important role. How sleep pressure is regulated is not completely 
understood [56].
Sleep insufficiency is highly prevalent, with 70.1 million adults reporting less than 6 
hours sleep per night [57]. Epidemiological studies strongly associate habitual short sleep 
duration (<5 hours per night) with many metabolic disorders [6, 58-60]. Interestingly, while 
most studies report a linear relationship between sleep duration and metabolic outcome 
parameters, others also report an association between long sleep duration (usually >9-
10 hours per night) and metabolic disorders, resulting in a U-shaped association [61, 62]. 
A recent study demonstrated that short sleep duration was a risk factor for BMI, but not 
perceived sleep loss [63]. The notion that optimal sleep duration exists, is supported by 
studies on sleep duration in absence of modern lifestyle demands such as artificial light and 
setting an alarm clock. Individuals living in pre-industrialized communities have a reported 
sleep duration of approximately 7 hours per night [64]. Likewise, young adults camping one 
week outdoors, banned from electrical lights, alarm clocks and watches, display similar 
sleep-wake cycles [65]. In both cases, sleep duration was not equal to the total hours of 
darkness, but rather was kept constant by staying awake by making campfires. Together 
these data suggest that the optimal sleep duration is about 7 hours sleep per night.
Interplay between lipid metabolism and the biological clock
Rhythms in lipid metabolism
It has long been investigated whether human plasma lipids display circadian variation. 
Under standardized meal circumstances, it is clear that TG levels are highly rhythmic with a 
reported variation of 30-60%. TG levels also display a clear postprandial excursion [66-68]. 
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The postprandial TG excursion shows variable peak levels throughout the day, with a higher 
excursion in the morning than in the afternoon [66, 69]. Circadian rhythm in TG uptake by 
the intestine may be a contributor, since enterocytes express clock genes [70]. Mice with 
a mutation of the Clock gene have increased lipid absorption and doubled plasma TG and 
cholesterol levels [71]. Cholesterol levels seem more stable throughout the day; some 
studies show some degree of rhythmicity [67, 72] while others do not [66, 73]. Furthermore, 
extensive lipidome analysis demonstrated that circulating plasma lipids are rhythmic 
independent of food intake in humans [74, 75] and rodents [76]. Therefore, the production 
and/or uptake of lipids by metabolic organs must be rhythmic. In rodents, genes involved 
in both TG and cholesterol production and uptake in the liver were shown to be rhythmic 
[76, 77]. In humans, cholesterol synthesis was estimated by determination of cholesterol 
precursors in plasma, and appeared to display a diurnal variation [73]. It is currently not yet 
known, whether the lipid uptake by metabolically active tissues displays a circadian rhythm.
Circadian disruption as a causal risk factor for metabolic disorders
In the past decade, animal studies have provided ample evidence for a causative link 
between disturbance of the biological clock and cardiometabolic disorders. Specific 
electrical ablation of the SCN induces obesity and insulin resistance in rodents [78]. Also, 
several genetic knock-out models of clock genes have been generated, which resulted in 
adverse metabolic phenotypes, including dyslipidemia and obesity [79-82]. The adverse 
metabolic phenotype observed in whole-body knock-out of clock genes may have a similar 
etiology as the SCN ablation, since the genetic deficiencies also affect the SCN [83]. 
Interestingly, tissue-specific disturbances of rhythm also induce metabolic disturbances. 
Mice with an adipocyte-specific knock-out of Bmal1 have higher body weight than control 
animals due to increased food intake. Interestingly, this was attributed to an increased FA 
release by WAT during daytime, which increases orexigenic signals in the hypothalamus 
[84]. Furthermore, tissue-specific disruption of clock genes can enhance atherosclerosis 
formation. Ldlr-/- mice that received bone marrow from Rev-erbα-/- mice exhibit a pro-
inflammatory phenotype due to M1 polarization of macrophages [85]. Apoe-/- mice that 
received bone marrow from Clock mutant mice have impaired cholesterol efflux from 
macrophages [71].
Unfortunately, these genetic models for disturbed circadian rhythms are not readily 
translatable to humans. Alternatively, light exposure changes can modulate the biological 
clock output without inducing genetic defects. In mice, constant light exposure induces 
a fast increase in weight gain, independent of physical activity and food intake. Instead, 
constant light exposure lowers total energy expenditure [86-88]. Mechanistically, constant 
light dampens the circadian electrical output of the SCN [86] and it was previously shown 
that constant light dampens circadian glucocorticoid levels [89, 90]. In humans, an 
experimental study showed that 2 hours of blue light exposure in the evening changes 
energy expenditure the following morning. This indicates that light exposure, presumably 
via the SCN, can causally influence metabolism in humans [91].
19
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OUTLINE OF THIS THESIS
The overall aim of this thesis is to investigate the role of circadian rhythm in metabolism, 
specifically involving lipid metabolism and its implications for metabolic disease.
Part I describes animal models of circadian rhythms with particular focus on the role 
of BAT. Since light exposure has been associated to increased body weight and BMI in 
humans, we set out to investigate how light exposure affects metabolism. In chapter 2 we 
investigated the effect of prolonged light exposure on body composition and evaluated 
underlying mechanisms to show that prolonged light dampens BAT activity. In chapter 3, 
we included both shortened and prolonged light exposure as modulators of the biological 
clock, and investigated diurnal rhythms in BAT activity and their consequences for plasma 
lipid metabolism. Next, we set out to further elucidate the mechanism by which the biological 
clock regulates BAT rhythmicity. We focused on the role of the HPA-axis by evaluating the 
effect of a dampened glucocorticoid rhythm on BAT rhythmicity in chapter 4. Since light 
exposure can alter metabolism, at least via BAT activity, we hypothesized that rotating light 
schedules may also underlie the association between shift work and atherosclerotic disease. 
In chapter 5 we, therefore, investigated the effect of light schedules on atherosclerosis 
development.
Part 2 focuses on human models for circadian rhythms. A common human disturbance 
of physiological day-night rhythms is shortened sleep duration. Previously, it was found 
that one night of short sleep increases insulin resistance. In chapter 6, we aimed to better 
understand the underlying mechanism for this finding by performing metabolomic analysis 
on plasma. Another human condition associated with deterioration of circadian rhythms 
is aging. We made use of this fact to better understand whether circadian rhythms in 
cholesterol levels are affected by the biological clock and may relate to human health. In 
chapter 7 we, therefore, determined diurnal plasma cholesterol concentrations in a cohort 
of individuals with a familial predisposition for longevity and their spouses.
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Disruption of circadian rhythmicity is associated with obesity and related disorders including 
type 2 diabetes and cardiovascular disease. Specifically, prolonged artificial light exposure 
associates with obesity in humans, although the underlying mechanism is unclear. Here, we 
report that increasing the daily hours of light exposure increases body adiposity through 
attenuation of brown adipose tissue (BAT) activity, a major contributor of energy expenditure. 
Mice exposed to a prolonged day length of 16 h and 24 h light, compared to regular 12 
h light, showed increased adiposity without affecting food intake or locomotor activity. 
Mechanistically, we demonstrated that prolonged day length decreases sympathetic input 
into BAT and reduces β3-adrenergic intracellular signaling. Concomitantly, prolonging day 
length decreased the uptake of fatty acids from triglyceride-rich lipoproteins as well as 
of glucose from plasma selectively by BAT. We conclude that impaired BAT activity is an 
important mediator in the association between disturbed circadian rhythm and adiposity 
and anticipate that activation of BAT may overcome the adverse metabolic consequences 




Modern world society is subjected to disturbances of circadian rhythms by shift work, 
sleep deprivation and environmental light pollution. Importantly, increasing prevalence of 
obesity is associated with disrupted sleep-wake pattern in humans [1] and coincides with 
the availability of artificial light [2, 3]. Additionally, a recent study revealed a relationship 
between exposure to light at night and obesity in a cross-sectional analysis of over 
100,000 women [4]. Light input is the most important cue for generation of circadian (~24 
h) rhythms by the master clock. Both in rodents and humans the master clock is situated 
in the suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN is responsible for 
synchronization of peripheral clocks throughout the body, which is mediated by endocrine 
and neuronal signals [5]. A causal role for a disturbed circadian rhythm in the development 
of obesity has been demonstrated by animal studies. Mice with genetically dysfunctional 
clock genes develop obesity and insulin resistance [6-9]. Moreover, specific ablation of the 
SCN induces acute weight gain [10]. These results indicate a crucial role for the SCN in the 
regulation of adiposity.
Interestingly, we previously showed that prolonged light exposure only is sufficient to 
enhance weight gain in mice. Constant light disrupts the central circadian clock, evidenced 
by an immediate reduction in the circadian amplitude of SCN electrical activity. Moreover, 
constant light induces body weight gain and insulin resistance, even faster than high-fat diet, 
which was not due to increased food intake or reduced locomotor activity [11]. Therefore, 
disruption of the central biological clock likely induces weight gain by decreasing energy 
expenditure.
Recently, it has been recognized that brown adipose tissue (BAT) importantly 
contributes to energy expenditure. BAT combusts high amounts of triglycerides (TG) 
into heat, a process called thermogenesis that is mediated by uncoupling protein 1 
(UCP1). Interestingly, SCN neurons project onto BAT and injection of glutamate into the 
SCN increases BAT thermogenesis in rats [12, 13]. This indicates that BAT may mediate 
the association between circadian rhythmicity and energy expenditure. Therefore, the 
aim of this study was to shed light on the association between prolonged light exposure 
and obesity in humans by investigating the effect of day length on BAT activity in mice in 
relation to body fat gain, independent of ambient temperature. We demonstrate that daily 
light exposure negatively associates with the uptake of TG-derived fatty acids and glucose 
from plasma by BAT, pointing to decreased activity of the tissue. Furthermore, we show 






All animal experiments were approved by the institutional ethics committee on animal care 
and experimentation at Leiden University Medical Center (LUMC), Leiden, The Netherlands. 
9-12 week old male C57Bl/6J mice (Charles River) were single housed in clear plastic 
cages within light-tight cabinets at constant room temperature of 22°C. Stable temperature 
inside the light-tight cabinets was verified in 12 h vs. 24 h light conditions. The cages 
were illuminated with white fluorescent light with an intensity of approximately 85 µW/
cm2. Before start of the experiment, mice were kept on a regular 12:12 light-dark cycle. 
Mice had ad libitum access to standard laboratory chow (Special Diets Services, UK) and 
water throughout experiments. Mice were matched on body weight and light intervention 
consisted of subjecting mice to either 12, 16 or 24 h light exposure per day (i.e. 24 h) for the 
duration of five weeks (n= 9).
In a second study, mice were randomized to either bilateral selective sympathetic 
denervation (n=17) of iBAT or sham surgery (n=6). Mice were anesthetized (isofluorane 
inhalation) and a midline incision of the skin was made, exposing both iBAT pads. 
Sympathetic branches were visualized and cut on both sides. Wounds were closed and 
mice received post-operative analgesia (0.03 mg/kg buprenorphine, Temgesic, Merck). 
Successful denervation was confirmed retrospectively by absence of TH in iBAT sections 
(see below). After four days of recovery, mice that underwent denervation were randomized 
based on body weight and exposed to 12, 16, or 24 h light per day for five weeks while sham 
operated mice were exposed to 12 h light per day and served as a reference group.
Body composition, food intake and locomotor activity
At the end of the experiment, body weight was measured and body composition (i.e., lean 
mass and fat mass) was determined in conscious mice using an EchoMRI-100 (EchoMRI, 
Houston, Texas). Food intake was monitored by weighing food on lids either during last two 
weeks of light intervention or throughout the five weeks of light exposure (denervation 
experiment). Behavioural activity of mice was assessed with passive infrared detectors and 
recorded using Actimetrics software (Wilmette, IL, USA).
TG and glucose clearance
At the end of the experiments, the clearance of TG and glucose was assessed. Glycerol tri[3H]
oleate ([3H]TO) labeled VLDL-like emulsion particles (80 nm) were prepared as previously 
described [14] and [14C]deoxyglucose ([14C]DG) was added (ratio 3H:14C = 6:1). After 5 weeks 
of light intervention, mice were fasted for 4 h (9AM to 1PM clock time, corresponding to 
Zeitgeber time (ZT) 2-6 for 12 h group and ZT 4-8 for 16 h group) and intravenously injected 
with the radiolabeled emulsion particles (1.0 mg TG in 200 µL PBS) and glucose via the 
tail vein. At time points t=2, 5, 10 and 15 min after injection, blood was taken from the tail 
vein to determine the serum decay of both radiolabels. Immediately after the last blood 
withdrawal, mice were euthanized by cervical dislocation and perfused with ice-cold PBS 
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for 5 min. Organs were harvested, weighed, and the uptake of 3H and 14C radioactivity was 
determined.
Histology
Formalin-fixed paraffin-embedded iBAT and gWAT sections were cut (5 µm). To determine 
gWAT cell size, sections were stained with Mayer’s haematoxylin and eosin. White adipocyte 
size was quantified using ImageJ software. To determine sympathetic activation of iBAT a 
TH staining was performed. Sections were rehydrated and incubated 15 min with 10 mM 
citrate buffer (pH 6.0) at 120°C for antigen retrieval. Sections were blocked with 5% BSA/
PBS followed by overnight incubation with anti-TH antibody (1:2000, AB-112, Abcam) at 
4°C. Next, sections were incubated with a secondary antibody (anti-rabbit antibody, DAKO 
enVision), stained with Nova Red and counterstained with Mayer’s haematoxylin. Percentage 
of area positive for TH staining was quantified using Image J software.
Gene expression analysis and mitochondrial assays
A part of iBAT and sBAT was snap frozen and stored at -80°C for gene expression analysis 
and protein analysis (see below). Total RNA was isolated using TriPure (Roche) according to 
the manufacturer’s instructions. 1 μg of total RNA was reverse-transcribed using M-MLV 
reverse transcriptase (Promega, Madison, WI, USA). Real-time PCR was carried out on a 
CFX96 PCR machine (Bio-Rad) using IQ SYBR-Green Supermix (Bio-Rad). Expression levels 
were normalized to 36B4 as housekeeping gene. Expression of mitochondrial genes was 
measured with quantitative PCR on a Roche Lightcycler 480 using Roche SYBR-green 
mastermix, using mitochondrial specific primers (Table S1). Mitochondrial DNA (mtDNA) 
abundance was quantified as described before [15]. In short, total DNA was extracted from 
sBAT tissue, using the QIAamp DSP DNA Mini Kit (Qiagen). Citrate synthase activity was 
measured in sBAT tissue as described before [16].
Western blot analysis
The iBAT samples stored at -80°C were homogenized in lysis buffer. Samples were diluted 
and denatured for 5 min at 95°C after adding Laemmli Sample Buffer (1:1, vol/vol; Serva, 
Heidelberg, Germany). Proteins within homogenates (15 μg) were separated on a 10% SDS-
page gel and subsequently transferred onto blotting membranes. The blotting membranes 
were blocked with 5% milk powder and incubated overnight at 4°C with the primary antibody 
β-actin, pCREB, pAMPK or pHSL S565 (Cell Signaling). Secondary antibody (anti-rabbit IgG 
HRP conjugate; 1:5000; Promega, Madison, WI, USA) was added and SuperSignal Western 
Blot Enhancer  (Thermo Scientific, Rockford, IL, USA) was used to visualize protein bands. 
Blots were analysed with Bio-Rad Quantity One and normalized to β-actin.
Statistical analysis
Data are presented as means ± SEM. Correlations between two dependent variables 
were made using Pearson’s correlation. Associations of variables with day length were 
assessed by linear regression analysis. Differences between groups were determined 
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using T-tests for normally distributed data. Contribution of light exposure as a covariate 
to body weight gain was analysed by mixed model analysis using IBM SPSS Statistics 
version 20. To assess behavioural activity, actograms were analysed using Clock lab and 
rhythmicity F periodogram analysis was performed on activity bins of 10 minutes of the 
last 10 consecutively recorded days, based on the algorithm of Dörrscheidt and Beck [17]. 
Differences at P values < 0.05 were considered statistically significant.
RESULTS
Entrainment to light schedules
Male 12 week old C57Bl/6J mice, fed ad libitum a regular chow diet, were exposed to 
daily light exposure of either 12 h, 16 h or to 24 h during 5 weeks at a constant ambient 
temperature of 22°C. During the last 2 weeks of light intervention, circadian rhythm in 
behavioural activity was assessed in their home cages. As compared to a day length of 12 h 
(Supplemental Figure 1A), mice exposed to a day length of 16 h showed a retained circadian 
(24 h) rhythm in behavioural activity, with high activity during night-time (Supplemental 
Figure 1B). In contrast, circadian rhythmicity of behavioural activity was largely reduced in 
mice exposed to constant light (Supplemental Figure 1c).
Prolonged daily light exposure increases adiposity without 
increasing food intake
After 5 weeks of light intervention, body weight was determined and body composition 
was assessed by EchoMRI. Prolonged light exposure did not significantly increase total 
body weight (Figure 1a) or lean mass (Figure 1b). Interestingly, we observed a daily light 
exposure-dependent increase in fat mass which reached significance for 24 h versus 12 h 
exposure (+57%; p=0.01; Figure 1c). In fact, duration of light exposure positively correlated 
with the body fat mass (β=0.053; r2=0.21; p=0.02) (Figure 1d). Mixed model analysis of 
weekly body weight development showed that light exposure significantly contributed 
to weight gain (p=0.028). After 5 weeks of light intervention, mice were sacrificed after a 
kinetic experiment with radioactive tracers (see below), and gonadal white adipose tissue 
(gWAT) was quantitatively weighed and examined histologically. A positive correlation 
was found between light exposure duration and gWAT weight (β=0.005; r2=0.20; p=0.02) 
(Figure 1e) as well as average adipocyte size (β=0.08; r2=0.20; p=0.04) (Figure 1f, g). The 
gWAT weight and adipocyte size were significantly increased in mice exposed to 24 h light 
compared to 12 h (+21%; p=0.02 and +21%; p=0.04, respectively). Notably, food intake 
was not different in mice exposed to 16 h light, and even tended to be reduced in mice 
continuously exposed to light (-13%; p=0.08) compared to mice exposed to 12 h light per 
day, (Figure 1h). Therefore, the positive correlation between day length and adiposity is not 
explained by hyperphagia, consistent with our previous observations that exposure of mice 
to constant light decreases energy expenditure rather than increasing food intake [11].
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Figure 1: Mice were exposed to either 12, 16 or 24 h light (n = 9) for 5 weeks, and body weight (a), lean 
mass (b) and fat mass (c) were determined. Correlations are depicted between the light exposure period 
and total fat mass (d), gWAT weight (e) and adipocyte size in gWAT (g). Representative images of gWAT 
stained with haematoxylin and eosin are shown (f). Food intake of the last two weeks of light intervention 
was measured (h). Data are presented as means ± SEM. Dotted lines represent 95% confidence interval of 
the regression line. **p<0.01.
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Prolonged daily light exposure decreases the nutrient uptake by 
brown adipose tissue
To investigate whether prolonged daily light exposure reduces BAT activity, consistent with 
decreased energy expenditure, we determined the effect of light exposure duration on the 
ability of BAT to take up TG-derived free fatty acids and glucose from plasma. Hereto, we 
assessed the kinetics of intravenously injected glycerol tri[3H]oleate ([3H]TO)-labeled VLDL-
like emulsion particles and [14C]deoxyglucose ([14C]DG) and determined the distribution of 
radiolabels at 15 min after injection.
 Prolonged daily light exposure did not substantially alter the kinetics of plasma 
clearance of [3H]TO and [14C]DG (Supplemental Figure 2a,B). In mice exposed to a 12 h 
light per day, the uptake of [3H]TO-derived radioactivity was much higher in the various 
BAT depots (interscapular BAT (iBAT), subscapular BAT (sBAT), and perivascular adipose 
tissue (pVAT)) as compared to liver (~3.5-fold), heart (~10-fold), muscle (~15-fold) and white 
adipose tissue (WAT) (~25-650-fold) (Figure 2a). Interestingly, the uptake of [3H]TO-derived 
activity by iBAT, sBAT and pVAT decreased with prolonged light exposure reaching -47% 
(p=0.001), -34% (p=0.03) and -48% (p=0.01) for 24 h versus 12 h light exposure (Figure 
2a). Accordingly, the day length negatively associated with the uptake of [3H]TO-derived 
activity by iBAT (β=-0.83; r2= 0.32; p=0.002) (Figure 2b), sBAT (β=-0.58; r2= 0.12; p=0.08) 
(Figure 2c) and pVAT (β=-0.90; r2=0.30; p=0.005) (Figure 2d). Prolonged light exposure did 
not alter the uptake of [3H]TO-derived radioactivity by organs other than BAT. Consistent 
with reduced TG-derived free fatty acid uptake by BAT, we found that prolonged light 
exposure associated to increased plasma free fatty acid levels (β= 0.03; r2=0.45; p<0.001) 
(Supplemental Figure 2c).
Prolonged daily light exposure also decreased the uptake of [14C]DG by BAT. As compared 
to 12 h light exposure, 24 h light exposure decreased the uptake of [14C]DG by iBAT (-54%; 
p=0.002), sBAT (-48%; p=0.02) and pVAT (-57%; p=0.001) (Figure 2f). Additionally, 16 h of 
light a day significantly decreased glucose uptake in pVAT (-32%; p=0.04) compared to 12 
h (Figure 2e). Similar to the uptake of [3H]TO-derived radioactivity, day length negatively 
associated with the uptake of glucose by iBAT (β=-0.02; r2=0.26; p=0.007) (Figure 2f), sBAT 
(β= -0.13; r2=0.18; p=0.03) (Figure 2g) and pVAT (β=-0.03; r2=0.42; p=0.0005) (Figure 2h).
Figure 2: (left page) Mice were exposed to either 12, 16 or 24 h light (n = 8-9) for 5 weeks, and the VLDL-
TG and glucose kinetics were assessed by injection of glycerol tri[3H]oleate ([3H]TO)-labeled emulsion 
particles and [14C]deoxyglucose ([14C]DG). Uptake of [3H]TO-derived activity by the various organs was 
determined (a), and correlations were determined between light exposure and [3H]TO-derived activity in 
iBAT (b), sBAT (c) and pVAT (d). Concomitantly, the uptake of [14C]DG by the various organs was determined 
(e), and correlations were determined between light exposure and the uptake of [14C]DG by iBAT (f), sBAT 
(g) and pVAT (h). Data are presented as means ±SEM. Dotted lines represent 95% confidence interval of 
the regression line.*p<0.05, **p<0.01, *** p<0.001. Abbreviations of organs: iBAT, interscapular BAT; sBAT, 




These data imply that prolonged daily light exposure decreases the uptake of nutrients 
from plasma quite specifically by the various BAT depots, indicating that prolonged daily 
light exposure decreases the activity of brown adipocytes.
Prolonged daily light exposure decreases intracellular adrenergic 
signalling in BAT
As the SCN is directly connected to BAT via the sympathetic nervous system, we reasoned 
that prolonged daily light exposure decreases sympathetic activation of BAT. Indeed, 
immunohistochemical analysis of iBAT showed that the amount of tyrosine hydroxylase 
(TH), the rate-limiting enzyme in the synthesis of noradrenalin tended to decrease 
with increasing day length, up to -42% in 24 h compared to 12 h (p=0.10) (Figure 3a,B). 
Additionally, the amount of TH detected in BAT correlated with the uptake of [3H]TO-derived 
activity by BAT (r2=0.17; p=0.056) (Figure 3c) as well as with the uptake of [14C]DG by BAT 
(r2=0.43; p=0.001) (Figure 3d).
Since activation of the β3-adrenergic receptor by noradrenalin increases intracellular 
levels of cyclic AMP (cAMP) which activates protein kinase A (PKA), resulting in 
phosphorylation of cAMP response-binding element (CREB) and activates AMP-activated 
protein kinase (AMPK), we next determined the phosphorylation status of these proteins 
involved in thermogenesis in iBAT. Phosphorylated CREB (pCREB) was decreased in 24 
h light exposure compared to 12 h (-27%; p=0.009) (Figure 3e). Phosphorylated AMPK 
(pAMPK) was decreased in mice on a day length of 16 h (-14%; p=0.05) and 24 h (-32%; 
p=0.002) (Figure 3f, h) compared to 12 h of light exposure per day, independent of total 
AMPK levels (Supplemental Figure 3a,b). Daily light duration negatively associated with 
levels of both pCREB (β= -0.03, r2=0.29, p=0.006) (Figure 3e, h) and pAMPK (β= -0.04, 
r2=0.47, p=0.0003) (Figure 3f,h). Both pAMPK and pCREB induce phosphorylation of the 
lipolytic enzyme hormone-sensitive lipase (HSL). While day length did not affect PKA-
mediated phosphorylation of HSL on serine 563 position (pHSL S563) (Supplemental Figure 
3a,c), it reduced AMPK-mediated phosphorylation of HSL on serine 565 (pHSL S565). A day 
length of 24 h decreased pHSL S565 compared to a day length of 12 h (-39%; p=0.009) and 
day length negatively correlated with pHSL S565 (β= -0.04, r2=0.33, p=0.0031) (Figure 3g, h).
Gene targets of pCREB include peroxisome proliferator-activated receptor 1α 
(PPARGC1α or PGC1α) that drives transcription of genes involved in mitochondrial 
biogenesis, and UCP1, which is essential for BAT thermogenesis. Prolonged daily light 
exposure (24 h vs. 12 h) decreased gene expression of Pgc1α (-55%; p<0.05) (Figure 3I) 
and tended to decrease gene expression of Ucp1 (-37%; p=0.08) (Figure 3J). Increasing day 
length negatively associated with expression of Ucp1 (β= -0.03, r2=0.39, p=0.0005) (Figure 
3j).
Next, we examined the possibility that prolonged light exposure reduces BAT 
thermogenic capacity by decreasing mitochondrial function. Prolonged light exposure did 
not affect gene expression of genes involved in mitochondrial biogenesis (Tfam, Cox7a1, 
Cyc1, Atp5g1), fatty acid oxidation enzymes (Acadvl, Acadl, Acadm) or mitochondrial 
fusion (Mfn2) (Supplemental Figure 4a). Additionally, the amount of mitochondrial DNA 
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Figure 3: Mice were exposed to either 12, 16, or 24 h light (n = 9) for 5 weeks, and interscapular BAT 
was isolated. Histological sections were stained for tyrosine hydroxylase (TH), representative images 
are shown (a; arrows indicate TH staining), and quantified (b). Correlation was determined between TH 
staining and uptake of [3H]TO-derived activity (c) and [14C]DG (d). Also, correlations were determined 
between light exposure and protein levels of pCREB (e), pAMPK (f), and pHSL S565 (g). Protein levels were 
normalized to β-actin levels. Representative blots for β-actin, pCREB, pAMPK and pHSL S565 are shown (h). 
Gene expression of Pgc1α (i) and Ucp1 ( j) were determined and normalized to 36B4 expression. Data are 
presented as means ± SEM. Dotted lines represent 95% confidence interval of the regression line. *p<0.05.
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Figure 4: Mice underwent bilateral sympathetic denervation of iBAT or sham surgery. Denervated 
mice were exposed to either 12, 16 or 24 h light (n = 5-6) while sham mice were exposed to 12 h light 
exposure (n=6). After 5 weeks, iBAT was isolated and histologically stained for tyrosine hydroxylase (TH). 
Representative images are shown (a). Total food intake (b), locomotor activity (c) , body weight gain (d) and 
fat mass gain (e) were determined. VLDL-TG and glucose kinetics were assessed by injection of glycerol 
tri[3H]oleate ([3H]TO)-labeled emulsion particles and [14C]deoxyglucose ([14C]DG). Uptake of [3H]TO-derived 
and [14C]DG activity by sBAT (f,g) and by iBAT was determined (h,i). Data are presented as means ±SEM. ns. 
= not significant, *p<0.05, **p<0.01, *** p<0.001.
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(supplemental figure 4b) as well as citrate synthase activity (supplemental figure 4c) was 
similar between the different light exposure groups. In line with this finding, total BAT 
amount was not different upon prolonged light exposure (supplemental figure 4d).
Together, these data indicate that prolonged daily light exposure reduces sympathetic 
signalling in BAT that is not accompanied by a decrease in mitochondrial capacity, but does 
result in reduced uptake of TG-derived fatty acids and glucose.
Sympathetic denervation of iBAT largely reduces nutrient uptake 
and abolishes effects of prolonged light exposure
To confirm that sympathetic outflow is crucial for the observed effects of prolonged daily 
light exposure, we performed selective, bilateral denervation of the iBAT prior to exposing 
mice to 12, 16 or 24 h light per day. A reference group of mice underwent sham surgery and 
were exposed to 12 h light per day. Denervation completely abolished sympathetic input 
into iBAT, as evidenced by absence of TH (Figure 4a). In line with the previous experiment, 
light exposure did not affect food intake (Figure 4b). Additionally, spontaneous locomotor 
activity was similar between all groups (Figure 4c). Interestingly, body weight gain only 
increased in mice that were subjected to 24 h light exposure (Figure 4d). This increase was 
likely due to increased fat mass gain in these animals (Figure 4e).
Next, iBAT and sBAT activity was investigated by determining the ability to take up 
TG-derived fatty acids and glucose from plasma by injection of radiolabeled particles as 
described above. While the uptake of [3H]TO and [14C]DG by non-denervated sBAT remained 
high (Figure 4f and Figure 4g resp.), specific iBAT denervation lowered the uptake of [3H]
TO-derived activity (Figure 4h) and [14C]DG (Figure 4i) by iBAT with approximately 70-80% 
compared to sham operated animals (p<0.001), indicating the importance of noradrenergic 
input in BAT activity. Importantly, prolonged daily light exposure did not further decrease 
the uptake of [3H]TO and [14C]DG. These data indicate the reduction in adrenergic signalling 
may be causal in the negative correlations of hours of light exposure and BAT activity.
DISCUSSION
This study addressed the effect of daily light exposure (12, 16 and 24 h) on energy metabolism 
in chow-fed C57Bl/6J mice. We show that prolonging the daily light exposure increases 
adiposity and reduces the uptake of TG-derived fatty acids and glucose specifically by BAT, 
accompanied by decreased ß-adrenergic signalling in BAT and decreased phosphorylation 
of intracellular proteins involved in thermogenesis.
Daily light exposure duration positively associated with body fat mass and white 
adipocyte hypertrophy. These data are in line with observations in field voles, switching the 
day length from 8 h to 16 h increased body weight by 24% in 4 weeks compared to animals 
that remained on a day length of 8 h [18]. Accordingly, we previously showed that prolonging 
day length from 12 h to 24 h decreases energy expenditure in mice without increasing 
food intake or locomotor activity [11]. Although acute light exposure at night can reduce 
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locomotor activity [19] and prolonged light exposure affects wheel running activity [20, 21], 
our present study confirms previous reports from us [11] and others [22] that prolonged 
light exposure does not decrease spontaneous locomotor activity. Together, these studies 
support the idea that prolonged daily light exposure increases body fat mass through a 
decrease in energy expenditure rather than to an increase in food intake or decrease of 
locomotor activity.
The present study strongly suggests that prolonged daily light exposure increases 
adiposity due to attenuation of BAT activity as reflected by the negative association 
between daily light exposure and the uptake of fatty acids and glucose by several BAT 
depots. Of note, prolonged daily light exposure did not affect uptake of nutrients by other 
metabolic organs, such as WAT. These data are consistent with our recent findings that 
attenuating BAT activity by inhibiting the central melanocortin system also reduces the 
influx of nutrients into BAT [23]. In fact, activation of BAT, e.g. by cold exposure, increases 
expression of genes involved in fatty acid oxidation, glucose uptake and lipogenesis [24] 
and strongly increases the uptake of TG-derived fatty acids [25] and glucose [24].
Our data are consistent with the hypothesis that prolonged daily light exposure 
decreases BAT activity through reduction of the sympathetic outflow towards BAT. Tyrosine 
hydroxylase (TH), the rate limiting enzyme in noradrenalin production, correlates with 
nutrient uptake by BAT and we observed a decrease in sympathetic signalling pathways in 
BAT. Prolonged light exposure decreased phosphorylation of CREB and AMPK, two main 
targets of β3-adrenergic signalling in the brown adipocyte. AMPK not only modulates 
intracellular lipolysis by phosphorylation of HSL, but also regulates uptake of lipids and 
glucose by inducing translocation of CD36, LPL and GLUT4 to the plasma membrane [26, 
27], which may explain the reduced nutrient uptake by BAT. Moreover, we showed that in 
the absence of sympathetic input, BAT activity is equal among the various light exposure 
groups.
We propose that the SCN directly mediates the decrease in sympathetic outflow upon 
prolonging daily light exposure. In previous studies we demonstrated that prolonged light 
exposure dampens the amplitude of electrical activity in the SCN in vitro [28] and in vivo 
[10]. Interestingly, the amplitude of electrical activity in the SCN is linked to sympathetic 
outflow towards multiple organs [29]. This mechanism also explains previous findings that 
exposure of mice to dim light (5 lux) during 10 h nights for 4 weeks already results in an 
increase in body weight, which was accompanied by an attenuated amplitude of circadian 
gene expression in the hypothalamus [30]. Also, sympathetic outflow towards BAT depots 
other than interscapular BAT would explain our observations that denervation of iBAT 
does not increase body weight. Only 24 h light exposure decreases sympathetic outflow 
to such an extent, that mice increase significantly in body weight. Of note, the effects of 
light exposure on BAT are independent of melatonin secretion, since C57Bl/6J mice are 
genetically melatonin deficient [31]. However, we cannot exclude the possibility that in 
humans melatonin does play a role in the association between light pollution and adiposity 




Based on our collective data, we thus propose the following mechanism by which 
prolonging daily light exposure increases adiposity: prolonged day length dampens the 
SCN amplitude thereby lowering sympathetic outflow towards BAT resulting in decreased 
β3-adrenergic signalling and thermogenesis in brown adipocytes. As a consequence, the 
uptake of VLDL-TG derived fatty acids and glucose by BAT is reduced. The decreased 
Figure 5: Proposed model on how light exposure modulates body fat mass through brown adipose 
tissue activity. Daily light exposure duration is perceived by the suprachiasmatic nucleus, that signals 
towards BAT via the sympathetic nervous system. At normal day length uptake of nutrients by BAT and 
WAT is in balance, while increasing daily light exposure result in reduced BAT activation and subsequent 
storage of excess energy in WAT. The decrease in noradrenaline (NA) availability for stimulation of the β3-
adrenergic receptor (B3-AR) leads 1) reduced phosphorylation of CREB, which decreases transcription 




combustion of fatty acids by BAT at equal energy intake thus results in a positive energy 
balance and therefore storage of lipids in WAT (Figure 5).
Recent evidence suggests that BAT activity in humans is physiologically regulated by 
the biological clock. The detectability of BAT by [18F]fluorodeoxyglucose (FDG)-PET-CT 
imaging at room temperature follows a circannual cycle, both in the northern and southern 
hemisphere [35-37], with low detectability of BAT in summer (i.e., short day) as compared 
to winter (i.e., long day). Although differences in outside temperature over the year would 
be a likely explanation for this phenomenon, the detectability of BAT showed a stronger 
correlation with day length than with outside temperature [35]. Based on our present data, 
the daily light exposure may thus well explain the circannual cycle of BAT detectability. 
Likewise, impaired BAT activity may also explain, at least partly, the relationship between 
obesity and disturbances in circadian rhythmicity in humans by light pollution [2, 3, 38], 
and possibly also by shift work [39-41] and sleep curtailment [1, 42, 43]. Additionally, our 
data may provide the link in the relationship between exposure to light in the bedroom and 
obesity [4]. The suggested causal relationship has clear implications for the prevention of 
obesity in humans. Although the association between light in the bedroom and BAT activity 
in humans remains to be investigated, future lifestyle advice could include instructing 
people to darken their bedroom.
In conclusion, our study provides evidence that prolonged daily light exposure 
increases body fat mass through reduction of BAT activity. The present findings support 
the hypothesis that the relationship between disturbed circadian rhythmicity and adiposity 
in humans is mediated by impaired BAT activity.
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Supplemental Figure 1. Prolonged daily light exposure affects behavioural rhythms in mice. Mice were 
exposed to either 12, 16 or 24 h light (n = 9) for 5 weeks, and behavioural activity was monitored by passive 
infrared detectors. Representative actograms (left panels) and the pertaining F periodogram (right panels) 
are shown of a mouse exposed to 12 (a), 16 (b) and 24 h (c) of light. The double-plotted actograms show 
consecutive days on successive lines and the vertical black upticks indicate behavioural activity measured 
by passive infrared detectors. The light regimes are plotted on top of the actograms; white areas represent 
light and black areas represent darkness. Periodogram analysis visualizes the strength of behavioural 
rhythmicity. The dotted lines in the periodograms indicate the 0.05 level of significance.
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Supplemental Figure 2. Effect of light exposure on TG and glucose plasma clearance. Prolonged daily 
light exposure does not affect TG and glucose plasma clearance. Mice were exposed to either 12, 16 or 
24 h light for 5 weeks, and the VLDL-TG and glucose kinetics were assessed by injection of glycerol tri[3H]
oleate ([3H]TO)-labeled emulsion particles and [14C]deoxyglucose ([14C]DG). Blood was drawn 2, 5, 10 and 
15 min after injection. [3H]TO (n=8-9) (a) and [14C]DG (n=6-7) (b) derived activity was assessed in plasma 
samples by liquid oscillation counting. Data are represented as means ±SEM. Statistical significance was 
determined by unpaired two-tailed Student’s t-test.
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Supplemental Figure 3. Prolonged daily light exposure does not affect AMPK and pHSL S563 in BAT. 
Prolonged daily light exposure does not affect AMPK and pHSL S563 in BAT. Mice exposed to either 12, 16, 
or 24 h light (n= 9) for 5 weeks, and interscapular BAT was isolated for protein quantification. Representative 
western blots are shown for β-actin, total AMPK and pHSL S563 (a). Correlation was determined between 
hours of light exposure and protein levels of AMPK (b) and pHSL S563 (c). Protein levels were normalized 
to β-actin levels. Data are represented as means ± SEM. Statistical significance between groups was 
determined by unpaired two-tailed Student’s t-test, linear regression analysis was performed to analyse 
the association of gene expression with light exposure.
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Supplemental Figure 4. Effects of prolonged light exposure on mitochondrial function. Prolonged daily 
light exposure does not decrease structural mitochondrial function in BAT and quantity of BAT. Mice were 
exposed to either 12, 16, or 24 h light (n= 9) for 5 weeks, and interscapular and subscapular BAT was isolated 
for gene expression and mitochondrial function analysis. Expression of genes involved in mitochondrial 
biogenesis, fatty acid oxidation and fusion genes did not change upon prolonged light exposure (a). The 
same is true for relative mitochondrial DNA quantity (b) and mitochondrial citrate synthase activity (c). 
iBAT was removed quantitatively and weighed (d). Gene expression levels were normalized to 36B4 levels. 
Mitochondrial DNA quantity is expressed as ratio of mitochondrial gene expression relative to nuclear 
gene expression (genes indicated below). Data are represented as means ± SEM. Abbreviations: Tfam, 
transcription factor A, mitochondrial; Cox7a1, cytochrome c oxidase subunit VIIa 1; Cyc1, cytochrome C-1; 
Atp5g1, ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1; Acadvl, acyl-Coenzyme 
A dehydrogenase, very long chain; Acadl, acyl-Coenzyme A dehydrogenase, long-chain; Acadm, 
acyl-Coenzyme A dehydrogenase, medium chain; Mfn2, mitofusin 2; mtCo2, cytochrome c oxidase II, 
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ABSTRACT
Brown adipose tissue (BAT) activation leads to a fast removal of lipids from the circulation 
in order to produce heat. Recently, diurnal BAT activity was demonstrated to determine 
rhythms in daily body temperature and glucose handling. In this paper, we have characterized 
the involvement of diurnal BAT activitiy in plasma lipid metabolism. We observed a high 
amplitude 24h rhythm in the fatty acid uptake by BAT with highest uptake at the onset of 
the active period coinciding with high LPL expression and low Angptl4 expression. Diurnal 
rhythmicity in BAT activity dictated a daily rhythm in plasma lipid concentrations as well as 
lipid clearance. Strikingly, in mice as well as humans we found postprandial lipid excursions 
to be nearly absent at the onset of the active period and high before sleep, consistent with 
the diurnal BAT activity pattern. We anticipate that restriction of food intake to the early 




Brown adipose tissue (BAT) is a key site of mammalian thermogenesis and its activity is 
critical for the survival of small mammals in cold environments and for arousal in hibernators. 
Heat arises primarily from mitochondrial uncoupling during the combustion of intracellularly 
stored lipids. To replenish these lipid stores, brown adipocytes take up triglyceride (TG)-
derived fatty acids (FA) from the circulation in a lipoprotein lipase (LPL)-dependent matter. 
Activation of BAT results in increased energy expenditure (EE) and a marked lowering of 
plasma TG levels [1, 2]. Therefore, BAT activation is considered a target for the treatment of 
metabolic disorders.
Recent studies linked control of the daily rhythm in body temperature of mice and their 
ability to adapt to cold to diurnal BAT activity [3, 4], which is consistent with earlier reports 
demonstrating circadian expression of clock genes in murine BAT [5] and oscillations in 
glucose uptake as determined by PET-FDG imaging [6]. Notably, human brown adipocytes 
also exhibit a rhythm in clock gene expression and glucose uptake [7]. Interestingly, in 
both mice [8] and humans [9, 10] variations in daily light exposure (LE) associate with the 
thermogenic capacity of BAT, suggesting plasticity in diurnal BAT activity.
We [11] and others [12] have shown that plasma lipid concentrations are highly rhythmic 
independent of food intake behavior, suggesting oscillations in the clearance of lipids by 
metabolic organs. Given the relevance of BAT function for lipoprotein metabolism [1, 13], 
we hypothesized that physiological diurnal rhythmicity of BAT activity regulates fasting and 
postprandial lipid concentrations. The aim of the present study was to unravel the diurnal 
rhythm of lipid uptake by BAT and its consequence for (postprandial) lipid handling, by 
performing studies in mice as well as in healthy humans.
METHODS
Animal Husbandry
Local ethics committee approved all animal experiments. Mice were single housed at 
22°C room temperature and fed ad libitum. Wild-type mice were fed standard laboratory 
chow (Special Diets Services, UK), APOE*3-Leiden.CETP mice were fed Western-type diet 
(WTD; 35% energy from fat; supplemented with 0.1% cholesterol; AB Diets, Woerden, The 
Netherlands).
Wild type mice experiments
12 week old male wild-type mice (C57Bl/6J background; Charles River) were housed on 12h 
light: 12h dark cycle (normal daily light exposure (LE), 8h light: 16h dark cycle (short daily 
LE) or a 16h light: 8h dark cycle (long daily LE) (n=24 per group). After five weeks, the uptake 
of triglyceride (TG)-derived fatty acid (FA) by metabolic organs was assessed (see below) 
at time points ZT (Zeitgeber Time, time after lights on) 0, 4, 6, 8, 12 and 18h. At the end of 
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this experiment, mice were killed and organs were collected for gene / protein expression 
analysis (see below).
In an addition group of male C57Bl/6J mice, 24 h rhythms in food intake, energy 
expenditure and substrate utilization was determined by means of indirect calorimetry 
in metabolic cages (PhenoMaster, TSE systems, Bad Homburg, Germany) containing 
automatized scales placed inside the calorimeters. All mice were first measured at 12h 
LE and subsequently housed in light tight cabinets and split into two groups which were 
acclimated to either short or long LE for five weeks. During the last week, mice were again 
housed in metabolic chambers to assess the effects of LE on energy metabolism.
Dyslipidemic mice experiments
Homozygous human cholesteryl ester transfer protein (CETP) transgenic mice were 
crossbred with hemizygous APOE*3-Leiden mice at our Institutional animal facility to 
obtain APOE*3-Leiden.CETP mice (C57Bl/6J background). Female mice were used as 
these specifically develop high levels of plasma triglycerides and cholesterol. Mice of 9-12 
weeks old were fed Western-type diet (WTD; caloric energy: 35% fat, 17% protein, 48% 
carbohydrates; addition of 0.1% cholesterol; AB Diets, Woerden, the Netherlands). After 
3 weeks, mice were matched for body weight and plasma TG and adapted to either short 
or long daily LE (n=27/group). In a subset of mice (n=5/group) a telemetric transmitter was 
implanted under isoflurane anesthesia. A small incision was made between the shoulder 
blades via which a TA-F10 miniature transmitter (Data Sciences International, MN, USA) 
was inserted subcutaneously in the flank. Data acquisition was performed using Dataquest 
A.R.T. TM Software (Data Sciences International). In the same subset of mice, after four 
weeks, seven consecutive blood samples via venous tail bleeding were obtained at time 
points ZT 0, 4, 8, 12, 16, 20, 24 and one week later, stress-free blood samples were obtained 
at ZT0, 8 and 16 by drawing blood within one minute of handling the mouse. Fasting and 
postprandial lipids were determined either at ZT 0, 8 or 16 (see below). After five weeks, 
the uptake of TG-derived FA by metabolic organs and clearance from the circulation was 
determined (see below) at the same time points.
For experiments at thermoneutrality, an additional group of APOE*3-Leiden.CETP 
mice was adapted to normal LE (n=7-8/group), fed a WTD for 3 weeks and switched to an 
environmental temperature of 30°C. After 2 days, postprandial lipid response experiment 
was performed and after four days, uptake of TG-derived FA and clearance was determined.
Rev-erbα-/- mice and control littermates were maintained on a 12 h light: 12 h dark 
cycle at thermoneutrality (30°C). iBAT was collected from 12-14 week old male mice at 
thermoneutrality at ZT10 or following a 6 hour 4°C cold exposure (ZT4-ZT10) for gene 
expression analysis.
Postprandial lipid response
To determine the postprandial lipid response, mice were fasted for 4h prior to the start 
of the experiment, after which a fasting blood sample via tail vein bleeding was drawn. 
Immediately thereafter, mice received an intragastric bolus of 200 µL olive oil (Carbonell, 
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Cordoba, Spain). Blood was collected after 1, 2, 4 and 8h to determine plasma lipid 
concentrations .
TG-derived FA uptake
Glycerol tri[3H]oleate-labeled lipoprotein-like particles (80 nm) were prepared as previously 
described[2, 14]. Mice were fasted for 4h prior to the start of the experiment, which started 
with an intravenous injection of radiolabeled particles (1.0 mg TG in 200 µL PBS). Blood was 
collected after 2, 5, 10 and 15 minutes to determine plasma decay of the radiolabel. After 
15 minutes, mice were killed by cervical dislocation, perfused with ice-cold PBS and organs 
were harvested. The uptake of [3H]oleate by metabolic organs was determined.
Indirect calorimetry and food intake
For the measurements of food intake, energy expenditure and respiratory exchange ratio, 
male C57Bl/6J mice fed chow diet were previously acclimated to the indirect calorimeters 
for a 2-day period. All experiments took place at 22°C, while food and water were provided 
ad libitum. Data points were collected at 20-min intervals.
Biochemical analyses
Mouse blood was collected into chilled paraoxon-coated capillaries to prevent ex vivo 
lipolysis. Capillaries were centrifuged at RT and plasma was isolated and stored at -80°C. 
Human blood samples were kept at RT for 1 h after collection. Serum was isolated and 
aliquoted into 500 µL tubes and stored at -80°C. Plasma was assayed using a commercially 
available enzymatic kit for TG (Roche Diagnostics, Mannheim, Germany) and free FA 
(NEFA-C kit, Wako Diagnostics, Instruchemie, Delfzijl, the Netherlands). Corticosterone 
measurements were performed in 2 µL blood samples by high sensitivity enzyme 
immunoassay according to the manufacturers’ protocol (Immunodiagnosticsystems, UK, 
kit reference: Ref AC-15F1).
Gene and protein expression
A part of iBAT was snap frozen and stored at -80°C for gene expression analysis. Total RNA 
was isolated using TriPure (Roche) according to the manufacturer’s instructions. 1 μg of 
total RNA was reverse-transcribed using M-MLV reverse transcriptase (Promega, Madison, 
WI, USA). Real-time PCR was carried out on a CFX96 PCR machine using IQ SYBR-Green 
Supermix (Bio-Rad). Melt curve analysis was included to assure a single PCR product 
was formed. Expression levels were normalized to 36b4 and Hprt housekeeping gene 
expression. Data was plotted as relative expression to expression in normal 12h daily LE 
group at ZT0.
To extract proteins, BAT was lysed in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 
1% NP-40, 1% sodium deoxycholate and 1% SDS; Thermo Fisher-Scientific, Landsmeer, 
the Netherlands) supplemented with cOmplete protease and phosSTOP phosphatase 
inhibitors (Roche Diagnostics, Almere, the Netherlands) with the Qiagen Tissuelyser II 
(Qiagen, Venlo, the Netherlands). Upon homogenization, lysates were placed on ice for 
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30 minutes and centrifuged 4 times at 13,000 rpm for 10 min at 4˚C to remove fat and 
cell debris. Protein concentrations were determined by using a bicinchoninic acid (BCA) 
assay (Thermo Fisher-Scientific). Equal amounts of protein (11.25 μg (LPL/HSP90) or 40 
μg (ANGPTL4) protein per lane) were combined with 2x Laemmli sample buffer, boiled at 
95˚C for 5 minutes, and loaded onto 8-16% (LPL/HSP90) or 10% (ANGPTL4) Criterion 
gradient gels (Bio-Rad, Veenendaal, The Netherlands). Next, proteins were transferred onto 
a PVDF membrane using the Transblot Turbo System (Bio-Rad). Membranes were probed 
with a goat anti-mouse LPL antibody (kind gift from André Bensadoun); a rabbit anti-
mouse HSP90 antibody (Cell Signaling Technology, #4874); or a rat anti-mouse ANGPTL4 
antibody (Adipogen, Kairos 142-2) at 1:5000 (LPL), 1:2000 (HSP90) or 1:1000 (ANGPTL4) 
dilution. Tris-buffered saline, pH 7.5, with 0.1% Tween-20 (TBS-T) and 5% w/v skimmed 
milk was used to block membranes and for primary and secondary antibody incubations. In 
between, membranes were washed in TBS-T only. Imaging of western blots was performed 
with the ChemiDoc MP system (Bio-Rad) and Clarity ECL substrate (Bio-Rad). Western blot 
quantifications were done with Image Lab software (Bio-Rad).
Mature glycosylated LPL (LPL in the Golgi and on the cell surface) was determined by 
digesting 40 μg of protein with EndoH (New England BioLabs) according to the manufacturer’s 
instructions. Briefly, BAT protein lysates were combined with glycoprotein denaturing buffer 
and boiled for 10 minutes at 95˚C. Following the addition of EndoH, the samples were 
incubated at 37 ˚C for 1h and, subsequently, combined with 5x Laemmli sample buffer, 
boiled at 95˚C for 5 minutes and loaded onto 10% Criterion gradient gels (Bio-Rad) for 
analysis by western blotting as described above. EndoH-resistant LPL represents mature 
glycosylated LPL located in the Golgi or on the cell surface, whereas EndoH-sensitive LPL 
represents LPL located in the endoplasmic reticulum with oligosaccharide side chains high 
in mannose residues [15].
Human study
As described in more detail previously, 38 healthy participants were recruited within the 
Switchbox study for in-depth endocrine and metabolic phenotyping, which included 
diurnal venous blood sampling as described in more detail earlier [16]. To be included in 
the Switchbox study, participants had to have a fasting glucose level <7 mM, hemoglobin 
level <7.1 mM, a body mass index (BMI) between 19 kg/m2 and 33 kg/m2 and had to be free 
of any significant chronic disease. Of the 38 participants, one participant was excluded 
because of a newly diagnosed hypertriglyceridemia, leaving 37 participants for the present 
study. After an overnight fast of 10-14 h, a catheter was inserted before start of the study, 
and blood sampling started at 09:00h. Every 10 min 1.2 mL of blood was collected in a K3-
EDTA tube and 2 mL of blood in a serum separator (SST)-tube. Participants received three 
standardized liquid meals at 09:00h, 12:00h and 18:00h during a day. All meals consisted 
of 600 kcal Nutridrink, containing a standard percentage of energy derived from fat (35%), 
carbohydrates (49%) and protein (16%) (Nutricia Advanced Medical Nutrition, Zoetermeer, 
the Netherlands). All participants were sampled in the same room with standardized ambient 
conditions, 630 ± 10 lux of light intensity and 22 ± 2 °C. Participants were not allowed to 
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sleep during the day, and except for lavatory use no physical activity was allowed during 
the study period. Lights were turned off between 23:00h to 08:00h to allow the participants 
to sleep.
Statistical analysis
Data are presented as means ± SEM. Statistical analysis was performed using Student’s 
T-test, one-way ANOVA with Tukey’s post-hoc test, two-way ANOVA and repeated measure 
(RM) ANOVA with Dunnett’s post-hoc test to compare time points within the series (relative 
to ZT0). Associations of variables with daily LE (expressed as hours of LE) as independent 
variable were assessed by linear regression analysis. Differences at p<0.05 were considered 
statistically significant. Analyses were performed using GraphPad v6.0 software (Prism, La 
Jolla, CA, USA). Differences at p<0.05 were considered statistically significant.
RESULTS
The 24h rhythm of fatty acid uptake is most pronounced in BAT
We determined the time-dependent uptake of fatty acids (FA) by BAT and other metabolic 
organs in male 12-week old C57Bl/6J mice housed under a standard 12:12 light-dark 
cycle (hereafter referred to as “Normal light exposure (LE)”). Since FA are predominantly 
transported in plasma as a constituent of triglycerides (TG) within lipoproteins, we assessed 
the kinetics of intravenously injected glycerol tri[3H]oleate-labeled TG-rich lipoprotein-like 
particles at six different times of the day (Zeitgeber times (ZT), lights turned on at ZT0) 
following a 4h fasting period. We found that the time of day during which the experiments 
took place determined the uptake of [3H]oleate ([3H]FA) in liver, subcutaneous white adipose 
tissue (sWAT), gonadal WAT (gWAT), heart, muscle, and especially in perivascular adipose 
tissue (pVAT, representing a mixture of white and brown adipocytes [17]), subscapular BAT 
(sBAT) and interscapular BAT (iBAT) (all pZT≤ 0.01; Fig. 1a-h, Table 1). The uptake of [3H]FA 
by sBAT and iBAT reached its peak at the onset of the dark period (ZT12) and was relatively 
high compared to the other metabolic organs. The difference between the maximum and 
minimum [3H]FA uptake was 4-, 12- and 15-fold for iBAT, sBAT and pVAT, respectively (Table 
1). From these data, we concluded that compared to other metabolic organs BAT depots 
specifically display a marked 24h rhythmicity regarding TG-derived FA uptake.
The 24h rhythm of fatty acid uptake by BAT adapts to daily light 
exposure duration
To determine the adaptability of diurnal BAT activity to environmental changes, we 
compared the diurnal [3H]FA uptake by metabolic organs under normal LE vs. the uptake 
in mice entrained to either a short daily LE (8h light : 16h dark cycle) or a long daily LE (16h 
light  : 8h dark cycle). Interestingly, the duration of LE changed the daily pattern in uptake 
of [3H]FA by the brown adipocyte depots pVAT (pLE = 0.014), sBAT (pLE =0.009) and iBAT 
(pLE=0.003) (Fig. 1f-h), but not in other metabolic organs (Fig. 1a-e).
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Irrespective of the daily LE period, highest [3H]FA uptake by iBAT and sBAT was 
reached around the onset of the dark period (Fig. 1g-h and Table 1). Notably, short daily LE 
increased the area under the curve for [3H]FA uptake (Supplementary Fig. 1a) and increased 
the average daily [3H]FA uptake of all time points by iBAT (+90%; p=0.016), sBAT (+107%; 
p=0.028) and pVAT (+130%; p=0.030) compared to long daily LE (Supplementary Fig. 1b). 
The LE length negatively correlated with the average [3H]FA uptake by iBAT (p=0.006, 
R2=0.11), sBAT (p=0.010, R2=0.11) and pVAT (p=0.011, R2=0.10) (Supplementary Fig. 1c-e) 
but not by other metabolic organs (not shown).
We previously showed that LE duration affects FA uptake by BAT via sympathetic 
outflow [8]. However, LE can also induce behavioral adaptations in food intake behavior 
and physical activity patterns [18]. Since we observed that adaptation of behavioral activity 
patterns to short and long LE (Supplementary Figure 1f-g), we further investigated the 
adaptations of whole energy metabolism in an additional group of mice housed at normal 
LE by diurnal measurements of EE, respiratory exchange rate (RER, a surrogate of substrate 
utilization), food intake, and ambulatory activity. Both calorimetric and behavioral rhythms 
showed distinct 24h patterns (Fig. 2a, c, e, g), with a sharp rise in food intake and ambulatory 
activity at the start of the dark period and a secondary peak in the last 4 h of the dark 
period. During the light period, food intake and ambulatory activity were nearly absent and 
RER was low, reflecting the resting period of mice. Subsequently, the mice were entrained 
to either short or long daily LE. Animals adapted to short LE displayed a longer period of 
wakefulness compared to long LE, as evidenced by the extended ambulatory activity and 
food intake duration in the dark period, which was accompanied by increased 24h EE (+15%, 
p=0.050, Fig. 2b), RER (+2%, p=0.012, Fig. 2d) and ambulatory activity (+90%, p<0.001 Fig. 
2h). However, despite changes in food intake patterns, total daily food intake was similar 
between the groups (Fig. 2f). Correlation analysis revealed strong positive correlations 
between EE and ambulatory activity (R2=0.91 (short LE), R2=0.80 (long LE); p<0.001), and 
to a lesser extent also between EE and food intake (R2=0.74 (short LE) R2=0.91 (long LE); 
p<0.001) in both short and long LE (Supplementary Fig. 2). Together, these data demonstrate 
that LE duration induces adaptations of diurnal BAT activity and concomitantly in diurnal 
patterns of ambulatory activity and food intake, which are reflected in the rhythm in total 
EE. Since these changes occur simultaneously, we cannot conclude whether behavioral 
and metabolic effects are causally related. FA uptake by BAT was generally determined 
Figure 1. (left page) Diurnal rhythm of TG-derived FA uptake by BAT adapts to daily light exposure. 
Wild-type mice were entrained to daily light exposure (LE) regimes of 8h (short LE), 12h (normal LE) or 16h 
(long LE) at standard 22°C ambient temperature for 5 weeks. Mice were injected with glycerol tri[3H]oleate-
labeled lipoprotein-like particles at 6 time points (n=4/group) and killed 15 min after the injection. The 
uptake of [3H]oleate was determined for liver (a), subcutaneous white adipose tissue (sWAT) (b), gonadal 
WAT (gWAT) (c), heart (d), skeletal muscle (e), perivascular adipose tissue (pVAT) (f), subscapular brown 
adipose tissue (sBAT) (g) and interscapular BAT (iBAT) (h). Times are given as Zeitgeber times (ZT) in hours 
with onset of light period at ZT0. Data are presented as means ±SEM and ZT0/ZT24 was double plotted 
for visualization purposes. pZT, pLE and pI represent p-values for the factors Zeitgeber Time, daily LE and 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2. Indirect calorimetry of mice adapted to normal, and short or long daily light exposure. 
Indirect calorimetry of mice adapted to normal, and short or long daily light exposure. Wild-type mice 
were entrained to a daily light exposure (LE) regime of 12h (normal LE) and energy expenditure (EE; a), 
respiratory exchange ratio (RER; c), food intake (e) and ambulatory activity (g) were determined by means of 
indirect calorimetry. Subsequently mice were adapted to daily LE regimes of 8h (short LE) or 16h (long LE) 
and the same factors were measured (b, d, f, h). Data points in the curves represent 1h binned values over 
a total of three consecutive days. Bars represent the average daily value. Data are presented as means ± 
SEM of 15-16 mice. *p<0.05, ***p<0.001 (two-tailed independent samples T-tests).
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after a standardized 4h fasting period designed specifically to avoid confounding factors 
caused by recently ingested food. When experiments were repeated following an 8h fast, 
the results were similar to 4h of fasting (Supplementary Fig. 3). Therefore, the length of 
fasting did not determine the difference in FA uptake by BAT between morning and evening.
The 24h rhythm in fatty acid uptake by BAT is reflected by 
rhythmicity in LPL and ANGPTL4 levels
Since BAT displayed such a remarkable daily rhythm in TG-derived FA uptake and adaptation 
to light-dark cycles, we investigated possible regulatory pathways in iBAT. At the cellular 
level, clock proteins drive tissue-specific rhythmic gene expression, which has been 
extensively studied in vitro and in vivo for liver tissue [19, 20], but only to a limited extent 
for BAT [5, 21, 22]. We first confirmed diurnal expression of the clock genes Rev-erbα (Fig. 
3a) and Per2 (Fig. 3b), both of which are known to have a role in BAT thermogenesis [3, 
4]. Next, we assessed expression of a broad set of genes involved in BAT thermogenesis 
(Supplementary Figure 3a). We observed marked diurnal rhythms in expression of 
transcription factors (Pgc1α and Prdm16) and genes involved in thyroid hormone signaling 
(Dio2 and Thrα1). To a lesser extent, rhythms were found in the beta-adrenergic receptor 
(Adrb3) and fatty acid transport and metabolism genes (Fatp1, Elovl3, Hsl, Atgl, Vldlr), while 
expression of mitochondrial genes and beige adipose markers were mostly independent 
of time. Expression of the key thermogenic gene Ucp1 was found to be rhythmic with 
an advanced peak in short LE (Fig. 3c). Importantly, the expression pattern of lipoprotein 
lipase (Lpl), an enzyme crucial for the uptake of TG-derived FA [1], was rhythmic (Fig. 3d), 
correlated with the [3H]FA uptake by iBAT (R2=0.1833; p<0.001; Supplementary Fig. 3a), 
and was inverse to its repressor angiopoietin-like 4 (Angptl4) [23] (Fig. 3e). Consistent with 
the gene expression pattern, protein levels of total LPL as well as active LPL were highest 
at the onset of the dark period and the diurnal pattern adapted to the daily LE. Total LPL 
levels correlated with the [3H]FA uptake by iBAT (R2=0.5258; p<0.001; Supplementary Fig. 
3b), while ANGPTL4 levels displayed an inverse rhythm reaching a peak at the onset of the 
light period (Fig. 3f-i). In particular, the levels of mature glycosylated LPL, representing LPL 
located in the Golgi or on the cell surface sensitive to ANGPTL4 [23], were regulated by the 
daily LE duration (Fig. 3i). Interestingly, while repression of Ucp1 expression was previously 
Figure 3. (right page) Diurnal rhythm in BAT lipoprotein lipase and angiopoietin-like 4 adapts to daily 
light exposure. Wild-type mice were entrained to daily light exposure (LE) regimes of 8h (short LE), 12h 
(normal LE) or 16h (long LE) at standard 22°C ambient temperature for 5 weeks. Interscapular brown 
adipose tissue (iBAT) was harvested at six time points (n=4/group). Gene expression was determined by 
qPCR, calculated relative to 36b4 and Hprt expression, and normalized to mean expression of ZT0 of 
normal LE group (a-e). Protein levels were determined by Western blot as normalized to HSP90 (f-i). Amount 
of mature glycosylated LPL protein was determined by EndoH digestion. EndoH-sensitive LPL (ER LPL) is 
indicated with S; EndoH-resistant LPL (Golgi and cell surface LPL) is indicated with R (i). Data are presented 
as means ± SEM and ZT0/ZT24 was double plotted for visualization purposes. pZT, pLE and pI represent 
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found to be dependent on the rhythmic expression of clock gene Rev-erbα [3] this was not 
the case for expression of Lpl and Angptl4 (Supplementary Fig. 3d).
The diurnal rhythm in FA uptake by BAT determines diurnal 
variations in plasma lipid levels and postprandial lipid responses 
in a mouse model of human lipoprotein metabolism
Activation of BAT has been shown to lower plasma TG levels [1, 13, 24]. Therefore, we next 
investigated the effect of the physiological rhythm in BAT activity on daily plasma TG and FA 
levels. To this end we used female APOE*3-Leiden.CETP mice, which is a well-established 
model for human-like lipoprotein metabolism [13, 25]. We first confirmed that these mice 
adapt to LE regimes in a similar fashion as wild-type mice. Mice were entrained for 5 weeks 
to short or long daily LE of which a subset was equipped with telemetric transmitters to 
monitor rhythms in ambulatory activity and in addition core body temperature. In both 
groups, ambulatory activity and body core temperature displayed a diurnal pattern, with a 
rise in ambulatory activity at the start of the dark period (Fig. 4a) and a rise in temperature 
just before the onset of dark period (Fig. 4c). In contrast to the wild-type animals, adaptation 
to the LE regimes did not affect total 24h ambulatory activity (Fig. 4b). Also the average body 
temperature remained unaffected (Fig. 4d). These adaptations were accompanied by a peak 
in corticosterone plasma concentrations at the onset of the dark period (Figure 4e-f). To 
study body temperature as a function of ambulatory activity a Reitman plot was generated, 
showing temperature as a function of physical activity [26]. The difference between the 
light and dark curves represents ambulatory activity-independent heat production, arising 
from either central modulation of heat loss [27, 28] or thermogenesis [29]. In mice adapted 
to short daily LE, there was a large light-dark difference (Fig. 4g), most likely reflecting 
the diurnal amplitude in BAT activity. Interestingly, in line with our observation that BAT 
activity may be lower in long LE, the difference between the curves for light and dark 
period disappeared in mice entrained to long LE (Fig. 4h) suggesting partial loss of activity-
independent regulation of the body temperature.
Figure 4. (right page) Diurnal rhythms in physiological parameters are present in dyslipidemic APOE*3.
Leiden-CETP mice. APOE*3-Leiden.CETP mice, fed a western type diet, were entrained to daily light 
exposure (LE) regimes of 8h (short LE) or 16h (long LE) and implanted with telemetric transmitters (n=4-
5/group) to measure body temperature and ambulatory activity. Five representative days of ambulatory 
activity rhythms (a) (black lines = short LE, grey lines = long LE) and body temperature rhythms (c) are 
shown. Mean 24h ambulatory activity (b) and body temperature (d) were calculated. Stress-free blood 
samples were obtained at ZT0, 8 and 16 and corticosterone was determined (e-f). The quadratic fit of 
the body temperature to the ambulatory activity was calculated separately for the dark and light periods 
for mice adapted short LE (g) or long LE (h). Dotted lines show the 95% confidence intervals of the fitted 
curves. 7 consecutive blood samples were drawn and TG (i-j) and free FA (k-l) levels were determined. pZT 
and pI represent p-values for the factors Zeitgeber Time (ZT) and interaction of LE on ZT respectively 
(two-way RM-ANOVA). Data are presented as means ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 





We measured non-fasted plasma lipid levels every 4h within a single day. Plasma TG and 
free FA levels were found to be rhythmic and were strongly dependent on LE duration (Fig. 
4i-l). Lowest TG and free FA levels were reached at the onset of the dark period (i.e. ZT8 for 
short day, ZT16 for long day). To evaluate whether these rhythms in plasma lipid levels were 
determined by the adaptive rhythm in FA uptake by BAT, we assessed the TG-derived FA 
uptake at three time points to confirm the high morning-evening amplitude of BAT activity. 
Indeed, like in wild-type mice, the uptake of [3H]FA specifically by the BAT depots was high at 
the onset of the dark period in APOE*3-Leiden.CETP mice either adapted to a short LE (Fig. 
5a) or long LE (Fig. 5b). This coincided with a faster clearance of plasma [3H]FA at the onset 
of the wakeful period for mice adapted either to a short LE (Fig. 5c-d) or long LE (Fig. 5e-f). 
As BAT was the only organ found to adapt to changes in LE, these data strongly suggest 
that diurnal rhythms in BAT activity are responsible for the time-dependent clearance of TG 
from the circulation.
To further investigate the consequence of the diurnal BAT activity for plasma lipid 
metabolism, we determined postprandial excursions of TG and free FA following an oral 
bolus of olive oil given when BAT was active or inactive (Fig. 6a). Comparable to the unfasted 
state (Fig. 4g-j), baseline 4h fasted plasma TG and free FA levels were low at the start of the 
dark period (Fig. 6b-c). In the mice adapted to short LE, the time of day at which the oral TG 
bolus was given clearly determined excursions of both plasma TG (pZT<0.001) (Fig. 6d) and 
free FA (pZT=0.010) (Fig. 6g). In addition, the area under the curve (AUC) was lowest when the 
oral TG bolus was given at the onset of the dark period (ZT8) for both TG (ZT0/8/16: 64±6 
/33±3 /84±5 mM*h, p<0.001 compared to ZT0) (Fig. 6f) and free FA (ZT0/8/16: 11.4±0.9/ 
8.7±0.5 /15.0±1.1 mM*h, p<0.001 (ZT0 vs. 16)) (Fig. 6i). Similarly, timing of the oral TG bolus 
in mice adapted to long LE determined the postprandial TG (pZT<0.001) (Fig. 6e) and free FA 
(pZT<0.001) (Fig. 6h) response. The AUC was lowest at the onset of the dark period (ZT16) 
for both TG (ZT0/8/16: 96±12/ 64 ±5/ 33±3 mM*h, p<0.01 (compared to ZT0)) (Fig. 6f) and 
free FA (ZT0/8/16: 13.6±1.1/ 9.0±0.5/ 7.3±0.3mM*h, p<0.001 (ZT16 vs. ZT8) (Fig. 6i). Short 
and long LE significantly changed the time of day-dependent postprandial excursion for TG 
(pZT<0.001, pLE=0.489, pI<0.001) (Fig. 6f) and free FA (pZT<0.001, pLE=0.011, pI<0.001) (Fig. 6i).
To investigate whether the rhythm in FA uptake by BAT and the effects on (postprandial) 
lipid levels were dependent on (cold-induced) sympathetic activity, we repeated experiments 
at thermoneutrality (30°C). At this temperature, FA uptake by BAT still displayed a marked 
difference in morning-evening TG-derived uptake accompanied by a fast clearance of TG-
derived FA at the onset of the dark period (Supplementary Figure 5a-c) and lower fasting 
concentrations of TG and FFA (Figure 6j, m). Following a bolus of olive oil, postprandial 
TG excursions were lower at the onset of dark compared to light (Figure 6k-l). In contrast, 
postprandial FFA excursions were comparable at both time points, suggesting an overall 
decreased BAT activity, also evident by the observation that the curves do not return to 
baseline (Figure 6n-o).
Collectively, irrespective of the LE regime, the highest removal rate of oral TG-derived 
FA from plasma was observed at the start of the dark period when FA uptake by BAT was 




































































































































































Figure 5. Diurnal rhythm in BAT activity in dyslipidemic mice adapts to daily light exposure. APOE*3-
Leiden. CETP mice, fed a western type diet, were entrained to daily light exposure (LE) regimes of 8h (short 
LE) or 16h (long LE). After five weeks, mice were injected with glycerol tri[3H]oleate-labeled lipoprotein-like 
particles at three time points (ZT0, ZT8 or ZT16) (n=7-8/group). Organ uptake of [3H]oleate was determined 
(a, b). Plasma clearance of [3H]oleate was determined (c, e) and half-life (t1/2) was calculated (d, f). Data are 
presented as means ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (compared to ZT0), $$$ p<0.001, 
$$$$ p<0.0001 (compared to ZT8) (ANOVA, Tukey’s post hoc test (a, b, d, f); RM-ANOVA with Dunnett’s 
post hoc test (c, e)). #p<0.05, ##<0.01 (short vs. long LE, Student’s T-test). iBAT = interscapular BAT, sBAT= 




levels of TG and free FA as well as postprandial lipid responses were lowest at the start of 
the dark period. Although we cannot exclude that the rhythmic uptake of nutrients from the 
gut may also have contributed to the observed effects, we concluded that lipids consumed 
at beginning of the active, wakeful period are very efficiently combusted by BAT.
Postprandial lipid response in humans is dependent on the time 
of the day
To evaluate whether timing of nutrient intake also determines postprandial lipid 
metabolism in humans, we determined the postprandial lipid response after an isocaloric 
meal at three time points of the day in a cohort of 37 healthy individuals [16] (characteristics 
are shown in Table 2). Participants were allowed to sleep from 23.00h to 8.00h, during which 
lights were off, and consumed a standard liquid test meal at clock time 9.00h, 12.00h and 
18.00h. Consistent with our observations in mice, postprandial free FA levels were low at 
the onset of the wakeful period (at 9.00h) and highest in the evening (Fig. 6j). Postprandial 
free FA excursions (measured as 3h postprandial area under the curve (AUC) gradually 
increased from 9.00h (AUC 1.64±0.09 mM*h) via 12.00h (AUC 1.89±0.13 mM*h; p=0.004) to 
at 18.00h (AUC 2.52±0.17 mM*h; p<0.0001) (Fig. 6k). We previously showed that TG levels 
of this cohort were highly rhythmic [11]. The postprandial excursions at 9.00h (AUC 3.2±0.2 
mM*h) were lower compared to 12.00h (AUC 5.0±0.3 mM*h; p<0.0001) and 18.00h (AUC 
4.0±0.2 mM*h; p<0.001) (Supplementary Fig. 5d-e), but in contrast to mice, absolute plasma 
TG values start to decline after 14.00h. Since clearance of plasma TG via LPL-mediated 
lipolysis results in FA ‘spillover’ into plasma that contributes up to 50% of postprandial 
plasma free FA concentrations in humans [30], FA levels likely inversely reflect the capacity 
of metabolic organs including BAT to take up TG-derived FA. Collectively these data show 
the postprandial lipid response to be lowest at the start of the wakeful period in mice as 
well as humans.
Table 2. Characteristics of the study population. Data are presented as means ± SEM or number (current 
smokers). $$$ p<0.001 men vs. women. #data of 1 person are missing.
All (n=37) Men (n=19) Women (n=18)
Age (y) 65.2 ± 0.9 65.7 ± 1.2 64.6 ± 1.2
BMI (kg/m2)# 25.1 ± 0.6 25.5 ± 0.7 24.6 ± 1.1
Fat mass (%)# 31.5 ± 1.4 24.8 ± 1.0 38.2± 1.2 $$$




In this study, we have shown that BAT in mice displays a strong diurnal rhythm with respect 
to uptake of TG-derived FA from the circulation, likely regulated through diurnal LPL activity 
within the tissue. In addition, FA uptake specifically by BAT and not by other organs was 
found to readily adapt to modulation of the daily LE. The peak in FA uptake by BAT peaked 
was aligned to the light-dark cycles and consistently occurred at the onset of the dark 
period. The daily pattern of BAT activity inversely related to daily patterns of plasma TG and 
FA levels and determined postprandial handling of TG in mice and possibly also in humans.
We first investigated time-dependent differences in the uptake of FA by metabolically 
active organs. We observed a steep rise in uptake of FA by BAT activity in anticipation of the 
dark period which corresponded with a rise in the core body temperature and EE. Within the 
tissue, we identified rhythms in the core clock genes Rev-erbα and Per2 as well as the key 
thermogenic gene Ucp1. In line with a previous report, Ucp1 expression was in anti-phase 
with the expression of its transcriptional repressor Rev-erbα [3]. Importantly, we identified 
a diurnal rhythm in mRNA expression and protein levels of LPL, a protein critical for TG-
derived FA uptake [2, 31], which correlated with FA uptake by BAT. In addition, mRNA and 
protein levels of ANGPTL4 were found to be rhythmic and almost undetectable at the onset 
of the dark period. We previously demonstrated that ANGPTL4 is a potent inhibitor of LPL 
function [23], therefore we anticipate that the combined effect of high levels of active LPL 
and low levels of ANGPTL4 causes the peak in FA uptake by BAT before the onset of the 
dark period.
How diurnal BAT activity is regulated exactly remains to be determined. The central 
biological clock (located in the suprachiasmatic nucleus of the hypothalamus) orchestrates 
diurnal anticipatory adaptations of energy metabolism through a complex interplay 
of endocrine, neuronal and behavioral factors. These oscillating factors can influence 
metabolic processes either directly or indirectly through synchronization of the cell-
autonomous clocks. BAT activity has been shown to be modulated at all of these levels of 
regulation. Examples include the modulation of BAT activity through food intake, physical 
activity, hormones such as glucocorticoids [32] and thyroid hormone [33], which are also 
known to adapt to seasonal cues [34, 35], and the cell-autonomous regulation through Per2 
[4] and Rev-erbα [3]. In addition, we previously showed that sympathetic innervation of BAT 
is affected by prolonged daily LE [8].
We investigated the adaptation of the tissue to changes in the environment, in this case 
daily LE duration, a physiological signal of the time of year. Interestingly, we observed a 
specific adaptation in activity of BAT with respect to FA uptake, and not in that of other 
metabolic organs. It is tempting to speculate on the reasons why BAT is relatively more 
sensitive to changes in daily LE. BAT has evolved as a natural defense system against 
hypothermia and the physiological importance of a seasonal and diurnal rhythm in BAT 
activity likely relates to this. From an evolutionary perspective, it would be waste of energy 
to have BAT constitutively active. Our data indicates that diurnal BAT activity is aligned with 





be exposed to cold environmental conditions. This observation could be analogous to the 
indispensable rise in BAT activity during arousal in hibernating mammals [36, 37]. Consistent 
with these data, previous studies demonstrated a stronger increase in oxygen consumption 
in response to cold at the start of the wakeful period in mice [3] and an enhanced insulin-
stimulated glucose uptake by human BAT explant in the morning[7]. Furthermore, mice with 
dysfunctional BAT through genetic modification or denervation display an aberrant sleep 
phenotype [38]. Since short LE signals winter, which is accompanied by lower temperatures, 
it stands to reason that short LE is an anticipatory signal to increase overall thermogenesis 
while long LE results in diminished heat production.
Importantly, changes in daily LE duration are pertinent to metabolic health. Human 
studies have shown that exposure to light at night correlates to a higher body weight [39, 
40] and prolonged duration of environmental light exposure predicts increased weight gain 
in children [41]. We previously identified impaired BAT activity as the potential missing link 
in the established association between perturbations in diurnal rhythms and metabolic 
disorders, by demonstrating that prolonged daily light exposure reduces BAT activity and 
induces adiposity in mice [8]. Moreover, we anticipate that diurnal BAT activity can be 
exploited to our benefit. We showed that postprandial lipids are lower in the morning than 
in the afternoon and propose that diurnal BAT activity is responsible for this phenomenon. 
In favor of this hypothesis and in line with our data, others have demonstrated that 
postprandial thermogenesis in humans is higher in the morning than in the evening [42] and 
that supraclavicular temperature, which was shown to associate with cold-induced glucose 
uptake by BAT [43] rises in the early morning [7].
Our data help to explain previous findings that time-restricted feeding contributes to 
metabolic phenotypes. Feeding mice at the biological ‘wrong’ time (i.e. the resting phase) 
increases body weight [44], while feeding at the ‘right’ time (i.e. the active phase) prevents 
diet-induced obesity and related health problems [45]. Humans eat virtually whenever they 
are awake [46]. Early eaters were shown to be more successful at weight-loss therapy than 
late eaters independent of caloric intake [47] and limited caloric intake in the evening has 
Figure 6. (left page) Postprandial lipid response depends on time of day in mice and humans. APOE*3-
Leiden.CETP mice, fed a western type diet, were entrained to daily light exposure (LE) regimes of 8h (short 
LE) or 16h (long LE) at 22°C (a-i) and an additional group was entrained to normal 12h LE and housed at 
30°C 2 days prior to experiments ( j-o). After four weeks, mice were fasted for 4h, blood was drawn and oral 
TG bolus was administered at three time points (ZT0, ZT8 or ZT16) (n=7-8/group) (a). Fasting TG (b, j) and 
FFA (c, m) were determined. Postprandial plasma TG excursion (d, e, j, k) and FFA (g, h, m, n) were determined 
at t = 1, 2, 4, and 8h after oral TG bolus. Postprandial AUC was calculated for TG (f,l) and FFA (i,p). 37 healthy 
individuals were fasted overnight before a diurnal venous blood sampling. At 9.00h, 12.00h, 18.00h a 
standard liquid meal was consumed. FFA levels were determined every 30 minutes (p) and postprandial 
AUC was calculated 3h after ingestion of isocaloric meal (q). Data presented as means ±SEM. *p<0.05, 
**,$$p<0.01, ***p<0.001, ****,$$$$p<0.0001. pt, pZT pI, represent p-values for the factors postprandial time 
point and for ZT (time of day of oral gavage) and the interaction respectively, based on two-way RM-ANOVA 




been associated with lower body mass index [48, 49]. Indeed, when overweight individuals 
were asked to limit the duration of food intake to a maximum of 11 h daily [46] they were 
metabolically healthier and more energetic. Taken together, these data strongly suggest 
that timing of food intake defines the fate of consumed calories and imply that BAT has 
a higher capacity to take up FA and combust calories in the morning than in the evening 
(Figure 7). This might be a mechanistic basis for early timing of food intake as a potential 
strategy to improve metabolic health.
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Supplementary Figure 1. Effect of light exposure on overall FA uptake and behavioral rhythms. Wild-type 
mice were entrained to daily light exposure (LE) regimes of 8h (short LE), 12h (normal LE) or 16h (long LE) at 
standard 22°C ambient temperature for 5 weeks. Mice were injected with glycerol tri[3H]oleate-labeled particles 
at 6 time points (n=4/group) and killed after 15 min of injection. AUC (a) and the average daily uptake of [3H]oleate 
was determined per organ (b). Correlations were made between light exposure duration in hours and uptake of 
[3H]oleate by iBAT (c), sBAT (d) and pVAT (e). Data are presented as means ±SEM. * p<0.05 (one-way ANOVA, 
Tukey’s post-hoc test). Correlations were analyzed by linear regression (dotted line represents 95%-confidence 
band). Abbreviations: AUC = area under the curve, iBAT = interscapular BAT; sBAT = subscapular BAT; pVAT 
= perivascular adipose tissue, sWAT = subcutaneous white adipose tissue; gWAT = gonadal white adipose 
tissue. Passive infrared monitors were fitted on the lid to monitor spontaneous ambulatry activity patterns. 
Representative actograms for mice adapted to short LE (f) and long LE (g) are shown. Stars indicate opening of 
cabinets for feeding. Actogram represent double-plotted activity data into 10-min bins.
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Supplementary Figure 2. Energy expenditure aligns with activity and food intake behavior under short 
and long LE. Wild-type mice were entrained to daily light exposure (LE) regimes of 8h (short LE) or 16h 
(long LE) at standard 22°C ambient temperature for 5 weeks and placed in metabolic cages to determine 
whole body energy metabolism by means of indirect calorimetry. Energy expenditure was correlated to 
ambulatory activity in beam breaks/h (bb/h) (a, c) and food intake (b, d). Data points in the curves represent 
1h binned values over a total of three consecutive days. Data are presented as means of 15-16 mice. 
Correlation was performed by linear regression analysis.
Supplementary Figure 3. (left page) Effect of fasting on FA uptake. Wild-type mice were entrained to 
short daily light exposure (LE) regimes of 8h at standard 22°C ambient temperature for 5 weeks. Mice were 
injected with glycerol tri[3H]oleate-labeled particles either at the onset of light or the onset of the dark 
period. At onset of light, food was removed either 4 or 8 hours prior to injection to mimic physiological 
diurnal fasting period (n=4-5/group) and killed after 15 min of injection. The uptake of [3H]oleate was 
determined for interscapular and subscapular brown adipose tissue (iBAT, sBAT), perivascular adipose 
tissue (pVAT), liver, muscle, heart, gonadal and subcutaneous white adipose tissue (gWAT, sWAT) (a). Plasma 
clearance of [3H]oleate was determined (b). Data presented as means ±SEM. *p<0.05, **p<0.01, ***p<0.001 
(compared to onset light/4h fasting), $p<0.05 (compared to onset light/8h fasting), (1-way ANOVA; a, two-
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Supplementary Figure 4. (left page) 24-h rhythm in BAT gene expression adapts to daily light 
exposure. Wild-type mice were entrained to daily light exposure (LE) regimes of 8h (short LE), 12h (normal 
LE) or 16h (long LE) at standard 22°C ambient temperature for 5 weeks. Interscapular brown adipose tissue 
(iBAT) was harvested at six time points (n=4/ group) and gene expression was determined by qPCR (a). 
Lpl gene expression (qPCR) (b) and LPL protein levels (Western blot) (c) were determined and correlation 
to FA uptake by iBAT was performed by linear regression analysis. Gene expression is relative to 36B4 or 
Hprt expression and normalized to mean expression of ZT0 of normal LE group. Rev-erbα-/- and control 
littermates were maintained on a normal 12h LE at 30°C. BAT was collected at ZT10 or following a 6h 4°C 
cold exposure (ZT4-ZT10) for gene expression analysis. Data are presented as means ±SEM and ZT0/ZT24 
was double plotted for visualization purposes. pZT, pLE and pI represent p-values for the factors Zeitgeber 
Time (ZT), LE and interaction respectively (two-way ANOVA)(a).*p<0.05, **p<0.01, ***p<0.001 (4 vs. 30°C), 
$p<p0.05, $$p<0.01 (WT vs. knock-out) (d).
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Supplementary Figure 5. Rhythmicity is present in TG-derived FA uptake by BAT in mice at 
thermoneutrality and postprandial TG concentrations in humans. APOE*3-Leiden.CETP mice, fed a 
western type diet and entrained to 12h daily light exposure, were housed at thermoneutrality (30°C) for 
four days. Mice were injected with glycerol tri[3H]oleate-labeled particles at 2 time points (ZT0 or ZT12) 
(n=7/group) and killed after 15 min of injection. Uptake of [3H]oleate was determined for interscapular 
and subscapular brown adipose tissue (iBAT, sBAT), perivascular adipose tissue (pVAT), liver, muscle, 
heart, gonadal and subcutaneous white adipose tissue (gWAT, sWAT) (a). Plasma clearance of [3H]oleate 
was determined 2, 5, 10 and 15 minutes after injection (b) and half-life (t1/2) was calculated (c). 37 healthy 
individuals were fasted overnight and diurnal venous blood sampling was started, at clock time 9.00h. At 
9.00h, 12.00h, 18.00h a standard liquid meal was consumed (arrows). TG levels were determined every 30 
minutes (A) and postprandial AUC was calculated 3h after ingestion of an isocaloric meal (d). Abbreviations: 
AUC = area under the curve, CT = clock time, TG = triglycerides. Data are presented as means ±SEM. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (Student’s T-test/ one-way ANOVA.
Chapter
Glucocorticoid rhythm regulates the 
diurnal activity of brown adipose tissue
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The biological clock regulates brown adipose tissue (BAT) activity. However, how the 
timing signal is conferred is poorly understood. We hypothesize that the diurnal rhythm 
in glucocorticoid levels (corticosterone in rodents) plays a crucial role. To address this 
hypothesis mice received subcutaneous pellets containing a low-dose of corticosterone, 
which markedly dampened the rhythm of endogenous circulating corticosterone 
concentrations. After one week the ability of BAT to take up triglyceride-derived fatty acids 
from the circulation was determined at AM and PM. In control mice fatty acid uptake by 
BAT displayed a large AM-PM fluctuation. In mice with dampened corticosterone rhythm 
this AM-PM fluctuation was abolished due to lowered PM uptake of fatty acids by BAT. 
This was accompanied by dampened AM-PM differences in the expression of Lpl and the 
phosphorylation of CREB, a downstream β3-receptor signaling target. Unexpectedly, known 
glucocorticoid-responsive element-controlled genes retained a rhythmic expression, 
suggesting that glucocorticoids did not directly act on the brown adipocyte. We conclude 
that short-term dampening of corticosterone rhythm in mice dampens the rhythmicity of 
BAT activity with respect to the uptake of triglyceride-derived fatty acids. Our data suggest 
that glucocorticoid rhythms may act as a signal from the biological clock to regulate diurnal 




Brown adipose tissue (BAT) is currently viewed as a promising therapeutic target to combat 
metabolic disease due to its ability to dissipate energy into heat [1]. Brown adipocytes 
contain large amounts of mitochondria that uniquely contain uncoupling protein 1 (UCP-1). 
UCP-1 uncouples electron transport from ATP synthesis, resulting in heat production [2]. To 
fuel thermogenesis, intracellular triglyceride (TG) stores are used, which are replenished by 
LPL-mediated uptake of TG-derived fatty acids (FA) from the circulation [3]. Activation of BAT 
increases energy expenditure and reduces plasma TG levels; in mice this prevents obesity 
and reduces dyslipidemia [4]. Low temperature is the physiological stimulus for BAT activity. 
Cold is perceived by skin; the signal is transmitted to the hypothalamus, which increases 
sympathetic nervous system output and increases peripheral release of noradrenaline that 
activates the β3-adrenergic receptor on the brown adipocyte [5]. In addition to adrenergic 
input, BAT activity is controlled by the endocrine system [6]. It is becoming increasingly 
clear that the biological clock regulates BAT function.
The mammalian biological clock system generates circadian (i.e. 24 h) rhythms in 
physiological and behavioral functions. It consists of a central pacemaker located in the 
suprachiasmatic nucleus (SCN) of the hypothalamus and peripheral clocks within organs, 
which regulate rhythmicity within the different tissues. Light-dark information is processed 
by the SCN, which synchronizes peripheral clocks via sympathetic and endocrine output 
[7]. Disturbances of day-night rhythms in humans, e.g. through shift work and artificial light 
exposure, are associated with an increased risk for obesity, type 2 diabetes and dyslipidemia 
[8-10]. Studies in rodents demonstrated a causal relationship between a disturbed biological 
clock and the development of metabolic disease [11-13]. We recently showed that BAT 
may be the missing link in this causal relationship. Prolonged light exposure duration 
specifically reduced the uptake of TG-derived FA by BAT resulting in increased adiposity 
in mice, without affecting food intake [14]. Furthermore, we demonstrated that BAT activity 
is not only regulated by light exposure duration but also displays a strong diurnal rhythm 
(Chapter 3). Although we showed that fatty acid uptake by BAT is highly rhythmic, the exact 
mechanism by which the SCN transfers diurnal information to BAT is not fully understood.
Besides noradrenalin, glucocorticoids are likely candidates for transferring the 
circadian time-keeping signal to BAT. The release of glucocorticoids, cortisol in humans 
and corticosterone in rodents, shows a pronounced diurnal rhythm. Glucocorticoids peak 
before wakening and show a trough before sleeping [15]. The diurnal profile of plasma 
corticosterone concentrations and FA uptake by BAT are strikingly similar, with a peak just 
before wakening and a through at the end of the waking period. Moreover, prolonged light 
exposure duration, which directly affects SCN output [16], shifts the peak time and decreases 
the amplitude in the diurnal rhythm of both plasma corticosterone concentrations and FA 
uptake by BAT, as shown by others [17] and us (Chapter 3). Therefore, we hypothesized 
that the diurnal rhythm of plasma corticosterone confers the diurnal timing signal of the 
SCN towards BAT. To investigate this hypothesis, we dampened the endogenous diurnal 
rhythm of corticosterone by implantation of a low dose corticosterone-containing pellet in 
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mice and evaluated the effects on rhythmicity of whole-body metabolism and BAT activity. 
The subcutaneously implanted pellets release a continuous dose of corticosterone, which 
inhibits production of CRH and ACTH through negative feedback on the hypothalamus 
and the pituitary [18]. In this study, we demonstrate that dampening of the corticosterone 
rhythm did not flatten whole-body energy metabolism rhythms, but did reduce the evening 
peak in FA uptake by BAT.
METHODS
Animal husbandry
All animal experiments were performed in accordance with the local ethics committee. Male 
8-week-old C57Bl/6J mice (Charles River) were single-housed in clear plastic cages within 
light-tight cabinets on a 12h:12h light:dark cycle (lights on 9.00h) at constant ambient 
temperature of 22°C with ad libitum access to food (standard chow, Special Diet Services) 
and water.
Experimental design
Mice (n=32) were housed in metabolic cages (Phenomaster, TSE systems) one day prior to 
the experiment. Mice (n=16/group) were implanted with a subcutaneous pellet containing 
2.5% w/w corticosterone (2.5 mg corticosterone, 97.5 mg cholesterol) or 100 mg cholesterol 
as placebo. After 6 days, stress-free AM and PM blood samples were drawn at Zeitgeber 
Time (ZT) 1 and ZT11. After 7 days, a TG clearance experiment was performed at either 
AM (ZT0) or at PM (ZT12). An additional group of 10 animals were also implanted with a 
corticosterone-containing or placebo pellet (n=5/group) as well as a telemetric system to 
continuously measure body temperature and activity rhythms.
Surgical procedures
Implantation of the corticosterone pellets was performed under 2.5% isoflurane anesthesia. 
A small incision was made between the shoulder blades and a subcutaneous pocket was 
created by blunt end of a scissor. The pellet was inserted subcutaneously in the flank. Mice 
which also received a telemetric system were implanted with a TA-F10 miniature transmitter 
(Data Sciences International, MN, USA, kindly provided by Linda van Kerkhof, RIVM) through 
the same incision in the contralateral flank.
Indirect calorimetry and body composition
Mice were housed in automated metabolic cages to measure oxygen consumption (volume 
O2; mL/h), carbon dioxide production (volume CO2; mL/h), respiratory exchange ratio (RER; 
VCO2/VO2), physical activity via infra-red beam breaks and food intake during 7 days. Means 
were calculated over 7 days. Mice were weighed and body composition was determined by 
echoNMR (EchoMRI-100, Houston, TX, USA) the day before acclimatization to metabolic 




To determine the effects of a corticosterone pellet on circulating corticosterone levels, 
stress-free (i.e. within 2 minutes of handling the cage) blood samples were taken after the 
onset of light (AM; ZT 1) and before the onset of dark (PM; ZT11) via tail vein bleeding. 
To evaluate possible effects of acute stress of the final experiment, blood samples were 
taken right before the start of TG-clearance experiment from the tail vein into EDTA-coated 
Eppendorf tubes. Total plasma corticosterone concentrations were determined using 
125I-RIA ELISA kit (MP Biomedicals, Orangeburg, NY, USA).
TG clearance experiment
After 7 days of corticosterone or placebo treatment, the kinetics of triglyceride (TG) and 
cholesterol clearance from plasma and uptake by organs were assessed at AM (ZT0) and PM 
(ZT12). TG-rich lipoprotein (TRL)-like emulsion particles (80 nm), radiolabeled with glycerol 
tri[3H]oleate ([3H]TO) and [14C]cholesteryl oleate ([14C]CO), were prepared as previously 
described [19]. Mice were fasted for 4h and received an intravenous injection of particles 
(1 mg TG in total volume of 200 µl) via the tail vein. After 15 minutes, mice were euthanized 
by cervical dislocation and perfused with ice-cold PBS for 5 min. Organs were harvested, 
weighed, and 3H and 14C radioactivity was determined by liquid scintillation.
Gene expression analysis
Interscapular brown adipose tissue (iBAT) was snap frozen and stored at -80°C. Total RNA 
was isolated using TriPure (Roche) and cDNA was reverse-transcribed starting with 1 µg of 
RNA using M-MLV reverse transcriptase (Promega, Madison, WI, USA). Quantitative real-
time PCR was performed in triplicate using SYBR-Green (Bio-Rad) on a CFX96 PCR machine 
(Bio-Rad). Expression levels were normalized to 36b4 housekeeping gene expression.
Protein isolation and Western blot
The iBAT samples stored at -80°C were homogenized and diluted in lysis buffer. The 
homogenates were centrifuged at 6.5 m/sec for 20 sec (FastPrep-24™ 5G, MP Biomedicals, 
California, USA) and the protein content was determined using a  BCA protein assay kit 
(Thermo Scientific). Subsequently, after adding Laemmli Sample buffer (1:1 vol/vol; Serva, 
Heidelberg, Germany), the samples were denatured for 5 min at 95°C. Proteins within 
homogenates (20 µg) were separated on a 10% SDS-page gel and subsequently transferred 
onto nitrocellulose blotting membranes. The blotting membranes were blocked with 
5% milk powder and incubated overnight at 4°C with the primary antibody rabbit pCREB 
(Cell Signalling; 1:1000) or mouse β-actin (Sigma; 1:1000). Subsequently, the membranes 
were incubated for 1 hour with secondary antibodies (anti-rabbit or anti-mouse IgG HRP 
conjugate; 1:5000; Promega, Madison, WI, USA), after which the protein bands were 
visualized with SuperSignal Western blot Enhancer (Thermo Scientific, Rockford, IL, USA). 
The Blots were analyzed with ChemiDoc Touch Imaging System (Bio-Rad) and normalized 




To assess lipid fraction within BAT the lipid-containing area was determined on Mayer’s 
hematoxylin and eosin (HE) stained formalin-fixed paraffin-embedded iBAT tissue sections 
(5 µm), using standard protocols. The lipid areas were quantified (as percentage of total 
area) using ImageJ.
Statistical analysis
Data are presented as means ± SEM. Differences between two groups were determined by 
T-tests and between more than two groups with a one-way ANOVA. To test for differences 
between AM-PM groups, post hoc Sidaks for multiple comparisons was used. For repeated 
measures, repeated measure ANOVA was used. Associations of variables with time were 
assessed by linear regression analysis. Graphpad Prism v6.0 was used for all analyses. P 
values < 0.05 were considered statistically significant.
RESULTS
Subcutaneous corticosterone-containing pellets dampen 
corticosterone rhythm
Mice were implanted with subcutaneous pellets containing vehicle or 2.5% corticosterone, 
aimed to flatten the endogenous diurnal corticosterone rhythm. To confirm this, we 
determined plasma corticosterone levels at AM (ZT1) and PM (ZT11). Mice implanted with 
placebo pellets showed a 29-fold difference between AM and PM plasma corticosterone 
levels (4.5 ± 1.2 vs. 129.9 ± 9.1 ng/ml, P < 0.0001) (Fig. 1a). In contrast, mice implanted 
with corticosterone pellets displayed similar plasma corticosterone levels at AM and PM 
(39.3 ± 3.3 vs. 46.9 ± 3.0 ng/ml, P = 0.408) (Fig. 1a). Moreover, corticosterone levels did 
not reach the physiological trough and peak values at either AM or PM. To further explore 
whether mice had been exposed to supraphysiological levels of corticosterone during the 
treatment, the thymus and adrenals were weighted after 7 days of implantation. The thymus 
and adrenals are sensitive to chronic hypercorticosteronemia and decrease in weight due 
to apoptosis of thymocytes [20] and lack of trophic effect of ACTH on adrenals. Thymus 
weight decreased by 34% in the corticosterone-treated group compared to the placebo 
group (43 ± 2 vs. 28 ± 2 mg, P < 0.001) (Fig. 1b). Adrenal weight also decreased by 20% in the 
corticosterone treated mice compared to placebo (1.4 ± 0.1 vs. 1.8 ± 0. 1 mg, P = 0.038) (Fig. 
1c). These data indicate that corticosterone pellets may have raised the total corticosterone 
exposure in treated mice. Therefore, we conclude that corticosterone pellets dampened 
the diurnal rhythm of endogenous corticosterone treatment, with a possible elevation of 
total 24h corticosterone exposure.
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Dampened rhythm of corticosterone levels does not affect body 
composition and diurnal energy expenditure
To investigate the effects of a dampened corticosterone rhythm on energy metabolism, we 
measured body composition before and after 7 days of treatment, and performed indirect 
calorimetric analysis. Corticosterone treatment did not affect fat mass (corticosterone vs 
placebo; 1.1 ± 0.1 vs. 1.3 ± 0.1 g, P = 0.122) (Fig. 2a), lean mass (22.5 ± 0.2 vs. 23.2 ± 0.3 
g, P = 0.083) (Fig. 2b), or total body weight (23.8 ± 0.3 vs. 24.5 ± 0.2 g, P = 0.135) (Fig. 2c). 
Also, flattening of the rhythm in corticosterone concentrations did not change the diurnal 
pattern of fat oxidation, carbohydrate (CH) oxidation, energy expenditure (EE), respiratory 
exchange ratio (RER), physical activity or food intake obtained over a period of 7 days (Fig. 
2d-i). Average values were different between light and dark period, but unaffected by a 
dampened corticosterone rhythm (Fig. 2d-i). In an additional group of mice equipped with 
telemetric systems, 24h body temperature (Fig. 2j) and activity (Fig. 2k) were simultaneously 
recorded. Overall, the diurnal rhythm of metabolic parameters as well as body temperature 
rhythms were similar between the placebo and corticosterone-treated mice.
Dampened rhythm of corticosterone levels flattens the rhythm of 
TG-derived FA-uptake specifically by BAT
To investigate the effect of a dampened diurnal corticosterone rhythm on BAT activity, we 
assessed the ability of BAT to take up TG-derived FA from plasma at two time points. To this 
end, mice were injected with double-labeled TRL-mimicking particles either at AM (ZT0) or 
PM (ZT12). The AM and PM uptake of [3H]oleate by interscapular BAT (iBAT) and subscapular 
BAT (sBAT) was higher than the uptake by subcutaneous white adipose tissue (sWAT), liver, 
gonadal WAT (gWAT), heart, spleen and muscle, indicating that iBAT and sBAT are highly 
metabolically active compared to other metabolic organs. The PM uptake of [3H]oleate by 






















































Figure 1. Implantation of corticosterone pellet flattens endogenous glucocorticoid rhythm. C57BL6/J 
mice were implanted with placebo pellets (n=16) or low-dose corticosterone pellets (n=16). After 6 days, 
corticosterone plasma levels were determined at AM (ZT1) and PM (ZT11) (a). After 7 days, mice were 
sacrificed at AM (ZT0) or PM (ZT12) and thymus (b) and an adrenal (left-sided) (c) were weighed. Data 
are presented as individual values and the mean ± SEM. *P < 0.05, ***P < 0.001, ****P < 0.0001 (repeated 
































































































































































































































































iBAT, sBAT and perivascular adipose tissue (pVAT) was higher compared to AM (iBAT: 35.2 
± 6.4 vs. 20.8 ± 2.6 % dose/g, P = 0.029; sBAT: 41.7 ± 6.4 vs. 21.0 ± 2.7 % dose/g, P = 0.004; 
pVAT: 24.1 ± 3.0 vs. 14.8 ± 1.8 % dose/g, P = 0.023) (Fig. 3a). Remarkably, corticosterone 
treatment abolished this difference between AM and PM in iBAT (22.0 ± 2.9 vs. 22.8 ± 2.0 
% dose/g, P = 0.985), sBAT (23.9 ± 2.7 vs. 24.5 ± 3.4 % dose/g, P = 0.993) and pVAT (17.5 ± 
2.1 vs. 18.1 ± 2.3 % dose/g, P = 0.982). Since the AM uptake decreased and the PM uptake 
remained the same, the average total uptake of [3H]oleate by brown adipocyte depots was 
decreased by corticosterone treatment. In placebo treated mice, the liver showed the 
highest uptake of [14C]CO, reflecting the clearance of cholesterol-rich remnant particles, 
when compared to all other organs (Fig. 3b). Remnant uptake by the liver was significantly 
higher PM versus AM in placebo treated mice (61 ± 3 vs. 46 ± 2 % dose/g, P=0.002), while in 
corticosterone treated mice, the PM and AM uptake of remnants was equal (58 ± 3 vs. 57 ± 3 
% dose/g, P=0.958). In conclusion, corticosterone pellet implantation dampened the diurnal 
rhythm in TRL clearance with respect to TG-derived FA uptake by BAT depots, as well as the 
rhythm in remnant uptake by the liver.
Dampened rhythm of corticosterone levels flattens the rhythm in 
clock gene expression in BAT
Corticosterone-containing pellets dampened both the rhythm in endogenous corticosterone 
levels and the rhythm in BAT activity with respect to TG-derived FA uptake. We aimed to 
further investigate the underlying mechanism by which corticosterone levels influence FA 
uptake by BAT. Corticosterone can act through binding of the mineralocorticoid receptor 
(MR) as well as the glucocorticoid receptor (GR). To investigate whether corticosterone 
directly acts on brown adipocytes, we determined the gene expression in iBAT of the 
known MR and GR responsive genes Fkbp5 (Fig. 4a), Gilz (Fig. 4b) and Hsd11b1 (Fig. 4c). 
Corticosterone pellets did not influence the AM-PM difference in expression of these 
responsive genes, showing that the corticosterone-containing pellets do not universally 
flatten GR and MR dependent gene expression within the brown adipocytes.
We previously demonstrated that diurnal FA-uptake by BAT is accompanied by diurnal 
clock gene expression (Chapter 3). We hypothesize that corticosterone may act on the cell 
autonomous clock to regulate diurnal FA-uptake. We studied genes in both the forward 
and negative feedback loop of the clock machinery. The expression levels of the genes 
in the positive loop, namely Clock (Fig. 4d) and Bmal1 (Fig. 4e) showed no rhythmicity in 
Figure 2. (left page) Dampened rhythm of corticosterone levels does not affect body composition 
and diurnal energy metabolism pattern. C57BL6/J mice were implanted with placebo pellets (n=16) or 
low-dose corticosterone pellets (n=16). Fat mass (a) and lean mass (b) were determined by EchoMRI at 
baseline and after 7 days and total body mass was determined after 7 days (c). Indirect calorimetry was 
used to determine fat oxidation (d), carbohydrate oxidation (e), energy expenditure (EE) (f), respiratory 
exchange ratio (RER) (g), physical activity (h) and food intake (i). Bars show mean value over 7 days. Body 
temperatures ( j) and activity (k) measured every 10 minutes from subcutaneously implanted thermometers 
in placebo (n=5) and corticosterone pellet treated (n=5) mice. Grey dotted line represents placebo, black 
line represents corticosterone. Data are presented as spline curve (d-l) or means ± SEM (a-c).
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Figure 3. Dampened rhythm of corticosterone levels dampens rhythmicity of TG-derived FA-uptake 
specifically by BAT. C57BL6/J mice were implanted with placebo pellets (n=16) or low-dose corticosterone 
pellets (n=16) and the VLDL-TG uptake was assessed after 7 days by injection of glycerol tri[3H]oleate 
([3H]TO) and [14C]cholesteryl oleate ([14C]CO)-labeled emulsion particles. Uptake of [3H]TO-derived (a) and 
[14C]CO-derived activity (b) by the various organs was determined. Open bars = placebo, hatched bars = 
corticosterone; grey bars = PM, white bars = AM. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, 
***P < 0.001
Figure 4. (right page) Dampened rhythm of corticosterone levels dampens clock gene expression 
rhythmicity within BAT C57BL6/J mice were implanted with placebo pellets (n=16) or low-dose 
corticosterone pellets (n=16). After 7 days, mice were sacrificed at AM (ZT0) or PM (ZT12) and 
interscapular BAT was isolated. Gene expression was determined by qPCR (a-l, o-u). Histological sections 
were stained with HE were analyzed for lipid content (m, n). Protein expression was determined by Western 
blot and quantified (normalized to actin levels, not shown) (v, w, x). Open bars = placebo, hatched bars = 
corticosterone, grey bars = PM, white bars = AM. Data are presented as means ± SEM. Relative expression 
was calculated normalized to AM-placebo values. Ns= not significant (P>0.05). *P < 0.05, **P < 0.01, ***P < 





both the placebo and corticosterone treated groups. Rev-erbα displayed a significant AM-
PM difference with highest expression at AM (Fig. 4f) in the placebo group (P<0.05) and 
after corticosterone intervention (P < 0.001). For the other clock genes, gene expression 
was highest at PM. The preservation of AM-PM difference in the corticosterone treated 
groups, was also observed for gene expression of Per2 (Fig. 4j), Cry1 (Fig. 4g), Cry2 (Fig. 
4h). Interestingly, the AM-PM difference in gene expression of Per1 (Fig. 4i) was blunted 
by corticosterone treatment. Therefore, we conclude that flattening of the plasma 
corticosterone rhythm specifically dampens the clock gene expression of Per1.
Next we investigated which thermogenic pathways within the brown adipocyte 
may be rhythmic and therefore blunted upon corticosterone rhythm flattening. Since 
intracellular TG stores are burned upon activation of BAT, the intracellular lipid content of 
BAT is an indirect measure of its activity. Histologic analysis. of BAT demonstrated that 
although not significant, BAT tended to contain less lipids at PM than AM, which would 
be consistent with a higher thermogenic activity at PM (Fig. 4m). However, the same 
trend was apparent in corticosterone-treated mice (Fig. 4n). Subsequently, we examined 
the possibility that corticosterone rhythm flattening reduces mitochondrial function 
which could eventually reduce FA uptake by brown adipocytes. The rhythmic expression 
of carnitine palmitoyltransferase 1a (Cpt1a) (Fig. 4k), which facilitates the transfer of FA 
into the mitochondrial matrix for oxidation, was blunted in corticosterone-treated mice. 
Likewise, gene expression of NAD-dependent deacetylase sirtuin-3 (Sirt3) (Fig. 4l), which 
regulates several mitochondrial metabolic enzymes, showed an AM-PM difference in the 
placebo treated mice, which lost significance in corticosterone treated mice. In contrast, 
thermogenic genes Prdm16, Pgc1α, Fasn and Elovl6, Dio2 (Fig 4o-s) did not display any AM-
PM difference. LPL is crucial for hydrolysis of TG within TRL and subsequent uptake FA by 
BAT. We previously found that expression of Angptl4, which encodes for the inhibitor of LPL 
activity, displays a diurnal rhythm within BAT (chapter 3). Although Angptl4 did not show a 
AM-PM difference (Fig 4t), Lpl expression was rhythmic, and this rhythmicity was dampened 
after corticosterone treatment (Fig. 4u). Thus, our data suggest that corticosterone rhythms 
may regulate BAT activity at the level of expression of genes involved in both cellular FA 
uptake (Lpl) and FA oxidation (Cpt1a, Sirt3).
Since expression of direct GR and MR targets retained their rhythmicity, we hypothesized 
that corticosterone affects BAT indirectly, e.g. via sympathetic output. We studied 
phosphorylated protein levels of hormone sensitive lipase (HSL), involved in TG hydrolysis, 
as well as CREB, a downstream target of adrenergic signaling. While HSL phosphorylation 
was not different between AM and PM (Figs. 4v,w), we found that near-significant rhythmic 





The uptake of FA uptake by BAT is higher at the onset of the active period (i.e. the dark 
period for mice, at PM) than at the onset of the resting period (the light period, AM). These 
data support our recent observations, demonstrating a pronounced diurnal rhythm in TG-
derived FA uptake by BAT (Chapter 3). The diurnal rhythmicity of TG-derived FA uptake 
parallels that of glucose uptake by BAT in mice [21] and supraclavicular temperature 
in humans [22] (a measure for human BAT activity since it highly correlates to glucose 
uptake [23]). We showed that implantation of a low dose corticosterone-containing pellet 
dampens the endogenous diurnal rhythm in plasma corticosterone concentrations in 
mice; corticosterone plasma levels increased at AM and decreased at PM. Together with 
the dampened corticosterone rhythm, BAT depots decreased TG-derived FA uptake at 
PM. Whole body energy expenditure retained a diurnal rhythm and body composition was 
maintained.
Dampened corticosterone rhythm may act on BAT activity either directly in the brown 
adipocyte by binding MR and GR, or indirectly, via the central nervous system (CNS). We 
examined effects on genes with a known high affinity GR-response element (GRE) [24]. 
Expression of Fkbp5 and Gilz retained rhythmicity, dismissing a direct effect of corticosterone 
rhythm via GRE-induced expression. Nevertheless, we observed a dampened rhythm in 
expression of Per1, which also has a known high affinity GRE. This phenomenon is in line with 
recent study in zebrafish with a genetic disturbance of diurnal cortisol levels. In that study, 
transcriptomic analysis showed a disturbance in rhythmic expression in many metabolic 
genes. Supplementation with a continuous dose of dexamethasone restored rhythmic 
expression in part of the arrhythmic genes [25]. In other words, constant glucocorticoid 
levels restore are sufficient to restore rhythmic gene expression of some genes, but for 
other genes, the rhythmicity of glucocorticoid levels is necessary to restore the rhythmic 
expression. The intracellular mechanisms remain obscure, but likely involve non-genomic 
effects of the GR, such as the interaction with clock proteins.
Implantation of low-dose corticosterone pellet resulted in decreased phosphorylation 
of CREB at PM. Adrenergic stimulation of BAT increases CREB phosphorylation [26]. 
Therefore, corticosterone rhythm may centrally regulate BAT activity via modulating the 
sympathetic outflow. No studies have yet demonstrated a diurnal sympathetic outflow 
towards BAT. Corticosterone is able to pass the blood-brain barrier, and can bind MR and 
GR present in the CNS. MR activation in the CNS increases hypertension and sympathetic 
outflow [27], which represents a possible pathway by which glucocorticoids may affect 
sympathetic outflow towards BAT.
The difference in AM and PM nutrient uptake by BAT was accompanied by a marked 
AM-PM difference in Lpl expression, which is in line with our previous finding that Lpl gene 
expression and protein levels are highly rhythmic and coincide with FA uptake rhythms 
by BAT (Chapter 3). Furthermore expression of Cpt1a and Sirt3 was dampened after 
implantation of low-dose corticosterone pellets. Cold-induced adrenergic stimulation 
92
4
Figure 5. Hypothetical model. Light information is processed by the SCN, which regulates rhythmic 
output of the HPA axis via the PVN. Under physiological circumstances, peak corticosterone levels do 
not directly regulate brown fat rhythm but rather feed back to the brain (possibly via the AH) and via the 
SNS, BAT rhythmicity is regulated. If a stressor is perceived, the PVN is activated, high levels of ACTH and 
corticosterone are reached in the circulation, which directly affect BAT activity. AH = anterior hypothalamus, 
SNS = sympathetic nervous system, PVN = paraventricular nucleus, SCN = suprachiasmatic nucleus.
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increases expression of these genes [28]. Therefore, the dampened expression support the 
hypothesis that glucocorticoid act indirectly via the CNS to modulate sympathetic outflow.
A few publications reported on the role of glucocorticoids on BAT activity. Increased 
glucocorticoid levels have been shown to inhibit thermogenic BAT activity in vitro in murine 
brown adipocytes [29]. On the other hand, elimination of endogenous glucocorticoids by 
adrenalectomy increases UCP-1 protein content and mitochondrial content in BAT in rats, 
which again decreases with increasing substitution dosages of corticosterone [30]. However, 
due to the ablation of negative feedback in these models, they are also characterized by 
increased ACTH levels, which has recently been demonstrated to activate BAT [31, 32]. 
Therefore, the question remains whether adrenalectomy increases BAT activity due to 
reduced glucocorticoid levels or because of increased ACTH levels. Furthermore, flattened 
glucocorticoid levels could affect BAT activity by lack of peak levels or by an increase of 
the through levels. In vitro experiments have demonstrated that GR agonism inhibits Ucp1 
expression in murine brown adipocytes [33, 34]. In these studies, supraphysiological doses 
of glucocorticoids or dexamethasone were administered. Gene expression responses 
as well as behavioral responses to glucocorticoids are context and dose dependent [35, 
36]. Notably, two human studies recently demonstrated that infusion of glucocorticoids 
increased BAT thermogenesis, as measured by supraclavicular skin temperature [29, 37]. 
Taken these data together, we propose that glucocorticoids may serve both as a signal for 
diurnal BAT activity and as a signal for stress, depending on the plasma levels.
A limitation of the current study is the use of only two time points to determine 
rhythmicity. Although our study confirmed previous finding of a large amplitude between 
AM and PM corticosterone rhythm as well as FA uptake by BAT, the detection of rhythms 
in e.g. expression of genes that have other peak and trough times may be missed. It 
has been previously shown that diurnal oscillations in gene expression in many of the 
peripheral circadian clocks can be shifted by the administration of glucocorticoids or by 
adrenalectomy [38]. Additionally, we cannot exclude that total 24h corticosterone plasma 
levels may be different between the groups only based on AM and PM corticosterone levels. 
Indeed, adrenal and thymus weight were slightly lowered upon corticosterone treatment. 
However, we did not observe metabolic effects associated with hypercorticosteronemia 
such as decreased lean mass [39].
In conclusion, we show that dampening of glucocorticoid levels specifically dampens FA 
uptake rhythm by BAT. Our study may help to understand how disturbed circadian rhythms 
can cause metabolic disorders. Chronic disruption of circadian rhythm in BAT may be such 
a mediator, as lower BAT activity is associated with lower energy expenditure, dyslipidemia 
and obesity in rodents [40]. Disturbed day-night rhythms, such as through shift work, may 
disturb circadian BAT function. Glucocorticoid administration may help to restore disturbed 
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Shift work is a risk factor for atherosclerotic disease in humans. However, whether shift 
work is causally involved in atherosclerosis and which facet of shift work is responsible are 
unknown. Here, we investigated the hypothesis that mistimed light exposure may causally 
contribute to atherosclerosis by performing studies in APOE*3-Leiden.CETP mice, a well-
established model for human-like lipoprotein metabolism and atherosclerosis. In two 
separate experiments, female mice were either subjected to constant light (LL) or to three 
different rotating light schedules, compared to control 12h light-dark (LD) schedule. While 
LL disturbed the circadian rhythm to some extent, it did not affect atherosclerotic lesion 
development. In contrast, a weekly 6 h advance light schedule increased plaque severity. 
Moreover, weekly reversal of LD schedule increased plaque severity as well as plaque 
size. Increased atherosclerotic development could not be attributed to higher plasma 
cholesterol levels. In conclusion, mistimed light exposure per se aggravates atherosclerotic 
development in mice, which may at least partly explain the association between shift 





Cardiovascular diseases (CVD) are currently the leading cause of death world-wide [1]. The 
main cause of CVD is atherosclerosis, to which a pro-inflammatory state and dyslipidemia 
are key contributors [2]. Dyslipidemia is characterized by increased levels of plasma 
triglycerides (TG) and LDL-cholesterol and decreased HDL-cholesterol [3]. Plasma levels 
of lipids display day-night variations independent of food intake [4], suggesting that 
the biological clock is an important determinant of lipid levels. Consequently, disturbed 
biological clock function may contribute to dyslipidemia and thereby increase the risk for 
CVD.
Epidemiological studies have repeatedly shown associations between disturbance 
of biological clock function, responsible for generating circadian (i.e. ~24 h) rhythms, and 
metabolic disorders such as obesity, type 2 diabetes and CVD [5-7]. Already in 1949 a 
Scandinavian observational study among factory workers reported an association between 
shift work and cardiovascular mortality [8]. Longitudinal studies indicate that shift work is 
indeed a causal risk factor for cardiovascular events, including hard end-points like ischemic 
stroke and myocardial infarction [9, 10]. However, the underlying mechanisms remained 
elusive. Meanwhile, the behavioral patterns of human activity, especially in industrialized 
countries, have undergone dramatic changes with respect to adherence to day and night 
rhythms. The use of electrical light has uncoupled the behavioral active period from the 
natural occurring day, social activities are shifted and the 24-hour economy necessitates 
working at night. Of note, in Europe approximately 20% of the working population is involved 
in some form of shift work [11].
Shift work likely contributes to adverse health outcomes via multifactorial pathways, 
including psychosocial factors, sleep loss, a decrease in physical activity, altered food 
intake quantity (i.e. an increase in caloric intake) and quality (i.e. changes in timing and 
choice of food) and lack of sun light exposure. An undervalued aspect is the contributing 
factor of mistimed light exposure itself. Prolonged light exposure is associated with obesity 
in humans [12-16]. Recently, we were able to show in mice that prolonged light exposure 
increases adiposity by attenuation of brown adipose tissue (BAT) activity, independent of 
food intake [17]. Upon activation, BAT takes up fatty acids from TG-rich lipoproteins to burn 
into heat, resulting in accelerated hepatic clearance of TG-rich lipoprotein remnants [18]. 
In fact, pharmacological activation of BAT in mice decreases plasma TG and cholesterol, 
accompanied with attenuation of atherosclerosis formation [19]. It is thus conceivable to 
reason that mistimed light exposure could reduce BAT activity, thereby increasing plasma 
cholesterol and accelerating atherosclerosis.
Although it has been established that mistimed light exposure by rotating light shifts 
increases breast cancer development in mice [20] and shift advance increases mortality 
[21], the effects of mistimed light exposure on lipid metabolism and atherosclerosis 
development are currently unknown. Therefore, the aim of the present study was to 
investigate the role of mistimed light exposure on atherosclerosis development. To 
investigate this, we subjected APOE*3-Leiden.CETP female mice, which have a humanized 
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lipoprotein metabolism and develop human-like atherosclerosis, to different light regimes 
and determined the effect on atherosclerosis development.
MATERIAL AND METHODS
Animal Husbandry
All animal experiments were approved by the Institutional Ethics Committee on Animal Care 
and Experimentation (Leiden University Medical Center). Mice heterozygous for the APOE*3-
Leiden gene were crossbred at our own facility with mice expressing human cholesteryl 
ester transfer protein (CETP) to yield APOE*3-Leiden.CETP (E3L.CETP) transgenic mice 
[22], a mouse model with a human-like lipoprotein metabolism [23]. Female E3L.CETP 
mice of 8-12 weeks old were fed ad libitum with Western-type diet (WTD) containing 15% 
fat from cocoa butter, 1% fat from corn oil (diet T, HopeFarms, Aldrich, Zwijndrecht, the 
Netherlands), enriched with 0.1% cholesterol. During a run-in period of three weeks mice 
were housed under standard 12h:12h light:dark (LD) conditions. Afterwards, mice were 
randomized based on fasting plasma total cholesterol (TC), TG, body weight and age to 
experimental groups described below. Mice were group-housed (n=3/cage) in clear plastic 
cages, placed in light-tight cabinets fitted with diffuse white fluorescent light with an 
intensity of approximately 85 µW/cm2. In the last two weeks of the experiment, behavioral 
activity patterns were assessed by housing mice individually in cages fitted with passive 
infrared detectors.
Experimental Design
In two separate atherosclerosis experiments, the effects of prolonged light exposure 
and of mistimed light exposure on atherosclerosis development were investigated. 
Blood drawing and final experiments started at ZT4 (ZT = Zeitgeber time in hours where 
ZT0 represents lights on) and groups were alternated. In the first experiment, mice were 
randomized to either a regular 12h:12h LD cycle or to constant light exposure (LL) (n=18/
group) for the total duration of 14 weeks. In week 2, 4, 8 and 12 after start of light exposure 
intervention unfasted blood samples were obtained. At the same time, body weight was 
measured and food intake was determined by weighing food on the lid of the cage. After 14 
weeks, body composition was assessed by EchoMRI-100 (EchoMRI, Houston, Texas), mice 
were anesthetized by intraperitoneal injection of acepromazin (6.25 mg/kg; Sanofi Sant 
Nutrition Animale, Libourne Cedex, France), midazolam (6.25 mg/kg; Roche, Mijdrecht, the 
Netherlands), and fentanyl (0.31 mg/kg; Janssen-Cilag, Tilburg, the Netherlands), and blood 
was drawn retro-orbitally into EDTA coated cups for immune cell analysis. Afterwards, mice 
were killed by cervical dislocation and organs were harvested for further analysis.
In the second experiment, mice were randomized to either LD, a 6-h phase advance 
every week (advance), a 6-h phase delay every week (delay) or a weekly reversal of the 12h 
light-dark cycle (LD-DL) (n=15/group) for the total duration of 15 weeks. In week 3, 7, 11 
and 15 after start of the light regime, when light regimes were aligned among the groups, 
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unfasted blood was drawn at ZT4 on the 2nd day and also on the 6th day after a shift where 
indicated. At the same time, body weight and food intake were measured as described 
above. At week 11, blood was collected into EDTA-coated cups and used for immune cell 
analysis. After 15 weeks, mice were killed by CO2 inhalation, blood was drawn into EDTA-
coated cups and organs were harvested for further analysis.
Biochemistry
Blood was drawn via the tail vein into paraoxon coated capillaries. Plasma was isolated by 
centrifugation, snap frozen into liquid nitrogen and stored at -80°C until further analyses. 
Plasma TC and TG were analysed by commercially available enzymatic kits according to 
manufacturer’s protocols (Roche Molecular Biochemicals, IN, USA). HDL was isolated by 
precipitation of ApoB-containing lipoproteins. Hereto, 20% polyethylene glycol (Sigma 
Aldrich) in 200 mM glycine-buffered saline (pH 10) was added to plasma, centrifuged for 
30 minutes at 6,000 rpm, and HDL-C was determined in the supernatant. Non-HDL-C was 
calculated by subtracting HDL-C from TC.
Immune cell composition
Immune cell composition of freshly isolated whole blood (100 µl) was determined using 
Sysmex using a XT-2000i hematology analyzer (Sysmex Corporation, Japan).
Histological analysis of the heart
Hearts were fixated in phosphate buffered 4% paraformaldehyde and embedded in paraffin 
and cross-sections of 5 µm were made in the aortic valve region. Sections were stained 
with haematoxylin-phloxine-saffron for histological analysis. Per mouse, lesion area was 
quantified in the aortic root starting from the appearance of open aortic valve leaflets in 
four subsequent sections with 50 µm intervals. Lesion area was determined by analysis 
using Image J software. Lesion severity was scored according to the guidelines of the 
American Heart Association adapted for mice [24].
Histological analysis of adipose tissue
Interscapular brown adipose tissue (iBAT) was fixated in phosphate buffered 4% 
paraformaldehyde, embedded in paraffin and cross-sections of 5 µm were made. Sections 
were stained with Mayer’s haematoxylin and eosin. BAT lipid droplet content was quantified 
using ImageJ software.
Gene expression analysis
A part of iBAT was snap frozen and stored at -80°C for gene expression analysis and 
protein analysis (see below). Total RNA was isolated using TriPure (Roche) according to 
the manufacturer’s instructions. 1 μg of total RNA was reverse-transcribed using M-MLV 
reverse transcriptase (Promega, Madison, WI, USA). Real-time PCR was carried out on a 
CFX96 PCR machine (Bio-Rad) using IQ SYBR-Green Supermix (Bio-Rad). Expression levels 




Behavioral patterns were analysed by plotting actograms using Clock lab (Actimetrics, 
Wilmette, IL, USA). F-periodogram analysis was performed on activity binned into 10 
minutes interval of the last 10 consecutively recorded experimental days according to the 
algorithm of Dörrscheidt and Beck [25].
Statistical analysis
Comparisons between group averages were performed using Student’s T-test or ANOVA 
with Fisher LSD post-hoc test (compared to LD light schedule), where appropriate 
(Graphpad Prism v.6). Correlations between two dependent variables were made using 
Pearson’s correlation analysis. Data are presented as means ± SEM. Differences at P values 
< 0.05 were considered statistically significant.
RESULTS
Constant light attenuates circadian rhythm strength in APOE*3-
Leiden.CETP mice
Dyslipidemic APOE*3-Leiden.CETP female mice were subjected to 14 weeks of either 
constant light (LL) or normal light dark cycles (LD). The effect of light intervention on the 
circadian behavior was assessed by monitoring spontaneous physical activity rhythms via 
passive infrared detectors. Periodogram analysis demonstrated that LL lengthened the 
period of physical activity rhythmicity, compared to the LD mice (26.29 ± 0.14 vs. 24.02 
± 0.03 h; p<0.0001) (Fig. 1a). In addition, average rhythm strength was decreased in LL 
mice compared to LD mice (0.59 ± 0.02 vs. 0.66 ± 0.01; p=0.038) (Fig. 1b). LL mice showed 
considerably higher variation compared to LD mice (CV 16% vs. 5%) and between various 
LL mice we observed different physical activity patterns between high and low amplitude 
actograms (Fig. 1c-h). These data indicate that, while chronic LL exposure does not render 
all mice arrhythmic as determined by physical activity patterns, LL clearly attenuates the 
rhythmic circadian clock output.
Figure 1. (right page) Constant light attenuates circadian rhythm strength in APOE*3-Leiden.
CETP mice. APOE*3-Leiden.CETP mice fed WTD were exposed to LD or LL (n=18/group) for 14 weeks. 
During the last 10 days, mice were individually housed and behavioral activity was monitored by passive 
infrared monitors (n=8 LD, n=18 LL). Rhythm length (a) and rhythm strength (b) was calculated using F 
periodogram analysis. Representative double-plotted actogram (c) and periodogram (d) is shown for 1 
LD mouse. Double-plotted actograms (e, g) and periodograms (f, h) are shown for 2 LL mice. Gray dotted 
line represents significance threshold. * = p<0.05; **** = p<0.0001 (unpaired T-test). Data is presented as 



















































Figure 2. Constant light decreases food intake without increasing body weight or adiposity in APOE*3-
Leiden.CETP-mice. APOE*3-Leiden.CETP mice fed WTD were exposed to LD or LL (n=18/group) for 14 
weeks. Food intake (a) and body weight (b) were determined at regular intervals. After 14 weeks, body 
composition (fat mass versus lean mass) was determined by EchoMRI (c) and subcutaneous white adipose 
tissue (sWAT), gonadal WAT (gWAT) and interscapular brown adipose tissue (iBAT) were weighed (d). Part of 
iBAT was stained with H&E for lipid content quantification (e) and in part used for gene expression analysis 
by qPCR (f). Expression is normalized for 36b4 and relative to mean LD expression. * = p<0.05; *** = p<0.001 
(unpaired T-test). Data is presented as means ± SEM.




































































































Constant light decreases food intake without altering body 
weight or adiposity in APOE*3-Leiden.CETP mice
Body weight and food intake were measured throughout the study and fat mass was 
determined after 14 weeks of light intervention. We observed a small but consistent 
decrease in food intake in mice subjected to LL (Fig. 2a), which resulted in a lower cumulative 
food intake in LL mice compared to LD mice over 14 days (232 ± 4 vs. 260 ± 5 g/mouse; 
p<0.0001). This difference in food intake did not result in differences in body weight of the 
mice over time (at 14 weeks 25.2 ± 0.6 vs. 25.7 ± 0.7 g; p=0.608) (Fig. 2b), nor in fat mass as 
measured by EchoMRI (4.3 ± 0.5 vs. 5.1 ± 0.5 g; p=0.301) (Fig. 2c). Also, wet tissue weights 
of subcutaneous and gonadal white adipose tissue (sWAT; gWAT) depots were similar in LL 
mice compared to LD mice after 14 weeks (sWAT 0.25 ± 0.02 vs. 0.23 ± 0.02 g; p=0.460) 
(gWAT 0.45 ± 0.07 vs. 0.55 ± 0.06 g; p=0.242) (Fig. 2d). BAT activation leads to increased 
delipidation of BAT, which is reflected by the weight and lipid content [26]. BAT weight did 
not decrease due to LL (iBAT 0.054 ± 0.004 vs. 0.067 ± 0.005 g; p=0.064) (Fig. 2d), which 
was in line with the lipid content, which was equal between mice exposed to LL and LD (39 
± 2 vs. 44 ± 2%; p=0.149) (Fig. 2e). Thermogenic gene Ucp1 showed a decreased relative 
expression in LL compared to LD (0.78 ± 0.06 vs. 1.00 ± 0.07 fold change; p=0.028) (Fig. 2f), 
however this was not accompanied by a lower expression of thermogenic genes Pgc1α 
(p=0.221) and Dio2 (p=0.400) (Fig. 2f).
Constant light increases total cholesterol exposure without 
increasing atherosclerosis
Compared to LD, LL exposure raised TC plasma levels after 4 weeks (+3.6 ± 1.5 mM; p=0.025), 
8 weeks (+3.0 ± 1.5 mM; p=0.056) and after 12 weeks (+4.5 ± 1.9 mM; p=0.025) of light 
intervention (Fig. 3a). This increase in TC was accompanied by a slightly lower TG level after 
4 weeks (-1.1 ± 0.5 mM; p=0.013) and 14 weeks (-1.1 ± 0.5 mM; p=0.044) (Fig. 3b), but not 
at the other time points. Determination of cholesterol in lipoprotein subfractions showed 
that TC levels were increased due to a selective increase in non-HDL-cholesterol levels, 
i.e. (V)LDL-cholesterol (Fig. 3c-d). We therefore calculated TC exposure for the duration of 
light intervention, which was elevated in LL mice compared to LD mice (288 ± 12 vs. 251 
± 11 mM*week; p=0.038) (Fig. 3e). Since atherosclerosis development depends on both 
dyslipidemia and inflammation, we explored whether light interventions may have altered 
immune cell composition by measuring white blood count in peripheral blood. Interestingly, 
we observed a decrease in white blood cell (2.8 ± 0.2 *109 vs. 4.7 ± 0.4*109 cells/l; p<0.001) 
and platelet counts (1.8 ± 0.2 *1012 vs. 1.4 ± 0.1*1012 cells/l; p=0.013) due to LL exposure 
(Fig. 3f).
We next determined atherosclerotic lesion formation by assessing atherosclerosis 
plaque size and severity in the aortic root. Despite the raised TC exposure in LL mice, we 
observed no difference in atherosclerotic lesion size between LL and LD exposed mice 
(11.3 ± 1.0*104 vs. 12.0 ± 1.2*104 mm2; p=0.540) (Fig. 3g). Likewise, lesion severity was not 
different (66 ± 5 vs. 62 ± 4% mild lesions; p=0.579) (37 ± 4 vs. 34 ± 5 % severe lesions; 





Figure 3. (left page) Constant light increases total cholesterol exposure without increasing 
atherosclerosis. APOE*3-Leiden.CETP mice fed WTD were exposed to LD or LL (n=18/group) for 14 weeks. 
Plasma total cholesterol (a) and triglycerides (b) was determined at regular intervals, HDL-cholesterol (c) 
and non-HDL-cholesterol (d) was determined after 8, 12 and 14 weeks. Total cholesterol exposure was 
calculated (e). After 14 weeks, mice were sacrificed and whole blood was collected and pooled (n=4-5/
group) for cell count using Sysmex (f). Hearts were isolated and, at the aortic root, atherosclerotic lesion 
size (g) and severity (h) was determined. Rhythm strength was correlated to total cholesterol exposure 
(i) and atherosclerotic plaque area ( j) for mice exposed to LL (Pearson correlation). * = p<0.05 (unpaired 
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Figure 4. Representative actograms of mistimed light exposure. APOE*3-Leiden.CETP mice fed WTD 
were exposed to LD, weekly 12 h reversal (LD-DL), weekly 6h advance or weekly 6h delay. During the last 
10 days, mice were individually housed and behavioral activity was monitored by passive infrared monitors. 




Figure 5. Weekly phase shift does 
not increase body weight or food 
intake. APOE*3-Leiden.CETP mice fed 
WTD were exposed to LD, weekly 12 h 
reversal (LD-DL), weekly 6h advance 
or weekly 6h delay (n=15/group). 
Food intake (a) and body weight (b) 
were determined at regular intervals. 
After 14 weeks, subcutaneous 
gonadal white adipose tissue (gWAT) 
and interscapular brown adipose 
tissue (iBAT) were weighed (c). Data is 
presented as means ± SEM. * (LD-DL 
vs LD), $ (Delay vs LD); ANOVA, Fischer 
LSD post-hoc) = p<0.05, **,$$ = p<0.01. 
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Figure 6. (right page) Weekly phase shift increases atherosclerotic development independent of 
cholesterol levels. APOE*3-Leiden.CETP mice fed WTD were exposed to LD, weekly 12 h reversal (LD-
DL), weekly 6h advance or weekly 6h delay (n=15/group). Plasma total cholesterol (a) was determined at 
regular intervals. Total cholesterol exposure was calculated (b). After 11 weeks, whole blood was collected 
and pooled (n=3/group) for cell count using Sysmex (c). After 15 weeks, mice were sacrificed, hearts were 
isolated and atherosclerotic lesion size was determined at the aortic root (d) as well as lesion severity (e). 
Representative histological slides are shown for each group (f). Data is presented as means ± SEM. * (LD-
DL vs. LD), $ (delay vs. LD), # advance vs. LD; ANOVA, Fischer LSD post-hoc) = p<0.05, ** = p<0.01. Data is 
presented as means ± SEM. WBC= white blood cells, RBC=red blood cells, PLT=platelets. Arrows indicate 





rhythm strength associated to either TC exposure or atherosclerotic lesion size. We found 
a weak positive correlation between rhythm strength and TC exposure (p=0.02, R2=0.28) 
and not with atherosclerotic lesion area (Fig. 3i-j). In summary, as compared to LD exposure, 
14 weeks of LL exposure attenuated circadian rhythm without increasing atherosclerosis 
development in dyslipidemic mice, despite raised TC exposure.
Weekly light shifts do not affect total food intake nor body 
weight
Previously, we showed that 5 weeks of LL exposure severely decreases rhythm strength 
in mice [27]. In the present experiment, we observed that after 14 weeks of LL a large 
subset of mice retained a strong rhythmicity, albeit with increased period length (Fig. 1). We 
reasoned that chronic LL exposure may have led to adaptation of mice to the light schedule. 
Additionally, constant light does not model human shift work, as in shift work light-dark 
cycles are maintained but shifted repeatedly depending on the shift rotation. This induces 
a repeated stress on the biological clock system, as the internal clocks need to adapt 
to the environmental light condition with every shift. For these reasons, we conducted a 
second experiment in which mice were subjected to either a weekly changing schedule of 
6 h advance (advance), 6 h delay (delay) or 12 h light-dark reversal (LD-DL), compared to 
regular 12h light-dark (LD) cycles. Typical physical activity patterns are shown in (Fig. 4).
Similar to LL exposure, weekly shifted schedules transiently affected food intake of 
the mice in the first 3 weeks of the intervention. Compared to LD (76.1 ± 0.7 g/mouse), 
cumulative food intake measured during the first three weeks was lower in LD-DL (66.1 ± 0.7 
g/mouse; p<0.0001) and advance (71.1 ± 0.7 g/mouse; p=0.0001) groups and higher in the 
delay group (81.1 ± 0.7 g/mouse; p=0.0001) (Fig. 5a). However, at subsequent time points, 
these differences did not persist. Also, body weight (Fig. 5b) and gonadal white adipose 
tissue mass did not differ between the different light schedules (Fig. 5c). Interestingly, 
compared to LD, iBAT weight decreased in LD-DL (0.076 ± 0.004 vs. 0.090 ± 0.005 g; 
p=0.015) and tended to decrease in the advance group (0.080 ± 0.003 g; p=0.084) (Fig. 5c).
Weekly light shifts increase atherosclerotic development 
independent of cholesterol levels
TC plasma levels were determined every 3-4 weeks. We did not observe consistent 
differences between the different groups with respect to TC levels (Fig. 6a), which was 
reflected by similar TC exposure between groups (Fig. 6b). After 11 weeks of light shifts, 
white blood count in peripheral blood was measured. In line with the decrease in white 
blood cells due to LL exposure, we observed also a decrease in white blood cell count due 
to LD-DL exposure (6.4 ± 1.5*109 vs. 11.5 ± 1.4*109 cells/l; p=0.010). However, advance or 
delay did not change immune cell counts in peripheral blood and platelet count was not 
affected (Fig. 6c).
After 15 weeks of light schedule intervention, we determined atherosclerosis 
development. Compared to LD mice (9.5 ± 1.3*104 mm2), the delay group did not show 
differences in atherosclerotic plaque size in the aortic root (12.6 ± 1.5*104 mm2; p=0.207). 
111
5
In contrast, 6h advance light schedule tended to increase atherosclerotic plaque size (13.9 
± 1.9*104 mm2; p=0.074). Strikingly, LD-DL increased plaque size by 1.8-fold compared to 
LD mice (17.5 ± 1.9*104 mm2; p=0.002) (Fig. 6d, f). The increased plaque size in LD-DL group 
and 6h advance group was accompanied by a shift of plaque severity, as LD-DL and 6h 
advance group displayed a decrease in mild plaques and an increase of severe plaques 
compared to LD (Fig. 6e).
DISCUSSION
This is the first study to demonstrate that mistimed light exposure aggravates 
atherosclerosis development. Specifically, we show that a weekly reversal of LD cycle, 
and to a lesser extent 6 h phase advance, increases atherosclerotic lesion size and lesion 
severity without considerable changes in plasma cholesterol levels. We therefore conclude 
that pro-atherogenic effects of disturbed rhythms may be due to mistimed light exposure, 
but are dependent on the timing of the light shift.
Constant light exposure of APOE*3-Leiden.CETP mice induced lengthening of the period 
of circadian physical activity rhythms in all mice, while only in a subset of mice it weakened 
the rhythm strength. We previously observed that 5 weeks of constant light exposure of 
male wild type mice induced a decrease in amplitude of the output of the central biological 
clock in the hypothalamus, the suprachiasmatic nuclei (SCN) [27]. Also, constant light 
induced an analogous decrease in rhythm strength in physical activity rhythms [17, 27]. 
Gender differences between these studies may have contributed to a different effect of 
light regime on rhythm strength. The SCN is sensitive to sex hormones, and gonadectomy 
experiments have demonstrated that sex hormones change circadian rhythms [28].
In our study, we did not observe an effect on body weight and adiposity. This is contrast 
with previous reports showing that constant light exposure increases body weight [29] and 
adiposity [17]. Most likely, this is due to use of different mouse models and gender. In our 
study, we used female APOE*3-Leiden.CETP mice on a C57Bl/6J background. It is known 
that female C57Bl/6J mice are less prone to diet-induced weight gain and development of 
insulin resistance than male C57Bl/6J mice [30] [31].
We did show that constant light exposure increased plasma TC levels, due to an increase 
in non-HDL-cholesterol. This effect could be explained by decreased BAT activity, since we 
previously observed that BAT activation increases hepatic uptake of remnants and thereby 
decreases TC levels in APOE*3-Leiden.CETP mice [19]. Short term LL exposure indeed 
decreased BAT activity [17]. In this study, we explored whether BAT was affected by long 
term LL but found only a lower Ucp1 gene expression to support this hypothesis. Further 
studies are needed to investigate whether chronic LL exposure also decreases FA uptake 
by BAT. The increased plasma TC may also be a result of increased cholesterol absorption 
in the intestine. Clockmt/mt mice, which have a genetic disturbance of the biological 
clock, display increased enteric uptake of cholesterol. Consequently, these mice have 
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increased plasma TC levels and, when crossbred with Ldlr-/- mice, also display enhanced 
atherosclerosis development [32, 33].
Weekly reversal of light exposure aggravated atherosclerosis development without 
detectable changes in plasma cholesterol levels. This is striking, as previous studies in 
APOE*3.Leiden-CETP mice consistently showed a strong correlation between TC exposure 
and atherosclerosis development [34, 35]. Possibly, activation of pro-inflammatory 
pathways may be more important in the atherogenic effects of LD-DL exposure. We 
observed a decrease in total white blood cell count, which traditionally is associated 
with anti-atherogenic phenotype [36]. Alternatively, it may indicate more clearance of 
white blood cells, e.g. into the arterial wall. Additionally, inflammatory cells may be more 
polarized towards a pro-inflammatory status. In line with this hypothesis, it was previously 
shown that macrophages derived from Clockmt/mt mice have increased expression of 
pro-inflammatory cytokines [33]. Also, selective hematopoietic overexpression of clock 
gene Rev-erbα in Ldlr-/- mice skewed macrophages towards an M1 phenotype, thereby 
aggravating atherosclerotic development [37]. Lastly, phase shift increased LPS-induced 
mortality in mice and heightened LPS response in macrophages [38]. Together, these 
data strongly suggest that disturbed biological clock function induces a pro-inflammatory 
status, which may underlie the pro-atherogenic effect of LD-DL. The various light conditions 
had different effects on atherosclerosis formation. A weekly 6 h advance induced more 
severe lesions and tended to increase lesion size, while delay did not. This is in line with a 
study showing that in aged mice, advance but not delay light schedule increases mortality 
[21]. Adaptation to phase advance is more disturbing for the biological clock function. 
Moreover, 12h shifts induced more atherosclerosis than a 6 h shift. Therefore, there seems 
to be a correlation between the extent of disturbance to the biological clock function and 
atherosclerosis development.
We conclude that severe disturbance of circadian rhythm by advance light schedules 
and alternating LD-DL schedules accelerates atherosclerosis formation independent of 
plasma cholesterol levels. In human shift work, it has been shown that rotating shift work 
has a higher risk for CVD than fixed schedules [39]. Also, the duration of shift work has 
been shown to correlate to increase risk for CVD [10, 40, 41]. Our study supports a dose-
dependent relationship between disturbance to the biological clock through mistimed 
light exposure and atherosclerosis. Together, these studies imply that employers and 




The authors thank M. Hoekstra and M. van Eck for use of hematology analyzer and EM de 
Ruiter and TCM Streefland for excellent technical assistance. Conflict of Interest: none. 
Funding: This research was supported by the Netherlands Organization for Scientific 
Research (NWO-VENI grant 016.136.125 to NR Biermasz), the European Foundation 
for the Study of Diabetes and the Programme Partner Novo Nordisk (grant 94802 to CP 
Coomans, JH Meijer and PCN Rensen), and the Dutch Diabetes Research Foundation (grant 
2013.81.1663 to CP Coomans). PCN Rensen is an Established Investigator of the Dutch 
Heart Foundation (grant 2009T038). Author contributions: RB designed the study, wrote 
manuscript, performed experiments and analysed data; MS, SK performed experiments 
and analysed data; AR, PPSJ, LWP, SB, KW, CPC; performed experiments, NRB, JHM, PCN 
supervised the study.
REFERENCES
1. Alwan, A., Global status report on noncom-
municable diseases 2010. 2011: World Health 
Organization.
2. Steinberg, D., Atherogenesis in perspective: hy-
percholesterolemia and inflammation as partners 
in crime. Nat Med, 2002. 8(11): p. 1211-7.
3. Anderson, K.M., W.P. Castelli, and D. Levy, 
Cholesterol and mortality. 30 years of follow-up 
from the Framingham study. JAMA, 1987. 257(16): 
p. 2176-2180.
4. Chua, E.C., et al., Extensive diversity in circadian 
regulation of plasma lipids and evidence for differ-
ent circadian metabolic phenotypes in humans. 
Proc. Natl Acad. Sci. U. S. A, 2013. 110(35): p. 
14468-14473.
5. Reutrakul, S. and K.L. Knutson, Consequences of 
Circadian Disruption on Cardiometabolic Health. 
Sleep Med Clin, 2015. 10(4): p. 455-68.
6. Reutrakul, S. and C.E. Van, Interactions between 
sleep, circadian function, and glucose metabo-
lism: implications for risk and severity of diabetes. 
Ann. N. Y. Acad. Sci, 2014. 1311: p. 151-173.
7. Laermans, J. and I. Depoortere, Chronobesity: role 
of the circadian system in the obesity epidemic. 
Obes Rev, 2016. 17(2): p. 108-25.
8. Eyv, T.-E., Skiftwarbeid og helse (Shift work and 
health): en undersøkelse av mortalitet og mor-
biditet hos arbeidere i en kjemisk fabrik. 1949: 
Porsgrunn; Jacobsen.
9. Brown, D.L., et al., Rotating night shift work and 
the risk of ischemic stroke. Am J Epidemiol, 2009. 
169(11): p. 1370-7.
10. Vetter, C., et al., Association Between Rotating 
Night Shift Work and Risk of Coronary Heart 
Disease Among Women. Jama, 2016. 315(16): p. 
1726-34.
11. Parent-Thirion, A.M., EnriqueHurley, 
JohnVermeylen, Greet, Fourth European Working 
Conditions Survey. 2007, EurWORK: Dublin: 
European Foundation for the Improvement of 
Living and Working Conditions.
12. McFadden, E., et al., The Relationship Between 
Obesity and Exposure to Light at Night: Cross-
Sectional Analyses of Over 100,000 Women 
in the Breakthrough Generations Study. Am. J 
Epidemiol, 2014.
13. Pattinson, C.L., et al., Environmental Light 
Exposure Is Associated with Increased Body Mass 
in Children. PLoS One, 2016. 11(1): p. e0143578.
14. Rybnikova, N.A., A. Haim, and B.A. Portnov, Does 
114
5
artificial light-at-night exposure contribute to the 
worldwide obesity pandemic? Int J Obes. (Lond), 
2016.
15. Koo, Y.S., et al., Outdoor artificial light at night, 
obesity, and sleep health: Cross-sectional analy-
sis in the KoGES study. Chronobiol Int, 2016. 33(3): 
p. 301-14.
16. Obayashi, K., et al., Exposure to light at night, noc-
turnal urinary melatonin excretion, and obesity/
dyslipidemia in the elderly: a cross-sectional anal-
ysis of the HEIJO-KYO study. J Clin Endocrinol. 
Metab, 2013. 98(1): p. 337-344.
17. Kooijman, S., et al., Prolonged daily light exposure 
increases body fat mass through attenuation of 
brown adipose tissue activity. Proc. Natl Acad. Sci. 
U. S. A, 2015. 112(21): p. 6748-6753.
18. Khedoe, P.P., et al., Brown adipose tissue takes up 
plasma triglycerides mostly after lipolysis. J. Lipid 
Res, 2015. 56(1): p. 51-59.
19. Berbee, J.F., et al., Brown fat activation reduces 
hypercholesterolaemia and protects from athero-
sclerosis development. Nat Commun, 2015. 6: p. 
6356.
20. Van Dycke, K.C., et al., Chronically Alternating 
Light Cycles Increase Breast Cancer Risk in Mice. 
Curr Biol, 2015. 25(14): p. 1932-7.
21. Davidson, A.J., et al., Chronic jet-lag increases 
mortality in aged mice. Curr Biol, 2006. 16(21): p. 
R914-6.
22. Westerterp, M., et al., Cholesteryl ester transfer 
protein decreases high-density lipoprotein and 
severely aggravates atherosclerosis in APOE*3-
Leiden mice. Arterioscler Thromb Vasc Biol, 2006. 
26(11): p. 2552-9.
23. van den Maagdenberg, A.M., et al., Transgenic 
mice carrying the apolipoprotein E3-Leiden gene 
exhibit hyperlipoproteinemia. J. Biol. Chem, 1993. 
268(14): p. 10540-10545.
24. Zadelaar, S., et al., Mouse models for atheroscle-
rosis and pharmaceutical modifiers. Arterioscler. 
Thromb. Vasc. Biol, 2007. 27(8): p. 1706-1721.
25. Dörrscheidt GL and B. L., Advanced methods for 
evaluating characteristic parameters of circadian 
rhythms. J Mathemat Biol, 1975. 2: p. 107-121.
26. Virtue, S. and A. Vidal-Puig, Assessment of brown 
adipose tissue function. Front Physiol, 2013. 4: p. 
128.
27. Coomans, C.P., et al., Detrimental effects of con-
stant light exposure and high-fat diet on circadian 
energy metabolism and insulin sensitivity. FASEB 
J, 2013. 27(4): p. 1721-1732.
28. Yan, L. and R. Silver, Neuroendocrine underpin-
nings of sex differences in circadian timing sys-
tems. J Steroid Biochem Mol Biol, 2016. 160: p. 
118-26.
29. Fonken, L.K., et al., Dim light at night disrupts 
molecular circadian rhythms and increases body 
weight. J. Biol. Rhythms, 2013. 28(4): p. 262-271.
30. Montgomery, M.K., et al., Mouse strain-dependent 
variation in obesity and glucose homeostasis in 
response to high-fat feeding. Diabetologia, 2013. 
56(5): p. 1129-39.
31. Yang, Y., et al., Variations in body weight, food in-
take and body composition after long-term high-
fat diet feeding in C57BL/6J mice. Obesity (Silver 
Spring), 2014. 22(10): p. 2147-55.
32. Pan, X., et al., Diurnal regulation of MTP and plas-
ma triglyceride by CLOCK is mediated by SHP. Cell 
Metab, 2010. 12(2): p. 174-186.
33. Pan, X., X.C. Jiang, and M.M. Hussain, Impaired 
Cholesterol Metabolism and Enhanced 
Atherosclerosis in Clock Mutant Mice. Circulation, 
2013.
34. Kühnast, S., et al., Niacin Reduces Atherosclerosis 
Development in APOE*3Leiden.CETP Mice Mainly 
by Reducing NonHDL-Cholesterol. PLoS One, 
2013. 8(6).
35. Kuhnast, S., et al., Anacetrapib reduces pro-
gression of atherosclerosis, mainly by reducing 
non-HDL-cholesterol, improves lesion stability 
and adds to the beneficial effects of atorvastatin. 
Eur. Heart J, 2015. 36(1): p. 39-48.
36. Kounis, N.G., et al., White Blood Cell Counts, 
Leukocyte Ratios, and Eosinophils as 
115
5
Inflammatory Markers in Patients With Coronary 
Artery Disease. Clinical and Applied Thrombosis/
Hemostasis, 2015. 21(2): p. 139-143.
37. Ma, H., et al., Increased Atherosclerotic Lesions in 
LDL Receptor Deficient Mice With Hematopoietic 
Nuclear Receptor Rev-erbalpha Knock- Down. J. 
Am. Heart Assoc, 2013. 2(4): p. e000235.
38. Castanon-Cervantes, O., et al., Dysregulation of 
inflammatory responses by chronic circadian dis-
ruption. J Immunol, 2010. 185(10): p. 5796-805.
39. Fujino, Y., et al., A prospective cohort study of 
shift work and risk of ischemic heart disease in 
Japanese male workers. Am. J. Epidemiol, 2006. 
164(2): p. 128-135.
40. Kawachi, I., et al., Prospective study of shift work 
and risk of coronary heart disease in women. 
Circulation, 1995. 92(11): p. 3178-3182.
41. Haupt, C.M., et al., The relation of exposure to 
shift work with atherosclerosis and myocardial 
infarction in a general population. Atherosclerosis, 
2008. 201(1): p. 205-211.

PART II 
Circadian rhythms in human studies: 
implications for metabolic health
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ABSTRACT
We have previously shown that acute sleep curtailment induces insulin resistance, both 
in healthy individuals as well as in patients with type 1 diabetes, suggesting a causal role 
for sleep disturbances in pathogenesis of insulin resistance, independent of endogenous 
insulin production. However, the underlying mechanisms remain unclear. This study aimed 
to explore the metabolic pathways affected by sleep loss using targeted metabolomics in 
human fasting plasma samples. Healthy individuals (n = 9) and patients with type 1 diabetes 
(n = 7) were studied after a single night of short sleep (4 hours) versus normal sleep (8 
hours) in a cross-over design. Strikingly, one night of short sleep specifically increased 
the plasma levels of acylcarnitines, essential intermediates in mitochondrial fatty acid 
oxidation (FAO). Specifically, short sleep increased plasma levels of tetradecenoyl-L-
carnitine (C14:1) (+32%, p=2.67*10-4), octadecanoyl-L-carnitine (C18:1) (+22%, p=1.92*10-
4) and octadecadienyl-L-carnitine (C18:2) (+27%, p=1.32*10-4). Since increased plasma 
acylcarnitine levels could be a sign of disturbed FAO, it is possible that sleep curtailment 
acutely induces inefficient mitochondrial function. Our observations provide a basis for 
further research into the role of acylcarnitines as a potential mechanistic pathway by which 





Diabetes mellitus (DM) is characterized by either an absolute (type 1; DM1) or relative (type 
2; DM2) deficiency of insulin. Both DM1 and DM2 are associated by increased morbidity and 
increased cardiovascular risk [1, 2]. Peripheral insulin resistance precedes the development 
of DM2 and recently it has been recognized that a certain degree of insulin resistance is 
also present in DM1 [3]. Therefore, uncovering modifiable risk factors in an early stage of 
insulin resistance development is of crucial importance to reduce the number of patients 
with DM2 and improve glycemic control in DM1. Interestingly, the DM2 epidemic coincides 
with a reduction in the average sleep duration, which has gradually declined with ~1.5 hours 
per night [4] over the past decades. In fact, large epidemiological cohorts have documented 
an association between sleep duration and increased insulin resistance [5]. Furthermore, 
short sleep has been associated with poor glycemic control in DM1 [6]. Both short and long 
duration of sleep are associated with an increased risk for insulin resistance, implying that 
there might be an optimal sleep duration of approximately 8 hours [7-10]. Several human 
intervention studies showed that decreased sleep duration causes insulin resistance. 
Repeated sleep curtailment during more than 6 nights increased insulin resistance in 
healthy individuals [11-13]. Moreover, we previously published that even one single night 
with partial sleep loss, i.e. 4 hours sleep allowed, a condition representative for incidental 
daily life sleep habits, is sufficient to induce peripheral insulin resistance in both healthy 
young individuals [14] as well as patients with DM1 [15].
The mechanism by which acute sleep curtailment induces insulin resistance has not 
been fully elucidated. Plasma metabolomics is considered a valuable approach to assess 
underlying biological processes, complementary to genomics and transcriptomics. 
Strikingly, metabolite levels reflect biological activity of the encoded proteins and are 
thus closer to the clinical endpoints [16]. Indeed, metabolomics has previously been 
demonstrated to be a powerful tool in investigating insulin resistance and DM2 [17]. Thus 
far, the effects of sleep loss on the human metabolome are poorly characterized. Prolonged 
sleep deprivation during 5 days has been shown to induce metabolite changes in lipid, 
carbohydrate, amino acid and protein pathways [18, 19]. In contrast, Davies et al. [20] 
subjected healthy individuals to complete sleep restriction of 24 hours. This extreme sleep 
deprivation resulted in increased plasma levels of glycerophospholipids, acylcarnitines, 
sphingolipids and amino acids. However, the sleep intervention and control sleep occurred 
on consecutive days in all individuals. Differences between metabolite levels were also 
observed between the wake periods, suggesting that the study conditions were not fully 
comparable. In addition, none of these previous studies included measurements of insulin 
resistance. Therefore, the aim of the present study was to use metabolomics to explore 
pathways involved in the relationship between sleep and insulin resistance in a cohort with 
proven insulin resistance upon short sleep duration [14, 15]. To this end, we examined 163 
metabolites in 16 individuals (healthy individuals and individuals with DM1) subjected to a 
night of normal sleep duration (8 hours) and one night of short sleep duration (4 hours). Here, 
we report that one night of sleep curtailment specifically increases the metabolic class of 
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acylcarnitines in plasma, suggesting that increased acylcarnitines are associated with the 
observed relationship between sleep curtailment and induction of insulin resistance.
MATERIALS AND METHODS
Protocol
Two studies were previously performed, to study the effect of one night of short sleep 
duration (4 hours) compared to normal sleep duration (8 hours) on peripheral insulin 
resistance [14, 15]. The studies applied the same study design in two different populations, 
namely healthy individuals and patients [14] with type 1 diabetes (DM1) [15]. Healthy 
individuals were studied to determine the effects of a single night of short sleep duration 
on insulin resistance. The second study assessed the effects of short sleep duration on 
insulin resistance in DM1 patients on stable insulin pump therapy. DM1 patients do not 
have endogenous insulin production and therefore cannot compensate for fluctuations 
in insulin resistance. We hypothesized that variations in sleep duration could contribute 
the intra-individual variations in glucoregulation. In both healthy individuals and individuals 
with DM1, decreased sleep duration induced insulin resistance. Therefore, we reasoned 
that a single night of short sleep duration may increase peripheral insulin resistance via a 
common metabolic pathway. To investigate which pathways could be involved, we analyzed 
metabolites from both studies and pooled the data.
Subjects
The study was approved by the medical ethical committee of the Leiden University 
Medical Center and all subjects gave written informed consent. We recruited a total of 
18 individuals. Briefly, nine healthy individuals were recruited by advertisement and nine 
individuals with DM1 with stable continuous subcutaneous insulin pump therapy were 
included from our outpatient clinic. Exclusion criteria for all individuals were BMI>26 kg/m2, 
history of sleep disorders, psychiatric disorders and use of sleep medication, β-blocking 
drugs and prokinetic drugs. All individuals had a stable weight in the past 3 months and had 
regular and non-extreme sleeping habits. Habitual sleep duration was assessed by 7 days 
of actigraphy (Actiwatch AW7; Cambridge Neurotechnology, Cambridge, UK) prior to both 
study days and sleep questionnaires (Epworth Sleepiness Scale, Pittsburg Sleep Quality 
Index and Berlin Questionnaire). Subjects were instructed to maintain a regular dietary, 
activity and sleep regiments 3 days prior to both study days, fitting their habits, which they 
recorded in a diary. DM1 patients were instructed to keep a stable insulin pump setting. Of 
the 18 recruited individuals, 2 individuals with DM1 were excluded from all analyses, one 




Subjects were subjected to in-hospital sleep registration for 3 days, of which study day 1 
was for basal measurements and habituation to hospital conditions. Sleep duration and 
quality (of parameters) was assessed by polysomnography as described previously [14, 15]. 
All subjects underwent both a normal sleep night of at least 8 hours and one night of 4 hours 
sleep, the order of which was determined by balanced assignment, in a cross-over design 
with at least 3 weeks interval between measurements. In both sleep conditions, subjects 
spent 8.5 hours (from 23:00 to 7:30) in bed and were fasting from 22:00 onwards. During sleep 
curtailment, subjects were allowed to sleep from 01:00 to 05:00, the remaining time they 
were allowed to read or watch movies in upward position in dim light. Their wakefulness was 
monitored. After the night of normal or short sleep, a fasting plasma sample was obtained 
at 8:30 am, after which a hyperinsulinemic euglycemic clamp was performed as described 
in detail previously [15] to establish peripheral insulin sensitivity, endogenous glucose 
production and hepatic insulin sensitivity. Briefly, a primed (17.6 µmol*kg-1) continuous (0.22 
µmol*kg-1*min-1) infusion of [6,6-2H2]glucose (Cambridge Isotope laboratory, Andover, MA) 
was administered via a catheter. Infusion of insulin (Actrapid, Novo Nordisk, Alphen a/d Rijn) 
occurred simultaneously according to DeFronzo [21]. Blood samples were obtained every 
5 minutes from the contralateral arm for glucose measurements to adjust variable infusion 
of 20% glucose with 3% [6,6-2H2]glucose to maintain euglycemia (i.e. 5.0 mM), which was 
started 4 min after start of insulin infusion. Free fatty acids were determined in basal fasting 
plasma samples as by enzymatic colorimetric assay [14, 15].
Metabolomics
Metabolomics analysis was performed on fasting plasma samples in all individuals using 
the Biocrates AbsoluteIDQTM p150 kit (Biocrates, Life Science AG, Innsbruck, Austria) 
in the Genome Analysis Center at the Helmholtz Zentrum, Munich, Germany. The assay 
procedures of the AbsoluteIDQTM p150 kit as well as the metabolite nomenclature have 
been described in detail previously [22, 23]. Briefly, 10 µL of each plasma sample was 
pipetted into a 96 well sandwich plate containing an inserted filter with previously applied 
stable isotope labeled internal standards. The filters in the wells were dried using a stream 
of nitrogen. Amino acids were derivatized with 5% phenylisothiocyanate reagent (PITC) and 
the filters were dried again. Metabolites as well as internal standards were extracted with 5 
mM ammonium acetate in methanol and the solutions were centrifuged through the filter 
membrane into the lower deep well plate. The extracts were diluted with MS running solvent 
and analyzed. Flow injection analysis (FIA) tandem mass spectrometry (MS/MS) method was 
used to quantify 163 metabolites, including free carnitine, 40 acylcarnitines, 14 amino acids 
(13 proteinogenic + ornithine), hexoses (sum of hexoses), 92 glycerophospholipids (15 
lysophosphatidylcholines (lysoPC) and 77 phosphatidylcholines (PC), and 15 sphingolipids. 
Internal standards served as reference for the calculation of metabolite concentrations 
(µM). The complete list of analyzed metabolites grouped by metabolite class is presented in 




For all metabolites, differences between short and normal sleep were calculated by 
subtracting plasma levels obtained after short sleep from those obtained after normal 
sleep. Paired Students T-tests for were performed comparing normal and short sleep (SPSS 
statistical package edition 20) with Bonferroni post-hoc correction for multiple testing. P< 
3.07*10-4 (=0.05/163; after correction) was considered statistically significant. Calculations 
for hyperinsulinemic euglycemic clamp analysis were described previously [14, 15]. Since 
we aimed to investigate the effect of short sleep on metabolite levels, individuals of both 
groups (healthy individuals and individuals with DM1) were pooled to determine effects of 
sleep duration. Two way repeated measure ANOVA was performed to analyze interaction 
effects of subgroup (healthy vs. DM1) with sleep duration. Data are presented as means ± 
SD. Since baseline characteristics and insulin sensitivity data were published for healthy 
individuals and individuals with DM1 separately, in this paper these data are shown for the 
two groups together. To allow comparison between subgroups, the baseline characteristics, 
sleep indices and insulin sensitivity data are included in the supplemental tables and were 
compared using Student’s t-test.
RESULTS
Basal clinical characteristics
Metabolites were measured in sixteen individuals after a night of short sleep (4 hours) 
versus after a night of normal sleep (8 hours) duration. Subjects had a mean age of 44 ± 
14 years and included 8 women. Individuals were lean, with an average BMI of 23.7 ± 2.2 
kg/m2 and a waist hip ratio of 0.85 ± 0.08 (Table 1). The study population consisted of nine 
healthy individuals (56%) and seven individuals with type 1 diabetes mellitus (DM1) (44%). 
Sleep duration prior to the study days did not differ healthy individuals (mean recorded 
sleep duration prior to study day 1 and 2: 420 ± 20 min vs. 476 ± 11 min; p=0.19) nor in 
individuals with DM1 (mean recorded sleep duration prior to study day 1 and 2: 475 ± 8 
min vs. 490 ± 7 min; p=0.12). Results of healthy individuals and individuals with DM1 were 
reported previously separately [14, 15]. Age, sex distribution, BMI and waist-hip ratio were 
comparable between these two subgroups (Table S1).
Subjects (n = 16) 
Females (%) 8 (50%)
Age (years) 44 ± 14
BMI (kg/m2) 23.7 ± 2.2
WHR 0.85 ± 0.08
Table 1: Study population characteristics1. BMI = body 
mass index. WHR = waist hip ratio. Data is presented as mean 
(SD or percentage). 1Data are pooled from two previously 
published studies [14;15]. 
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Short sleep increases insulin resistance
Short sleep intervention was effective in reducing total sleep time (TST) by -51% (461 
± 25 vs 225 ± 26 min, p < 0.001). The reduction of sleep duration was due to decreased 
sleep duration of both non-REM (stage 2 and stage 3) and REM sleep (Table 2). Fasting 
plasma free fatty acids did not differ between sleep conditions (Table 2) or between 
subgroups (Table S2). Next, the effect of short sleep on insulin resistance was investigated 
by hyperinsulinemic euglycemic clamp studies. Interestingly, a single night of short sleep 
increased peripheral insulin resistance, as indicated by a decreased glucose disposal rate 
(GDR) (34.1 ± 13.8 vs 27.9 ± 9.8 μmol*kg LBM−1*min−1, p = 0.001) and decreased glucose 
infusion rate (GIR) (29.0 ± 14.7 vs 22.1 ± 10.7 μmol*kg LBM−1*min−1, p=0.001). Short sleep 
tended to increase endogenous glucose production (EGP) by the liver in all subjects (4.7 
± 1.9 vs 5.5 ± 1.6 μmol*kg LBM−1*min−1, p=0.08; Table 2). This was mainly due to increased 
endogenous glucose production in the subset of healthy individuals (Table S2; previously 
published in [14]). Expectedly, individuals with DM1 displayed higher baseline insulin 
resistance than in healthy individuals [3] (EGP 6.2 ± 1.9 vs. 3.6 ± 0.6, p=0.003; GDR 25.5 ± 6.4 
vs. 40.7 ± 14.3, p=0.028; GIR 19.0 ± 7.0 vs. 36.9 ± 14.4, p=0.014, Table S2). Moreover, short 
sleep increased peripheral insulin resistance irrespective of this difference in baseline 
insulin sensitivity, suggesting a that short sleep may induce insulin resistance in healthy 
individuals and individuals with DM1 via a common pathway. Therefore, the effect of short 
sleep was investigated for healthy individuals and individuals with DM1 together.
Table 2: Effects of short sleep on sleep parameters and insulin sensitivity1. Insulin sensitivity parameters 
were determined by hyperinsulinemic euglycemic clamp. EGP = endogenous glucose production, GDR = 
glucose disposal rate (glucose Rd), GIR = glucose infusion rate. LBM = lean body mass. Sleep characteristics 
were determined by polysomnography. TST = total sleep time. SWS = slow wave sleep. Data is presented 
as means (SD). Effect of sleep intervention was tested with paired Students T-test, significant differences 
shown in bold. 1 Data are pooled from two previously published studies [14;15].
Subjects (n = 16) 
Sleep parameters Normal sleep Short sleep p
TST (min) 461 ± 25 225 ± 24 <0.001
Stage 1 (% of TST) 10 ± 3 10 ± 6 0.798
Stage 2 (% of TST) 43 ± 7 37 ± 9 0.002
Stage 3 (% of TST) (SWS) 24 ± 7 34 ± 10 <0.001
REM sleep (% of TST) 23 ± 4 18 ± 8 0.025
Sleep efficiency (%) 93 ± 4 91 ± 7 0.418
Plasma parameter
Free fatty acids (mmol/l) 0.65 ± 0.24 0.61 ± 0.19 0.24
Insulin sensitivity parameters
EGP (μmol * kg LBM−1 * min−1) 4.7 ± 1.9 5.5 ± 1.7 0.087
GDR (μmol * kg LBM−1 * min−1) 34.1 ± 13.8 27.9 ± 9.8 0.001




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Short sleep specifically increases plasma acylcarnitines
To investigate possible pathways which could be involved in the increased of insulin 
resistance by short sleep duration, we performed metabolomics analysis on fasting 
morning plasma samples. A total of 163 metabolites representing 5 different classes 
were measured (Table S3). Short sleep increased thirteen metabolites (p<0.05) (Table 3). 
Strikingly, all of these are acylcarnitines. After stringent post-hoc correction, short sleep 
significantly increased plasma levels of tetradecenoyl-L-carnitine (C14:1) by +32% (plasma 
level difference: +0.017 µM, p=2.67*10-4), octadecenoyl-L-carnitine (C18:1) by +22% 
(plasma level difference: +0.015 µM, p=1.92*10-4) and octadecadienyl-L-carnitine (C18:2) 
by +27% (plasma level difference: +0.005 µM, p=1.32*10-4). Short sleep duration increased 
acylcarnitines in both subgroups, indicating that the effect of short sleep on acylcarnitines 
was not dependent on having DM1 or being healthy. There was no interaction effect of the 
subgroup (healthy vs. DM1) with the sleep duration (short vs. normal) for the 13 increased 
acylcarnitines. Baseline acylcarnitine levels (i.e. after normal sleep) did not differ between 
healthy individuals and DM1, except for a higher level of C:12-DC in DM1 (0.087 ± 0.005 vs 
0.101 ± 0.005 µM, p<0.0001) (Table S5). Acylcarnitines levels did not differ between healthy 
individuals and DM1 after short sleep (Table S6). We therefore conclude that a single night 
of short sleep specifically increased plasma acylcarnitines (Table 4).
DISCUSSION
The present study aimed to explore the metabolic pathways affected by sleep curtailment 
using targeted plasma metabolomics in individuals (healthy individuals and individuals with 
type 1 diabetes (DM1)) subjected to both short sleep (4 hours) and normal sleep (8 hours). As 
part of the same study, we previously reported that this short sleep intervention increased 
peripheral insulin resistance in both study groups as determined by hyperinsulinemic 
Table 3: (previous pages) Difference between short sleep and normal sleep duration in acylcarnitine 
levels. 
1Difference in metabolite levels (µM) as measured by BiocratesIDQTM p150 kit between short and normal 
sleep duration. Positive mean difference indicates an increase after short sleep duration. Negative mean 
difference indicates a decrease after short sleep duration.
2Change (%) represents percentage of change in metabolite level in short compared to normal sleep 
(metabolite level (short sleep) – metabolite level (normal sleep)) / metabolite level (normal sleep).
DM1 = individuals with type 1 diabetes. P-values are based on paired Students t-tests. N= 16 (healthy: n=9, 
DM1: n=7). Full results table is shown in Supplemental Table S2. Abbreviations of acylcarnitines are shown 
in Supplemental Table S3.
$: Significant difference (p<0.05). #: Significant difference after Bonferroni correction (p<3.0*10-4 
(=0.05/163)). Significant differences metabolites in all subjects are displayed in bold.
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euglycemic clamp analysis [14, 15]. We now show that one night of short sleep specifically 
increases plasma levels of acylcarnitines, in both healthy individuals and DM1 patients.
Our study is the first to show that short sleep duration increased plasma acylcarnitines 
in concert with increased insulin resistance in both healthy individuals and individuals 
with DM1. This indicates that short sleep duration affects metabolism irrespective of 
pre-existing insulin producing capacity. The relationship between increased plasma 
acylcarnitine levels and increased insulin resistance is supported by association studies. 
Human studies showed increased plasma levels of acylcarnitines in individuals with 
impaired fasting glucose and with type 2 diabetes (DM2), compared to healthy controls [24, 
25]. The significance of this association is still a matter of debate, since human intervention 
studies are lacking [26].
It is interesting to speculate about the biological relevance of increased plasma 
levels of acylcarnitines. Acylcarnitines are vital to energy homeostasis. They are esters 
of fatty acids and carnitine, which are transported over the outer and inner mitochondrial 
membranes by carnitine palmitoyl transferases (CPTs). Thus, acylcarnitines are essential 
to shuttle fatty acids from the cytoplasm into mitochondria were they can be oxidized and 
enter the tricarboxylic acid (TCA) cycle to generate ATP. An excess of acylcarnitines is 
generally viewed as a result from a mismatch between TCA flux and fatty acid oxidation 
(FAO) [27]. Previously reported causes of this mismatch include prolonged fasting and 
excessive muscle activity [28-30]. The present study, in which subjects participated in a 
protocol that controlled for food intake and physical activity, adds sleep deprivation as a 
provoking event. A mismatch between FAO and TCA flux has been related to mitochondrial 
dysfunction. Patients with inborn errors of FAO have increased plasma levels of especially 
Table 4. Interaction effects of diabetes status and short sleep on increased acylcarnitine levels. DM1 
= individuals with type 1 diabetes. Abbreviations of acylcarnitines are shown in Supplemental Table S3. 
$p<0.05, #p<0.004 (0.05/13) (two way repeated measure ANOVA).
Metabolite Interaction P-value Effect of sleep P-value Effect of DM1 status P-value
C2 3.24 * 10-2 6.70 * 10-3$ 8.33 * 10-1
C7-DC 1.10 * 10-3 <1.0 * 10-4# 4.53 * 10-1
C12 4.48 * 10-1 1.80 * 10-3# 2.35 * 10-1
C12:1 4.43 * 10-1 1.90 * 10-3# 2.25 * 10-1
C14 2.24 * 10-1 8.70 * 10-3# 1.01 * 10-1
C14:1 4.05 * 10-1 3.00 * 10-4# 1.68 * 10-1
C14:2 2.30 * 10-1 4.00 * 10-4# 4.22 * 10-1
C16 3.48 * 10-1 1.68 * 10-2$ 2.09 * 10-1
C16:1 8.94 * 10-1 1.25 * 10-2$ 3.82 * 10-1
C16:1-OH 1.42 * 10-1 3.30 * 10-3# 8.79 * 10-1
C16:2 8.34 * 10-2 4.30 * 10-3$ 6.62 * 10-1
C18:1 5.97 * 10-1 3.00 * 10-4# 7.64 * 10-1
C18:2 1.35 * 10-1 <1.00 * 10-4# 1.81 * 10-1
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long chain acylcarnitines [31]. Interestingly, altered mitochondrial parameters have been 
frequently linked to insulin resistance in the context of both DM1 and DM2 [32-38]. 
Moreover, mitochondrial dysfunction in mice induces skeletal muscle insulin resistance [27] 
while TCA-FAO mismatch predisposes mice to diet-induced obesity and insulin resistance 
[39]. It is therefore tempting to speculate that in our model of insulin resistance due to 
short sleep deprivation, the increased plasma acylcarnitine levels are a sign of inefficient 
mitochondrial function.
The tissue distribution of acylcarnitines coincides with important targets of insulin, i.e. 
muscle and liver. The majority of the body’s L-carnitine is stored in muscle (~ 97% of the 
body’s L-carnitine), followed by liver which contains 1% of the total L-carnitine pool [40]. 
Acylcarnitine results from the acylation of L-carnitine, and is therefore dependent on the 
fatty acid pool of the tissue. Interestingly, animal studies demonstrate the distribution of 
acylcarnitines is different between metabolic organs. In mice, the muscle tissue contains 
relatively more long-chain acylcarnitines, including C14:1 and C18:1, while liver is richer 
in free carnitines and short-chain carnitines [41]. Collectively, these data suggest that 
plasma short-chain acyl- and free carnitines are mainly derived from the liver, as indeed 
demonstrated in pigs [42], while plasma long-chain acylcarnitines in plasma presumably 
originate from muscle tissue. These data thus suggest that the increase in long-chain 
acylcarnitine that we observe after a single night of short sleep is likely derived from muscle.
Mechanistically, increased acylcarnitine levels after short sleep duration could be a 
marker of altered metabolic processes: increased fatty acid oxidation (FAO), inefficient 
mitochondrial function or a disturbed metabolism of the branched-chain amino acids 
(BCAA) valine, isoleucine or leucine. Although disturbed  BCAA metabolism has been 
associated with insulin resistance in humans [43], our data do not support a role of BCAA 
metabolism as short sleep duration did not increase  BCAA plasma levels or short-chain 
acylcarnitines. Increased acylcarnitine levels due to increased FAO can be caused by either 
increased energy demand and/or prolonged fasting. In the present study, the length of 
fasting was equal; however energy expenditure was not measured. Therefore, we cannot 
exclude that the increased acylcarnitines after short sleep are due to increased FAO. Sleep 
is accompanied by lower resting energy expenditure than wakefulness [44] and therefore 
short sleep duration may increase energy demand. In fact, complete (24 h) sleep deprivation 
increases energy demand by 7% [45]. However, the effects of short sleep duration on energy 
expenditure are inconclusive [46]. A recent study shows that short sleep intervention for 
five consecutive days increased long-chain plasma acylcarnitines [19]. Interestingly, after 
one night of recovery sleep, plasma acylcarnitines did not normalize. Likely, the increased 
acylcarnitines were not due to differences in overnight energy expenditure. Besides being 
a marker of insulin resistance and/or mitochondrial processes, acylcarnitines could also 
play a causal role in development of insulin resistance. In vitro studies have shown that 
acylcarnitines have bioactive properties and indeed have pro-inflammatory effects [47, 48]. 
Of note, treatment of both rodent and human myotubes with acylcarnitines in a physiological 
concentration caused decreased insulin signaling and glucose uptake in response to insulin 
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[49]. Although this finding needs to be confirmed in vivo, it provides a putative causal link 
between acylcarnitines and insulin resistance.
Taken all these data together, it is interesting to speculate on a mechanistic model 
for the relationship between sleep curtailment and insulin resistance. Upon sleep 
curtailment, the energy demands of peripheral tissues increases at a time conflicting with 
the physiological circadian rhythm. The energy homeostasis is adapted to anticipate the 
changing energy need and availability throughout the day. Indeed, muscle tissue is also 
under circadian control [50]. These clock genes are also important in driving rhythmicity 
in energy producing capacity of the mitochondria, as evidenced by mice studies [51]. We 
hypothesize that the mismatch in energy producing capacity and demand could be the 
cause of incomplete FAO, leading to accumulation of intermediates of FAO. Acylcarnitine 
levels increase, which may increase insulin resistance either through direct interaction with 
insulin signaling or through increased inflammatory pathways.
Our findings are supported by three studies which have investigated the effects of 
sleep on the human metabolome. Davies et al. [20] subjected 12 healthy individuals to an 
extreme sleep deprivation of 24 hours and reported nine increased short and medium-chain 
acylcarnitines, including tetradecenoyl-L-carnitine. Bell et al. [18] reported a trend towards 
increased acylcarnitines after prolonged mild sleep curtailment of 8 consecutive nights 
of 5.5 hours sleep in 11 young individuals with family history of DM2. Weljie et al [19] also 
reported increased C18:1, C10:0 and C12:0 acylcarnitines upon five consecutive nights of 
4 hours sleep. Strikingly, despite the difference in study populations and sleep curtailment 
protocols of the present and previous studies used, the acylcarnitines invariably increase 
after sleep curtailment.
In conclusion, the present study shows that a single night of 4 hours short sleep, 
which induces insulin resistance [14, 15], also increases plasma levels of acylcarnitines, 
in particular tetradecenoyl-L-carnitine, octadecenoyl-L-carnitine and octadecadienyl-
L-carnitine. We propose that sleep curtailment impairs mitochondrial function, which 
coincides with insulin resistance. Our findings provide a basis for mechanistic studies to 
further elucidate the role of acylcarnitines in the complex relationship between short sleep 
and increased insulin resistance.
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Females (%) 4 (44%) 4 (57%)
Age (years) 45 ± 14 43 ± 16
BMI (kg/m2) 23.8 ± 2.2 23.5 ± 2.2
WHR 0.88 ± 0.05 0.81 ± 0.09
Table S1. General population characteristics 
of healthy individuals and patients with type 1 
diabetes1. DM1 = individuals with type 1 diabetes. 
BMI = body mass index. WHR = waist hip ratio. Healthy 
individuals n= 9, DM n= 7. Data are represented as 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































C3-DC / C4-OH Malonyl-L-carnitine / hydroxybutyryl-L-carnitine











































































lysoPC a C14:0 lysoPhosphatidylcholine acyl C14:0
lysoPC a C16:0 lysoPhosphatidylcholine acyl C16:0
lysoPC a C16:1 lysoPhosphatidylcholine acyl C16:1
lysoPC a C17:0 lysoPhosphatidylcholine acyl C17:0
lysoPC a C18:0 lysoPhosphatidylcholine acyl C18:0
lysoPC a C18:1 lysoPhosphatidylcholine acyl C18:1
lysoPC a C18:2 lysoPhosphatidylcholine acyl C18:2
lysoPC a C20:3 lysoPhosphatidylcholine acyl C20:3
lysoPC a C20:4 lysoPhosphatidylcholine acyl C20:4
lysoPC a C24:0 lysoPhosphatidylcholine acyl C24:0
lysoPC a C26:0 lysoPhosphatidylcholine acyl C26:0
lysoPC a C26:1 lysoPhosphatidylcholine acyl C26:1
lysoPC a C28:0 lysoPhosphatidylcholine acyl C28:0
lysoPC a C28:1 lysoPhosphatidylcholine acyl C28:1
lysoPC a C6:0 lysoPhosphatidylcholine acyl C6:0
PC aa C24:0 Phosphatidylcholine diacyl C 24:0
PC aa C26:0 Phosphatidylcholine diacyl C 26:0
PC aa C28:1 Phosphatidylcholine diacyl C 28:1
PC aa C30:0 Phosphatidylcholine diacyl C 30:0
PC aa C30:2 Phosphatidylcholine diacyl C 30:2
PC aa C32:0 Phosphatidylcholine diacyl C 32:0
PC aa C32:1 Phosphatidylcholine diacyl C 32:1
PC aa C32:2 Phosphatidylcholine diacyl C 32:2
PC aa C32:3 Phosphatidylcholine diacyl C 32:3
PC aa C34:1 Phosphatidylcholine diacyl C 34:1

















PC aa C34:3 Phosphatidylcholine diacyl C 34:3
PC aa C34:4 Phosphatidylcholine diacyl C 34:4
PC aa C36:0 Phosphatidylcholine diacyl C 36:0
PC aa C36:1 Phosphatidylcholine diacyl C 36:1
PC aa C36:2 Phosphatidylcholine diacyl C 36:2
PC aa C36:3 Phosphatidylcholine diacyl C 36:3
PC aa C36:4 Phosphatidylcholine diacyl C 36:4
PC aa C36:5 Phosphatidylcholine diacyl C 36:5
PC aa C36:6 Phosphatidylcholine diacyl C 36:6
PC aa C38:0 Phosphatidylcholine diacyl C 38:0
PC aa C38:1 Phosphatidylcholine diacyl C 38:1
PC aa C38:3 Phosphatidylcholine diacyl C 38:3
PC aa C38:4 Phosphatidylcholine diacyl C 38:4
PC aa C38:5 Phosphatidylcholine diacyl C 38:5
PC aa C38:6 Phosphatidylcholine diacyl C 38:6
PC aa C40:1 Phosphatidylcholine diacyl C 40:1
PC aa C40:2 Phosphatidylcholine diacyl C 40:2
PC aa C40:3 Phosphatidylcholine diacyl C 40:3
PC aa C40:4 Phosphatidylcholine diacyl C 40:4
PC aa C40:5 Phosphatidylcholine diacyl C 40:5
PC aa C40:6 Phosphatidylcholine diacyl C 40:6
PC aa C42:0 Phosphatidylcholine diacyl C 42:0
PC aa C42:1 Phosphatidylcholine diacyl C 42:1
PC aa C42:2 Phosphatidylcholine diacyl C 42:2
PC aa C42:4 Phosphatidylcholine diacyl C 42:4
PC aa C42:5 Phosphatidylcholine diacyl C 42:5
PC aa C42:6 Phosphatidylcholine diacyl C 42:6
PC ae C30:0 Phosphatidylcholine acyl-alkyl C 30:0
PC ae C30:1 Phosphatidylcholine acyl-alkyl C 30:1
PC ae C30:2 Phosphatidylcholine acyl-alkyl C 30:2
PC ae C32:1 Phosphatidylcholine acyl-alkyl C 32:1
PC ae C32:2 Phosphatidylcholine acyl-alkyl C 32:2
PC ae C34:0 Phosphatidylcholine acyl-alkyl C 34:0
PC ae C34:1 Phosphatidylcholine acyl-alkyl C 34:1
PC ae C34:2 Phosphatidylcholine acyl-alkyl C 34:2
PC ae C34:3 Phosphatidylcholine acyl-alkyl C 34:3
PC ae C36:0 Phosphatidylcholine acyl-alkyl C 36:0
PC ae C36:1 Phosphatidylcholine acyl-alkyl C 36:1
PC ae C36:2 Phosphatidylcholine acyl-alkyl C 36:2

















PC ae C36:4 Phosphatidylcholine acyl-alkyl C 36:4
PC ae C36:5 Phosphatidylcholine acyl-alkyl C 36:5
PC ae C38:0 Phosphatidylcholine acyl-alkyl C 38:0
PC ae C38:1 Phosphatidylcholine acyl-alkyl C 38:1
PC ae C38:2 Phosphatidylcholine acyl-alkyl C 38:2
PC ae C38:3 Phosphatidylcholine acyl-alkyl C 38:3
PC ae C38:4 Phosphatidylcholine acyl-alkyl C 38:4
PC ae C38:5 Phosphatidylcholine acyl-alkyl C 38:5
PC ae C38:6 Phosphatidylcholine acyl-alkyl C 38:6
PC ae C40:0 Phosphatidylcholine acyl-alkyl C 40:0
PC ae C40:1 Phosphatidylcholine acyl-alkyl C 40:1
PC ae C40:2 Phosphatidylcholine acyl-alkyl C 40:2
PC ae C40:3 Phosphatidylcholine acyl-alkyl C 40:3
PC ae C40:4 Phosphatidylcholine acyl-alkyl C 40:4
PC ae C40:5 Phosphatidylcholine acyl-alkyl C 40:5
PC ae C40:6 Phosphatidylcholine acyl-alkyl C 40:6
PC ae C42:0 Phosphatidylcholine acyl-alkyl C 42:0
PC ae C42:1 Phosphatidylcholine acyl-alkyl C 42:1
PC ae C42:2 Phosphatidylcholine acyl-alkyl C 42:2
PC ae C42:3 Phosphatidylcholine acyl-alkyl C 42:3
PC ae C42:4 Phosphatidylcholine acyl-alkyl C 42:4
PC ae C42:5 Phosphatidylcholine acyl-alkyl C 42:5
PC ae C44:3 Phosphatidylcholine acyl-alkyl C 44:3
PC ae C44:4 Phosphatidylcholine acyl-alkyl C 44:4
PC ae C44:5 Phosphatidylcholine acyl-alkyl C 44:5








SM (OH) C14:1 Hydroxysphingomyeline C 14:1
SM (OH) C16:0 Hydroxysphingomyeline C 16:0
SM (OH) C22:1 Hydroxysphingomyeline C 22:1
SM (OH) C22:2 Hydroxysphingomyeline C 22:2
SM (OH) C24:1 Hydroxysphingomyeline C 24:1
SM C16:0 Sphingomyeline C 16:0
SM C16:1 Sphingomyeline C 16:1
SM C18:0 Sphingomyeline C 18:0
SM C18:1 Sphingomyeline C 18:1
SM C20:2 Sphingomyeline C 20:2
SM C22:3 Sphingomyeline C 22:3
SM C24:0 Sphingomyeline C 24:0
SM C24:1 Sphingomyeline C 24:1
SM C26:0 Sphingomyeline C 26:0













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Healthy DM1 Healthy vs. DM1
Metabolite Mean SD Mean SD P-value
C0 31.9 5.8 26.6 4.8 0.073
C2 4.24 0.57 3.58 1.06 0.133
C3 0.273 0.043 0.192 0.042 0.002
C3:1 0.010 0.002 0.012 0.003 0.139
C3-DC (C4-OH) 0.074 0.062 0.049 0.011 0.304
C3-OH 0.020 0.003 0.024 0.005 0.020
C4 0.105 0.019 0.105 0.057 0.979
C4:1 0.022 0.003 0.031 0.007 0.005
C5 0.120 0.032 0.097 0.027 0.153
C5:1 0.022 0.003 0.024 0.004 0.148
C5:1-DC 0.020 0.004 0.019 0.002 0.628
C5-DC (C6-OH) 0.017 0.003 0.019 0.005 0.273
C5-M-DC 0.035 0.003 0.039 0.004 0.047
C5-OH (C3-DC-M) 0.023 0.003 0.025 0.004 0.405
C6 (C4:1-DC) 0.066 0.022 0.058 0.014 0.385
C6:1 0.027 0.003 0.026 0.002 0.828
C7-DC 0.025 0.008 0.024 0.008 0.975
C8 0.172 0.126 0.121 0.066 0.356
C8:1 0.065 0.009 0.088 0.043 0.151
C9 0.025 0.010 0.024 0.005 0.817
C10 0.274 0.228 0.181 0.073 0.321
C10:1 0.124 0.073 0.093 0.039 0.324
C10:2 0.027 0.006 0.028 0.004 0.593
C12 0.084 0.051 0.055 0.015 0.179
C12:1 0.080 0.035 0.059 0.018 0.163
C12-DC 0.087 0.005 0.101 0.005 0.000#
C14 0.029 0.008 0.022 0.004 0.044
C14:1 0.071 0.028 0.049 0.015 0.080
C14:1-OH 0.009 0.002 0.009 0.001 0.684
C14:2 0.027 0.016 0.020 0.008 0.300
C14:2-OH 0.007 0.001 0.007 0.001 0.277
C16 0.072 0.018 0.060 0.010 0.136
C16:1 0.059 0.004 0.056 0.006 0.231
C16:1-OH 0.006 0.001 0.005 0.001 0.174
C16:2 0.007 0.002 0.006 0.001 0.164
C16:2-OH 0.010 0.001 0.010 0.002 0.684
C16-OH 0.006 0.001 0.007 0.003 0.714
C18 0.025 0.007 0.024 0.007 0.798
C18:1 0.073 0.009 0.074 0.019 0.949
C18:1-OH 0.009 0.001 0.009 0.001 0.668
C18:2 0.025 0.006 0.028 0.006 0.467
Table S5: Acylcarnitine levels after normal sleep duration. Mean = mean plasma metabolite level (µM). 
DM1 = individuals with type 1 diabetes. #P<0.001 (0.05/41). P-values are based on independent Students 




Healthy DM1 Healthy vs. DM1
Metabolite Mean SD Mean SD P-value
C0 32.3 7.0 26.6 6.4 0.113
C2 0.287 0.212 0.208 0.078 0.434
C3 0.120 0.057 0.115 0.037 0.839
C3:1 0.027 0.005 0.028 0.005 0.680
C3-DC (C4-OH) 0.094 0.056 0.070 0.018 0.309
C3-OH 0.094 0.034 0.080 0.023 0.356
C4 0.089 0.006 0.104 0.011 0.004
C4:1 0.032 0.008 0.028 0.006 0.300
C5 0.087 0.032 0.073 0.026 0.336
C5:1 0.009 0.001 0.010 0.003 0.261
C5:1-DC 0.032 0.016 0.028 0.008 0.595
C5-DC (C6-OH) 0.007 0.001 0.008 0.002 0.447
C5-M-DC 0.077 0.016 0.070 0.014 0.398
C5-OH (C3-DC-M) 0.063 0.006 0.061 0.011 0.577
C6 (C4:1-DC) 0.007 0.002 0.007 0.002 0.610
C6:1 0.008 0.002 0.008 0.003 0.715
C7-DC 0.010 0.001 0.010 0.001 0.937
C8 0.006 0.001 0.007 0.002 0.213
C8:1 0.027 0.009 0.027 0.006 0.932
C9 0.088 0.014 0.092 0.024 0.664
C10 0.010 0.002 0.011 0.002 0.225
C10:1 0.031 0.006 0.037 0.009 0.103
C10:2 4.421 1.169 4.859 1.478 0.517
C12 0.271 0.065 0.180 0.039 0.006
C12:1 0.010 0.002 0.010 0.003 0.810
C12-DC 0.080 0.047 0.057 0.015 0.241
C14 0.021 0.003 0.024 0.005 0.255
C14:1 0.113 0.028 0.120 0.072 0.793
C14:1-OH 0.024 0.004 0.032 0.007 0.012
C14:2 0.132 0.038 0.106 0.036 0.188
C14:2-OH 0.021 0.005 0.026 0.006 0.121
C16 0.019 0.004 0.021 0.004 0.209
C16:1 0.015 0.003 0.019 0.003 0.028
C16:1-OH 0.034 0.005 0.040 0.007 0.086
C16:2 0.023 0.003 0.025 0.005 0.222
C16:2-OH 0.068 0.016 0.069 0.025 0.919
C16-OH 0.027 0.003 0.027 0.004 0.637
C18 0.027 0.008 0.033 0.008 0.159
C18:1 0.166 0.109 0.135 0.063 0.507
C18:1-OH 0.073 0.028 0.104 0.048 0.128
C18:2 0.024 0.007 0.025 0.005 0.645
Table S6: Acylcarnitine levels after short sleep duration. Mean = mean plasma metabolite level (µM). 
DM1 = individuals with type 1 diabetes. P-values are based on independent Students t-tests. Abbreviations 
of all metabolites are shown in Supplemental Table S3. Healthy individuals n=9, DM1 n=7.
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ABSTRACT
The biological clock, whose function deteriorates with increasing age, determines bodily 
circadian (i.e. 24h) rhythms, including that of cholesterol metabolism. Dampening of 
circadian rhythms has been associated with ageing and disease. Therefore, we hypothesized 
that individuals with a familial predisposition for longevity have a higher amplitude circadian 
serum cholesterol concentration rhythm. We investigated circadian rhythmicity of serum 
cholesterol concentrations in offspring of nonagenarian siblings and their partners. 
Offspring from nonagenarian siblings (n=19), and their partners as controls (n=18), were 
recruited from the Leiden Longevity Study. Participants (mean age 65 years) were studied in 
a controlled in-hospital setting over a 24h period, receiving three isocaloric meals at 9:00h, 
12:00h and 18:00h. Lights were off between 23:00h and 8:00h. Serum total cholesterol 
(TC), HDL-cholesterol (HDL-C), non-HDL-C and triglycerides (TG) were determined every 
30 min over a 24h period. The serum TC concentrations were higher during day than during 
night in offspring (5.2 vs. 4.7 mM, p<0.001) and in controls (5.3 vs. 5.0 mM, p<0.001). The 
difference in TC concentrations between day and night tended to be greater in offspring 
than in controls (0.5 vs.0.3 mM, p=0.109), reaching statistical significance in females 
(p=0.045). Notably, the day-night serum differences in non-HDL-C were 2-fold greater in 
offspring than in controls (0.43 vs. 0.21 mM, p=0.044) and most explicit in females (0.53 
vs. 0.22, p=0.078). We conclude that familial longevity is characterized by a high circadian 




During the past decades, life expectancy has increased substantially, resulting in a growing 
number of individuals with a high age [1]. Ageing has been associated with an increased 
risk of dyslipidaemia [2]. Familial human longevity has been associated with a less 
atherogenic lipid profile, which includes a larger LDL particle size [3], and lower circulating 
concentrations of triglycerides [4]. Furthermore, multiple polymorphisms associated with 
human longevity were identified in genes involved in lipid metabolism, including several 
apolipoproteins (e.g., APOA1 [5], APOB [6], APOC1 [5] and APOE [7] which are involved in 
lipid transport), uncoupling protein-1 (which mediates triglyceride lowering effects through 
mediating thermogenesis in brown adipose tissue [8]), adiponectin (an anti-inflammatory 
adipokine that increases ß-oxidation and triglyceride clearance [9]), and cholesteryl ester 
transfer protein (involved in determining the lipoprotein balance by mediating transfer of 
cholesteryl esters from HDL to LDL [3, 7]).
Ageing and lipid metabolism have both been related to functioning of the biological 
clock [10]. The mammalian biological clock is a hierarchical system with a central clock, 
located in the suprachiasmatic nuclei (SCN) of the hypothalamus, and peripheral clocks at 
the tissue level [11]. The SCN conveys circadian timing signals, such as light information, 
to peripheral clocks in the body through neuronal and hormonal cues [11]. The biological 
clock ultimately serves to maintain circadian (i.e. 24h) rhythms in bodily functions, such 
as sleep-wake cycles, hormone levels and plasma metabolites. In fact, human plasma lipid 
concentrations, including those of triglycerides and cholesterol, are rhythmic over a 24h 
period [12], independent of feeding and waking conditions [13].
The capacity of the biological clock to sustain circadian rhythms deteriorates with 
increasing age, which is reflected by reduced size of the SCN in the elderly, lower melatonin 
secretion, and lower amplitudes of temperature rhythms [14]. Animal studies indicate 
a crucial role for high circadian rhythmicity, i.e. high amplitude rhythms, in maintenance 
of health. For example, transplantation of SCN grafts from young to old animals restores 
the amplitude of electrical activity in the SCN and prolongs the life span of aged hamsters 
[15]. Conversely, a lower amplitude of circadian rhythmicity in blood pressure has been 
associated with higher cardiovascular risk [16], independent of hypertension [17]. For 
this reason, we hypothesized that human familial longevity, which is associated with a 
lower risk of metabolic syndrome [18] and cardiovascular and cardiometabolic diseases 
at advanced middle-age [19], is associated with a higher rhythmicity in serum cholesterol 
concentrations. We investigated this hypothesis by comparing circadian rhythmicity of 
serum cholesterol concentrations between individuals with a familial predisposition for 





The Medical Ethical Committee of Leiden University Medical Center approved this study. 
The study was performed according to the Helsinki declaration. Written informed consent 
was obtained from all study participants.
Study participants
Participants were recruited from the Leiden Longevity Study, which aims to investigate 
genetic factors and biomarkers associated with familial longevity. A more detailed 
description of the study design and recruitment strategy of the Leiden Longevity Study has 
been described elsewhere [37]. In short, a total of 421 long-lived families were recruited, 
without selection based on health condition or demographics. Families were included when 
at least two long-lived siblings were still alive and fulfilled the age criteria of 89 years for 
men and 91 years for women. In total, 1671 offspring of these long-lived individuals were 
recruited and 744 partners thereof as controls.
Of these, a subsample of 38 healthy participants were recruited in the Switchbox 
study for in- depth endocrine and metabolic phenotyping [26], which included 24h venous 
blood sampling. To be included in the Switchbox study, participants had to have a fasting 
glucose level <7 mM, haemoglobin level <7.1 mM, a body mass index (BMI) between 19 kg/
m2 and 33 kg/m2 and had to be free of any significant chronic disease. These conditions 
included, among others, renal, hepatic or endocrine diseases as well as the use of 
medication known to influence lipid concentrations or interfere with hormonal axes. A 
complete list of criteria that were considered prior to study inclusion has been published 
elsewhere [38]. Of the 38 participants, one participant was excluded because of a newly 
diagnosed hypertriglyceridemia, leaving 37 participants for the present study (19 offspring 
and 18 controls). Habitual sleep quality was assessed using the Pittsburgh sleep quality 
index (PSQI) questionnaire [39, 40]. With this questionnaire different aspects of sleep are 
subjectively assessed (e.g., sleep onset latency, sleep quality, and daytime dysfunction). A 
summary score was calculated to obtain an overall impression of a person’s quality of sleep, 
ranging from a score of 0 (good sleep) to 21 (worse sleep). Chronotype was assessed using 
the Munich Chronotype Questionnaire, which has been described and validated before [41, 
42]. For the present study, we assessed whether a person has any shortage of sleep during 
a normal week day.
Study and sampling procedure
After an overnight fast of 10-14 hours, a catheter was inserted before start of the study, 
and blood sampling started at 09:00h. During 24 hours, every 10 minutes 1.2 ml and 2 ml 
blood was collected in a K3-EDTA tube and a serum separator (SST)-tube respectively. 
Participants received three standardized meals at three fixed time points (namely, 
between 09:00h-10:00h, 12:00h-13:00h and 18:00h-19:00h). All meals consisted of 
600 kcal Nutridrink, containing a standard percentage of energy derived from fat (35 %), 
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carbohydrates (49 %) and protein (16 %) (Nutricia Advanced Medical Nutrition, Zoetermeer, 
the Netherlands). All participants were sampled year-round in the same room with 
standardized ambient conditions. Offspring and control couples were studied on the same 
day. Participants were not allowed to sleep during the day and except for lavatory use no 
physical activity was allowed during the study period; lights were turned off between 23:00h 
to 08:00h to allow the participants to sleep.
Biochemical analyses
After blood withdrawal, the serum tubes were kept at room temperature and immediately 
centrifuged when the samples were clotted. Serum was aliquoted into 500 µl tubes and 
stored at -80°C. For the present study, we determined serum concentrations of total 
cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), non-HDL-C and triglycerides 
(TG) every 30 minutes. TC and TG were analysed by a commercially available enzymatic 
kit according to the manufacturer’s protocols (Roche, Mannheim, Germany), with an inter-
assay coefficient of variation (CV) of 7% and intra-assay CV of 3%. HDL was isolated by 
precipitation of ApoB-containing lipoproteins, with an inter-assay CV of 13% and intra-
assay CV of 4%. Hereto, 20% polyethylene glycol (Sigma Aldrich) in 200 mM glycine buffered 
saline (pH 10) was added to serum, centrifuged for 30 minutes at 6,000 rpm, and HDL-C was 
determined in the supernatant. Non-HDL-C was calculated by subtracting HDL-C from TC.
Anthropometrics
At the study centre, we measured the height, weight and body fat percentage of the 
participants. Weight (in kg) was divided by the squared height (in m) to calculate the 
body mass index (BMI). The percentage of body fat was measured using a bioelectrical 
impedance analysis (BIA) meter at a fixed frequency of 50 kHz (Bodystat® 1500 Ltd, Isle of 
Man, British Isles).
Statistical analyses
We calculated the overall mean TC, HDL-C and non-HDL-C per participant for the whole 24h 
study period, for the day period (9.00h – 23.00h and 8.00h – 9.00h), and the night period 
(23.00h – 8.00h). Comparisons between offspring and controls were performed using 
independent sample Student’s T-tests (continuous outcomes) and with chi square statistics 
(dichotomous outcomes). We used paired sample Student’s T-tests to analyse differences 
between day and night serum cholesterol values. To assess whether the differences 
in mean TC, HDL-C, non-HDL-C and TG between day and night were different between 
offspring and controls, we calculated the individual mean difference between mean day 
and night values and tested the differences using independent sample T-tests. All analyses 
for the comparisons between offspring and controls were additionally stratified by sex. All 
statistical analyses were conducted using SPSS v.20 for Windows (SPPS Inc., Chicago, IL, 





Characteristics of the study population
We performed 24h venous blood sampling in 37 participants under highly controlled 
conditions at our research facility. During the 24h study period, participants minimized 
physical activity, received three isocaloric meals (at 9.00h, 12.00h and 18.00h) and were 
allowed to sleep from 23.00h to 8.00h. The total study population consisting of 19 offspring 
from nonagenarian siblings (9 men, 10 women) and 18 of their partners as controls (10 
men, 8 women), with a mean age of 65.0 ± 1.2 vs. 64.7 ± 1.2 years, respectively. The 
characteristics of the study population were similar between offspring and controls (Table 
1), except that the mother’s age at death or at inclusion of the study participants was 
higher in the offspring than in controls (92.1 ± 1.8 vs. 78.6 ± 3.3 years, p<0.01). Habitual 
sleep quality and chronotype were similar between offspring and controls (Table 1). We 
first characterized circadian rhythms in cholesterol concentrations for the entire study 
population. Serum total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) 
concentrations were measured in samples collected every 30 min over the 24h period and 
from these measurements corresponding concentrations of non-HDL-C were derived. 
Twenty-four hour mean concentration profiles for TC, HDL-C and non-HDL are shown in 
Figure 1 together with the overall mean TC, HDL-C and non-HDL-C concentration during 
the day period and night period. In the entire study population, serum concentrations of 
TC, HDL-C and non-HDL-C exhibited an intra-individual coefficient of variation (CV) of 13%, 
19% and 14%, respectively. The mean concentrations of TC, HDL-C and non-HDL-C were 
higher during the day than during the night (p<0.001).
Comparison of circadian rhythmicity in serum cholesterol 
between offspring and controls
Mean serum concentrations of TC, HDL-C and non-HDL-C are presented for every 30 min 
for 24h stratified for offspring and controls in Figure 2 together with the overall mean TC, 
HDL-C and non-HDL-C concentration during the day period and night period. We observed 
no difference between offspring and controls in the 24h mean TC (p=0.36), HDL-C (p=0.63) 
and non-HDL-C (p= 0.59) (Table 2). The serum cholesterol concentrations as measured 
during the first and last time point of the 24 h period were not statistically significantly 
different (data not shown). Both offspring and controls had higher serum concentrations 
of TC during the day than during the night (offspring: 5.2 ± 0.2 vs. 4.7 ± 0.2 mM; p<0.001; 
controls: 5.3 ± 0.1 vs. 5.0 ± 0.1 mM; p<0.001) (Figure 2a, b) (Table 3). However, the day-night 
difference in TC concentrations tended to be larger in offspring than in controls (0.51 ± 
0.10 vs. 0.31 ± 0.07 mM, p=0.109). Mean HDL-C concentrations were also higher during 
the day than during the night in both offspring (1.3 ± 0.1 vs. 1.2 ± 0.1 mM, p=0.002) and 
controls (1.3 ± 0.1 vs. 1.2 ± 0.1 mM, p=0.001) (Figure 2c, d) (Table 3). However, the day-night 
difference in mean HDL-C was similar between offspring and controls (p=0.928). In line with 
the TC concentrations, the mean non-HDL-C concentrations were also higher during the 
day than during the night, both in offspring (4.0 ± 0.2 vs. 3.5 ± 0.2 mM, p<0.001) and controls 
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(4.0 ± 0.2 vs. 3.8 ± 0.2 mM, p=0.002). Notably, the day-night difference in mean non-HDL-C 
concentrations was significantly larger in offspring than in controls (0.43 ± 0.09 vs. 0.21 
± 0.06 mM, p=0.044) (Figure 2e, f) (Table 3). Since the non-HDL lipoproteins transport 
triglycerides (TG) in addition to cholesterol, we determined TG concentrations. Similar to 
the HDL-C concentrations, TG concentrations showed a difference between day and night, 
but this day-night difference was not different between offspring and controls (p=0.852) 
(Figure S1a-b).
Table 1: Characteristics of the study population. Abbreviations: BMI, body mass index. Data are presented 
as the mean ± SEM, unless indicated otherwise. BMI and fat mass were missing for 1 participant. P-value 
calculated for offspring vs. controls, Student’s T-test.
1 Scores obtained from Munich Chronotype Questionnaire (P-values calculated with Mann-Whitney test). 
2 Scores obtained from Pittsburg sleep quality index, ranging from 0 (good sleep) to 21 (worse sleep) 
(P-values calculated with Mann-Whitney test).
Offspring (n = 19) Controls (n = 18) P-value
Men, n (%) 9 (47%) 10 (56%) 0.75































































Sleep Quality PSQI, median (IQR)2 4.0 (2.0 – 7.0) 3.0 (1.0 – 5.0) 0.91
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Figure 1: Circadian pattern of serum cholesterol concentrations in all participants combined. Mean 
serum cholesterol concentrations are displayed every 30 min over a 24h period for all participants 
combined (n=37); total cholesterol (TC) (a), HDL-cholesterol (HDL-C) (c), and non-HDL-cholesterol (non-
HDL-C) (e) Shaded area indicates dark/sleeping period. Black arrows indicate the time of three isocaloric 
meals (9:00h, 12:00h, and 18:00h). Figures b, d, and f present the mean ± SEM serum cholesterol 
concentrations during the day and night period for TC, HDL-C, and non-HDL-C, respectively.
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Figure 2: Serum cholesterol concentrations in offspring and controls. Mean serum cholesterol 
concentrations are displayed every 30 min over a 24h period stratified for offspring (n=19) (open circles) 
and controls (n=18) (solid circles); total cholesterol (TC) (a), HDL-cholesterol (HDL-C) (c), and non-HDL-
cholesterol (non-HDL-C) (e). Shaded area indicates dark/sleeping period. Black arrows indicate the time 
of three isocaloric meals (9:00h, 12:00h, and 18:00h). Figures b, d, and f present the mean ± SEM serum 
cholesterol concentrations during the day and night period for TC, HDL-C, and non-HDL-C, respectively.
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Comparison in cholesterol rhythmicity between offspring and 
controls, stratified by sex
The analyses stratified by men and women are displayed in Table 3 and Supplemental Figure 
2 (Figure S2). Both in men and women, the mean serum TC concentrations during the day 
were higher than during the night (p<0.05) (Table 3) (Figure S2a-d). In both men and women, 
the day-night difference seemed higher in offspring than in controls, however this was only 
statistically significant in women (0.68 ± 0.11 vs. 0.36 ± 0.09 mM, p=0.045) and not in men 
(0.31 ± 0.14 vs. 0.27 ± 0.10 mM, p=0.822). The HDL-C concentrations in women were higher 
during the day than during the night in both offspring and controls (p<0.05) (Table 3) (Figure 
S2e,f), while this was not observed in men (p>0.05) (Table 3) (Figure S21g, h). In line with 
the observations in all subjects combined, both in men and women there was no difference 
between offspring and controls in the day-night difference in HDL-C concentrations. The 
mean non-HDL-C concentrations were higher during the day than during the night in both 
men and women (p<0.05) (Table 3) (Figure S2i-l). In women, the day-night differences in 
non-HDL-C tended to be larger in offspring than in controls (0.53 ± 0.13 vs. 0.22 ± 0.08 mM; 
p=0.078) (Table 3). Similarly, day-night differences in non-HDL-C concentrations in men 
were also slightly larger in offspring than in controls, but this was not statistically significant 
(0.33 ± 0.12 vs. 0.20 ± 0.08 mM; p=0.388) (Table 3).
DISCUSSION
The present study aimed to investigate differences in circadian rhythmicity of serum 
cholesterol concentrations between individuals with and without a familial predisposition 
for longevity. Irrespective of the study groups, we observed that serum cholesterol 
Table 2: Mean 24h serum cholesterol concentrations. Abbreviations: HDL-C = HDL-cholesterol, non-
HDL-C = non-HDL cholesterol. Mean 24h parameters were calculated using the individual 24h serum 
cholesterol concentrations. Data are presented as means ± SEM. P-value calculated for offspring vs. 
controls, Student’s T-test.
Offspring (n=19) Controls (n=18) P-value





























concentrations displayed a 24h rhythm with mean concentrations being higher during the 
day compared to the night. Previous studies on the daily variation in serum cholesterol 
concentrations have been conflicting. Some studies reported no variation during the day 
[20, 21], while others reported circadian variation in serum cholesterol with a CV up to 4% 
[12] and circadian variation in cholesterol precursors [22] or cholesterol production rate 
[23]. However, in all these studies, sampling frequency was at most every 1.5 hours and the 
study populations included up to 25 young adults, and the studies showing no circadian 
rhythm in cholesterol included only 5 individuals. Within the current study sampling rate 
was every 30 minutes in 37 individuals, which therefore gives more detailed data about 
possible rhythmicity. Within our study population of 37 healthy older participants, we found 
a 24h variation in serum TC concentrations with a CV of 13%. Moreover, we observed a 
clear difference between day and night serum total cholesterol concentrations, showing 
that in this population of healthy elderly, cholesterol concentrations are rhythmic.
We observed that participants with a predisposition for familial longevity had a 
higher circadian rhythmicity (observed by a greater day-night difference) in cholesterol 
concentrations compared with their partners as controls. Ageing has been associated with 
a decreased functioning of the biological clock, with respect to hormonal rhythms, core 
body temperature and sleep-wake cycles [14]. Likely, the age-related changes originate 
within the central biological clock, the SCN. Post-mortem analysis showed that in individuals 
over 50 years of age, the SCN has decreased neuronal activity and rhythmicity compared 
to the SCN of younger individuals, as determined by arginine vasopressin expression 
[24]. Notably, the number of active SCN neurons correlated with the amplitude in activity 
patterns in elderly [25]. Previously, we observed within the Leiden Longevity Study cohort 
that familial longevity is associated with higher mean thyroid stimulating hormone (TSH) 
concentrations, in the absence of differences in free T3 or T4 serum concentrations 
[26]. We also observed a stronger temporal association between TSH and free T3 in 
offspring compared to in controls, which is indicative of a stronger correlation between 
circadian TSH and free T3 rhythms [27]. Based on the current study, we speculate that a 
familial predisposition of longevity is characterized by subtle changes in some rhythmic 
parameters rather than their 24h mean serum concentrations resulting from a preserved 
biological clock function.
In the complete Leiden Longevity Study cohort, no difference in unfasted HDL-C 
concentrations between offspring and controls was observed [4], in contrast to 
observations of Barzilai et al. in offspring of Ashkenazi Jewish centenarians and controls 
[28]. In line with the larger Leiden Longevity Study cohort, in the present subset no 
difference in HDL-C rhythms between offspring and controls were found. The differences 
observed in the current study between offspring and controls were specifically in non-
HDL-C concentrations during day and night, independent of triglyceride concentrations, 
habitual lifestyle and food intake. Therefore, there is likely an intrinsic difference in non-
HDL-C metabolism in individuals with familial longevity.
The higher rhythmicity in non-HDL-C concentrations in offspring compared to controls 
could be a marker of a maintained clock function at a higher age. Alternatively, the increased 
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rhythmicity in serum non-HDL-C concentrations could directly contribute to the increased 
life expectancy that is associated with familial longevity. The differences between the 
offspring and control group were mainly observed in non-HDL-C concentrations. This is 
particularly interesting with respect to life expectancy since non-HDL-C concentrations 
are implicated as causal in the pathogenesis of cardiovascular disease, which represents 
the number one cause of death world-wide. In humans, non-HDL-C concentrations mainly 
represent LDL-C [29]. LDL can be modified and taken up by macrophages, triggering 
atherosclerotic lesion development [29]. Indeed, Mendelian randomization studies have 
demonstrated that life-long low-range LDL-C concentrations (compared to higher LDL-C 
concentrations) decreases cardiovascular risk [30]. Accordingly, long-term high-range 
cholesterol concentrations are associated with a significantly increased cardiovascular risk 
[31]. It is therefore tempting to speculate that a stronger day-night rhythm of non-HDL-C 
(likely LDL-C) contributes to a lower cardiovascular disease risk.
We investigated the sex-specific effects on cholesterol rhythms in this study. Both 
men and women tended to display a higher rhythmicity in offspring than in controls in TC 
and non-HDL-C concentrations, but not in HDL-C concentrations. However, this day-night 
difference was more prominent in women than in men, where the differences between 
offspring and controls did not reach significance, while in women day-night difference in 
TC concentrations was significantly different and the day-night difference in non-HDL-C 
concentrations showed a trend. Of note, there is evidence pointing towards sex specific 
differences with respect to activity of the SCN. The SCN is sensitive to regulation by gonadal 
hormones [32]. Furthermore, in mice, ageing-induced decrease of the locomotor activity is 
higher in male mice than in female mice [33]. These data imply that also ageing may affect 
biological clock function in a sex-specific manner. This observation may also account for 
any possible sex differences in cholesterol rhythmicity in our study.
In this study, we observed that familial longevity is characterized by larger difference 
between night and day serum non-HDL-C concentrations. For human metabolism, the 
transition from night to day indicates the switch from fasting to feeding and thus from a 
catabolic to an anabolic state. This is for example apparent by the morning increase in 
insulin sensitivity [34]. Since cholesterol is a major substrate for synthesis of membranes 
and hormones, the observed increase of non-HDL-C upon waking may be a function of 
this anabolic state. The lower night concentrations of non-HDL-C are analogous to the 
diurnal rhythm of blood pressure. The absence of a decrease in blood pressure during the 
night, a phenomenon which is called ‘non-dipping’, has been associated with increased 
cardiovascular risk [16], independent of hypertension [17]. However, as these studies 
were done in observational settings, the question remains whether the lower amplitude in 
blood pressure is a marker of underlying disease or a causal factor affecting cardiovascular 
disease risk. Animal studies support a causal role for dampened rhythms in metabolic 
disease. We previously showed that constant light exposure induces a dampened rhythm 
in SCN electrical activity as well as feeding and locomotor rhythms [35]. Interestingly, 
constant light increased weight gain independent of total food intake and activity, but by 





















































































































































































































































































































































































































































































































































































































































































































































































































A limitation of the current study is the relatively small sample size. Although our 
study cohort was larger than previous cohorts that studied 24h cholesterol rhythms, our 
sample size of 37 individuals is likely too limited to find subtle differences. This was also 
apparent from the stratification by sex. Visually, the HDL-C concentrations in female control 
individuals seemed higher than those of female offspring, however only two out of the eight 
female control individuals displayed elevated 24h HDL-C concentrations. Likewise, the 
differences in day-night non-HDL-C serum concentrations were larger in offspring than in 
controls, but only significant in women. Possibly, effects are more subtle in men, which were 
therefore not detected in a small study such as the present one.
In conclusion, we show that in advanced middle-age, familial longevity is characterized 
by a high rhythmicity of serum non-HDL-C concentrations in a subset of healthy individuals. 
Our study supports the hypothesis that high amplitude rhythms may contribute to 
healthy ageing and therefore, decreased rhythmicity may be an additional risk factor for 
development of disease. Increasing circadian rhythmicity may be an attractive target to 
promote longevity.
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Supplemental Figure 1: Serum triglyceride concentrations in offspring and controls. Mean serum 
triglycerides (TG) concentrations are displayed every 30 min over a 24h period stratified for offspring 
(n=19) (open circles) and controls (n=18) (solid circles) (a), the mean ± SEM serum TG concentrations 
during the day and night period (b). Shaded area indicates dark/sleeping period. Black arrows indicate the 
time of three isocaloric meals (9:00h, 12:00h, and 18:00h).
168
7
Supplemental Figure 2: (continues on right page) Serum cholesterol concentrations in offspring and 
controls in women and men. Mean serum cholesterol concentrations are displayed every 30 min over a 
24h period separately for women (triangles) and men (squares), and stratified for offspring (open symbols) 
and controls (solid symbols); total cholesterol (TC) (a;c), HDL-cholesterol (HDL-C) (e;g), and non-HDL-
cholesterol (non-HDL-C) (i;k). Shaded area indicates dark/sleeping period. Black arrows indicate the time 
of three isocaloric meals (9:00h, 12:00h, and 18:00h). Figures b, d, f, h, j, and l present the mean ± SEM 




















































































































































































































































































GENERAL DISCUSSION AND FUTURE PERSPECTIVES
For centuries, the use of artificial light permitted man to stay awake after dark. From campfires 
in prehistoric times, to the use of an oil lamp ancient Greece, humans have invented ways 
to bring light. The invention of the light bulb in 1879 by Thomas Edison is heralded as the 
birth of ‘artificial light’. This coincided with the advent of the industrial revolution, and the 
increased need to working at night commenced to have a large impact on society. In the 
19th century, factory labor was among the hardest shift work circumstances with shift work 
rotations of 12 hours for two weeks straight, without a day rest [1]. Today, it is estimated that 
in Europe, approximately 20% of the working population is involved in some form of shift 
work [2]. The 24 hour economy is not just exemplified by the common use of shift work but 
also by shifting of social activities to nightly hours. This habit has only further encouraged 
shift work, as nowadays leisure businesses are also open 24/7, including supermarkets, 
bars, gas stations and restaurants. In terms of our biological clock, these habits are 
severely disturbing via at least three different pathways. Firstly, humans are widely exposed 
to bright light during the natural occurring night. Since light exposure directly acts on the 
central biological clock, the mistimed light exposure may disrupt synchronization of the 
clock. Secondly, in our modern society physical activity, wakefulness and food intake take 
place throughout the light-dark cycle. This induces a misalignment between the metabolic 
demand, i.e. energy intake, storage and expenditure, and the endogenous circadian rhythms 
of metabolic organs, which are entrained to the light-dark cycle. Thirdly, staying up late in 
the evening and night for work or leisure has led to shortened sleep duration [3]. All of these 
human circadian disruptions have been associated with metabolic disease.
 In this thesis we have investigated which metabolic pathways may mediate the 
interaction between the biological clock and energy metabolism. To gain more insight in 
how circadian disruption causes metabolic disease, we studied the effect of light exposure 
on metabolic phenotypes in mice (Part I). We demonstrated that prolonged light exposure 
attenuates brown adipose tissue (BAT) activity, thereby increasing adiposity (Chapter 2). 
Subsequently, we demonstrated that BAT activity displays a marked 24h rhythm, which 
determines the 24h rhythm in plasma lipid levels (Chapter 3), and which is attenuated 
upon dampening of the endogenous glucocorticoid rhythm (Chapter 4). Finally, we show 
that mistimed light exposure can aggravate atherosclerosis development in dyslipidemic 
mice (Chapter 5). In Part II, we evaluated the relationship between circadian rhythms and 
metabolism in humans. We showed that shortened sleep duration increases acylcarnitines 
in plasma, suggesting a defect in mitochondrial fatty acid oxidation (Chapter 6). Finally, 
we demonstrate 24h rhythms in plasma cholesterol and observed a higher rhythmicity in 
plasma cholesterol in the context of longevity (Chapter 7). In this chapter, I will discuss these 
novel findings in the context of the three pathways – mistimed light exposure, behavioral 
misalignment and short sleep – that mediate the relationship between light exposure and 
metabolic disease (see graphical summary). I will conclude by discussing the implications 
for future research and possible therapeutic strategies.
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The rhythm in brown adipose tissue in relation to 
cardiometabolic disease
A very recent study on light pollution reports that an astonishing 83% of the world population 
lives under light-polluted skies [4]. In the US and Europe, this proportion even reaches 99%. 
The human retina has three photoreceptors sensitive to light: rods and cones, which are 
crucial for visual perception, and the melanopsin-containing intrinsically photoreceptive 
retinal ganglion cells (ipRGCs) [5]. The ipRGCs transmit light-dark information directly to the 
SCN, although mice lacking melanopsin can still entrain to light-dark cycle [6, 7]. Conversely, 
ipRGCs are also sufficient to entrain to light-dark cycle [8]. The illumination levels that 
constitute light pollution [4] not only reach the human retina, but are also sufficient to 
trigger the photoreceptors [9]. Evidence is accumulating that in humans, light exposure 
at night associates with increased body weight [10-13]. Although constant light exposure 
has previously been shown to induce a fast increase in weight gain due to a decrease in 
24h energy expenditure in mice [14], it remained unknown which tissues contributed to 
this difference. In chapter 2, we provide evidence that BAT plays a crucial role. BAT is a 
highly metabolically active tissue that burns glucose and fatty acids (FA) to produce heat. 
Activation of BAT increases energy expenditure, decreases and prevents diet-induced 
obesity and decreases dyslipidemia [15-18]. We showed that prolonged light exposure 
duration decreases SNS output towards BAT and reduces the capacity of BAT to take up 
TG-derived FA from the circulation [19]. Without compensation in food intake, this led to 
increased storage of energy in WAT. Specific sympathetic denervation of BAT abolished the 
rhythm-attenuating effect of prolonged light exposure.
Our findings support recent human studies demonstrating that exposure to light can 
alter metabolism. Healthy individuals that were exposed to low levels of blue light in the 
evening showed a lower energy expenditure in the morning, without alterations in sleep 
duration or quality [20]. Other evidence for the effect of light exposure on metabolism in 
humans is mainly derived from epidemiological studies. Light duration inversely correlates 
to detectability of BAT throughout the year, as shown by uptake of [18F]fluorodeoxyglucose. 
This association is stronger and more significant than the association between ambient 
temperature and BAT activity [21]. Take together with our findings in mice, it can be 
hypothesized that short light duration, presumably via the SCN, increases basal BAT 
activity in humans. Since light duration is a more stable predictor for seasonal changes 
than ambient temperature, this mechanism seems to have biological relevance: shortening 
of days predicts the approach of winter, a season in which higher BAT activity is needed for 
heat generation to maintain body temperature. Therefore, turning up the heat by activation 
of BAT as the days grow shorter may more likely be an adaptive mechanism than merely a 
reaction to the outside temperature. Whether light exposure duration regulates BAT activity 
in humans as well remains to be investigated.
Besides showing that disruption of circadian rhythm lowers BAT activity, we 
demonstrated a marked diurnal rhythm in TG-rich lipoprotein-derived FA uptake by BAT in 
mice (chapter 3). This diurnal rhythm aligns with the known rhythms of energy expenditure 
and core body temperature, which peak before the start of the wakeful period in both day-
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8active and night-active mammals [22]. In our study, prolonged and shortened light exposure 
shifted the peak time in BAT activity to the respective onsets of the dark (active) period. 
This was accompanied by a fast postprandial lipid clearance at the onset of the dark 
period irrespective of the light exposure period. These data suggest that BAT should be 
influenced by circadian misalignment. Indeed, an experimental jet-lag protocol of 6 days 
in healthy individuals led to decreased energy expenditure and a decreased thermic effect 
of food [23]. These results may be explained by misalignment between food intake and 
the endogenous BAT rhythm. In another misalignment study, 10 healthy individuals were 
subjected to 7 repeated cycles of a 28h ‘day’. Metabolic hormones changed, including 
decreased total leptin levels, increased insulin levels, but interestingly also decreased 
plasma epinephrine [24]. This suggests that reduced sympathetic output towards BAT may 
play a role in lowering BAT activity upon circadian disruption.
Although humans are day-active and mice are night-active, it is likely that the circadian 
BAT activity found in mice is analogous to humans, i.e. highest activity at wakening. A 
recent human study found a circadian rhythm in supraclavicular temperature, a proxy for 
human BAT activity, which was low during the night and higher during daytime. Furthermore, 
human brown adipose tissue explants sustain a circadian rhythm in gene expression [25]. 
Circumstantial evidence also points towards a circadian human BAT activity with a trough 
at night and peak at wakening. In humans, BAT activation also contributes to energy 
Figure 1. Graphical Summary representing the main conclusions based on the studies described in 
this thesis. See text for explanation.
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expenditure [15] and decreases free FA [18]. Energy expenditure displays a robust circadian 
rhythm in humans [26]. Our data demonstrate that plasma free FA display a circadian 
rhythm, with low FA in the morning, which is not explained by food intake (chapter 3). From 
an evolutionary point of view, a circadian rhythm in BAT constitutes an energy saving ability. 
BAT developed to maintain body temperature in homeotherms, however keeping BAT 
constitutively active would be a ‘waste’ of energy. Moreover, circadian body temperature 
may serve as a synchronization signal for peripheral clocks. In vitro, temperature cycles 
specifically regulate the cyclic expression of cold-inducible RNA-binding protein (CIRP) and 
mice lacking CIRP have a decreased circadian amplitude in rhythmic gene expression [27]. 
Since BAT contributes to body temperature, the diurnal BAT rhythm may be important in 
the synchronization circadian rhythms throughout the body and contribute to wakening. 
Together, human data support the hypothesis that circadian BAT activity is high at wakening 
and low during sleep.
A key question remains to be elucidated: how does the SCN regulate the rhythm in BAT 
activity? Possible pathways can be divided in indirect vs. direct regulation of BAT by the SCN. 
Meal timing has been shown to entrain peripheral circadian clocks in metabolic tissues, and 
is therefore a likely indirect regulator of rhythmic BAT activity. Restricting food intake to the 
usual sleep period of rodents induces a shift in the rhythm of metabolic tissues, both in 
clock gene expression and metabolic function [28]. The SCN itself however is not affected 
by the restricted feeding regimens [29]. Therefore, food intake rhythm has an independent 
effect on synchronizing metabolic tissues. The SCN does align food intake behavior to the 
light-dark cycle. SCN lesioned rats display arrhythmic locomotor activity and food intake 
behavior [30, 31]. Light exposure duration induces adaptations in food intake rhythms in 
wild type animals [32]. These adaptations are dependent on intact SCN functioning, as 
VIP-knockout mice (a genetic model for SCN dysfunction) cannot entrain to light exposure 
duration [33]. The effect of food intake rhythm on BAT activity has not extensively been 
characterized. Under normal chow feeding, there is no effect of night-restricted feeding 
on gene expression rhythms of BAT. However, after 20 weeks of high fat diet feeding, night 
time restriction of food intake increases overall BAT activity and improves the rhythm in 
gene expression of several thermogenic genes [34]. The authors attribute this effect to 
increased bile acid synthesis during feeding within the liver. Due to increased production 
by liver after a meal, the spill-over into the circulation would ultimately result in higher bile 
acid plasma levels that can directly increase BAT activity [34]. Hormones released upon 
feeding such as insulin and GLP-1 are also known to increase BAT activity [35, 36]. Changes 
in hormone release due to changes in food intake behavior may provide additional indirect 
pathways by which the SCN regulates rhythmic BAT.
The SCN may also directly signal towards BAT. I will start by evaluating how the SCN 
in general synchronizes peripheral tissues. Presumably, the SCN synchronizes peripheral 
organs through the sympathetic nervous system (SNS) and through endocrine output 
[37]. In case of metabolic tissues, it is demonstrated in rats that specific ablation of the 
SCN abolishes circadian both at both gene expression level and the functional level, e.g. 
production of insulin and leptin. Furthermore, liver denervation abolishes the circadian 
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rhythm in glucose plasma levels [38], demonstrating that the SNS is necessary to sustain 
a circadian rhythm in liver function. BAT is densely innervated by the SNS. The best known 
trigger for SNS activation towards BAT is cold sensing [39]. Tracing studies in Siberian 
hamsters demonstrated a direct neural connection between the SCN and BAT [40]. In rats, 
administration of the excitatory neurotransmitter glutamate to the retinohypothalamic tract 
or directly to the SCN induced a thermogenic response of BAT [41, 42]. Furthermore, we 
found that light exposure duration dose dependently decreased noradrenergic outflow as 
demonstrated by reduced tyrosine hydroxylase staining within BAT. In our study, prolonged 
light exposure duration was associated with decreased intracellular β-adrenergic signaling, 
such as CREB phosphorylation. Specific denervation of the BAT depots abolished the 
attenuating effects of prolonged light exposure on BAT activity, suggesting mediation via 
SNS [19] (chapter 2). The SCN likely accomplishes the SNS output towards BAT by signaling 
through the ventromedial hypothalamus (VMH). Specific knock out of clock gene Bmal1 in 
the VMH dampened energy expenditure and body temperature rhythms, and dampened 
the naturally occurring increase in nocturnal expression of Ucp1 and mitochondrial genes 
Nrf1 and Cpt1b within BAT. From these data, it seems that the VMH produces an intrinsic 
rhythm in SNS output towards BAT. Light exposure modulates SCN output towards brain 
areas including the VMH, thereby changing the amplitude and timing of SNS output [43]. 
For the SCN to be able to signal towards BAT, an intact signaling via VMH and SNS is thus 
at least necessary.
Besides SNS input, endocrine systems have been implicated in synchronizing 
peripheral tissue activity. Glucocorticoid rhythms are a likely candidate to transmit the 
timing signal. In vitro, non-SCN cells do not retain rhythmicity in gene expression [44, 45]. 
Synchronization of these in vitro rhythms can be accomplished by at least three methods: 
heat shock, serum shock or administration of the glucocorticoid receptor (GR) agonist 
dexamethasone [46-48]. Interestingly, the intracellular mechanisms by which heat shock 
and serum shock achieve synchronization are not fully understood. Moreover, attempts 
to identify which factors within serum synchronize the cells have failed. In this respect, 
it is intriguing that the dexamethasone is the only single molecule known to synchronize 
cells in vitro. There is some evidence that glucocorticoids can synchronize the rhythm in 
BAT activity. In chapter 4, we provide evidence that dampening of glucocorticoid rhythms 
flatten the TG-derived FA uptake by BAT. The finding that the peak corticosterone aligns 
with peak FA uptake by BAT may seem surprising. Previous studies showed that high 
concentrations of dexamethasone strongly inhibit BAT activity in vivo and in vitro [49, 
50]. The peak concentration of corticosterone during circadian peak is two-fold lower 
than the corticosterone peak in response to stress [51]. Therefore, we hypothesize that 
the concentration of corticosterone is crucial in determining whether BAT is activated or 
inhibited. In our laboratory, we have investigated the effect of a high versus a low dose 
of dexamethasone on brown adipocytes. Indeed, our preliminary data show that only 
high concentrations of dexamethasone downregulate thermogenic gene expression, but 
that both a high and a low dose of dexamethasone are able to synchronize clock gene 
expression of brown adipocytes.
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Taken together, the link between artificial light and cardiometabolic disease in humans 
may be mediated via decreased BAT activity. What are the implications to prevent or treat 
cardiometabolic diseases? Firstly, exposure to artificial light at otherwise dark periods could 
be reduced or altered. Blue light is the most potent signal for the SCN [52]. Indeed, exposure 
to light-emitting screens in the evening disturbs sleep in healthy individuals [53]. One study 
investigated whether selectively removing blue light wavelength prevents adverse health 
effects. Although sleepiness was indeed improved without blue light exposure, effects 
on physical parameters, such as cortisol and melatonin levels, were not significant [54]. 
More studies are needed to further investigate whether blue light specifically mediates the 
effects of artificial light on metabolism, which would support the use of blue light filters 
of screens to maintain cardiometabolic health. Although there are no systematic data 
available, the amount of smartphone software-applications to filter out blue light from 
smartphone and tablet screens is increasing; the newest Windows operating system has 
a blue light filter incorporated aimed at “reducing blue light at night to help you sleep” [55]. 
Secondly, pharmacological activation of BAT may be tailored to the circadian rhythm of its 
activity. This concept of ‘chronotherapy’ is gaining ground in various research areas [56]. 
For example, cancer cells are not synchronized in their circadian rhythm of cell proliferation, 
making them relatively more susceptible to chemotherapy during the night compared to 
healthy cells, as these are in their resting phase during night time [57]. In cardiovascular 
disease, it has been known that myocardial infarctions occur mostly in the morning [58], 
coinciding with the circadian rise in blood pressure [59] and increased platelet aggregation 
[60]. In fact, aspirin therapy in the evening more effectively lowers the morning peak in 
platelet aggregation function than aspirin in the morning [61]. Interestingly, preliminary data 
have shown that cooling of individuals in the morning increases their energy expenditure 
more than cooling in the evening (Kooijman, unpublished data), suggesting that activation 
of BAT may be optimal in the morning, when it is presumably peaking in humans.
Of note, impaired BAT activity may also explain the relationship between disturbed 
glucocorticoid rhythms and obesity in humans. Individuals who depend on oral 
supplementation of glucocorticoids, e.g. with adrenal insufficiency, have increased risk 
of metabolic syndrome even though they are adequately treated [62]. Current standard 
replacement therapy of glucocorticoids attempts to mimic the circadian rhythm with 2-3 
doses divided over the day; one high dose in the morning and two lower doses in the 
afternoon and evening. Even so, the resulting glucocorticoid levels poorly resemble the 
endogenous circadian – not the mention ultradian – rhythm [63]. If glucocorticoid rhythms 
are indeed an important synchronizer for BAT activity in humans, individuals on exogenous 
glucocorticoids may have a disturbed rhythm of BAT, which may lead to decreased 
thermogenesis and subsequent increased lipid levels and adiposity.
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The role of light exposure in the relationship between shift work 
and atherosclerosis
While studies have established a clear association between shift work and cardiovascular 
events in humans [64], proving a direct causal relationship is challenging. Shift work is 
accompanied by many confounding factors. Shift workers may adopt a different life style 
due to their irregular working hours, as their sleep pattern, physical activity and food intake 
habits may be different compared to non-shift workers [65, 66]. Furthermore, there is a 
difference among individuals in shift work tolerance, which is commonly defined as the 
ability to carry out shift work without adverse consequences [67]. On the other hand, the 
causes of cardiovascular diseases (CVD) are multifactorial. Contributing factors include 
dyslipidemia, a pro-inflammatory state, hypertension, pro-thrombotic state and obesity. 
Shift work and/or circadian rhythm disturbances have been linked independently to all of 
these individual contributing factors. The work described in this thesis aimed to dissect 
the contributing pathways, in particular whether mistimed light exposure can induce CVD.
The data described in chapter 5 are the first to demonstrate that mistimed light exposure 
is a causal factor in atherosclerosis formation. We previously showed that continuous light 
(LL) exposure in mice decreases SCN amplitude, decreases energy expenditure [14] and 
decreases BAT activity [19]. Since pharmacological activation of BAT lowers the levels 
pro-atherogenic VLDL and chylomicron remnants in dyslipidemic mice by accelerating 
their clearance from plasma [16], it stands to reason that LL would be pro-atherogenic by 
reducing BAT activity. Although we did observe increased total cholesterol levels, gene 
expression of BAT activation markers and lipid content within BAT was not affected by 
chronic LL exposure. Possibly, LL transiently disturbs the rhythm in mice and consequently, 
transiently lowers BAT activity. A five week LL exposure in wild type male mice induced an 
arrhythmic phenotype, evidenced by arrhythmic locomotor behavior and flattened plasma 
corticosterone levels [14]. Exposing dyslipidemic mice to 15 weeks of LL induced arrhythmic 
locomotor behavior in a small subset of mice (chapter 5). In contrast to LL exposure, 15 
weeks of mistimed light exposure did aggravate atherosclerosis development. The lesion 
size and severity depended on the severity of SCN disturbance. The SCN is disturbed more 
by a 12 h shift than by a 6 h shift. Moreover, the SCN adapts faster to phase delays than to 
phase advances [68]. In mice, phase advance but not delay was shown to increase mortality 
[69]. Atherosclerosis development was not affected by 6 h delay, modestly affected by 6 h 
advance and severely affected by 12 h reversal of the light-dark cycle. Therefore, the extent 
(i.e. 6 h vs 12 h) and direction (advance vs delay) of circadian disruption possibly correlates 
to the extent of atherosclerosis formation.
 A crucial question is how mistimed light exposure induces a pro-atherogenic phenotype. 
Although plasma cholesterol concentrations play a dominant role in atherosclerosis 
development we did not find an increase in total cholesterol exposure after exposure to 
12h reversal and 6h phase advance for 15 weeks compared to a regular LD light regime. 
However, absence of increased plasma cholesterol levels do not exclude the possibility 
that mistimed light exposure may affect cholesterol metabolism in various other ways and 
thereby contributes to atherosclerosis development. LDL particles may be more prone to 
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oxidation, which makes them prone to be taken up by macrophages, resulting in foam cell 
formation. Furthermore, the cholesterol efflux capacity of macrophages may play a role. 
Efflux capacity depends on expression of cholesterol transporters on the macrophages, 
which is at least partly regulated by circadian genes. For instance, Clock regulates the 
expression of Abca1. Macrophages from ClockΔ19/Δ19Apoe-/- mice have an impaired 
cholesterol efflux capacity [70].
Another explanation that we did not observe increased total cholesterol levels after 
mistimed light may be the timing of sampling. Plasma cholesterol levels display a modest 
diurnal rhythm in humans [71]; we confirmed an oscillation of approximately 2 mM during 
the day in APOE*3-Leiden.CETP dyslipidemic mice (van den Berg, unpublished data). 
Since the biological clock adapts to light shifts during the first days after the light regime 
changes, the 24h rhythms in plasma cholesterol are possibly in phase between the groups. 
The cholesterol levels of different groups could be similar at a specific time point, even 
though the groups exhibit different 24h rhythms in plasma cholesterol levels. To determine 
whether total cholesterol exposure is affected by mistimed light exposure, repeated 24h 
plasma curves of cholesterol levels should therefore be determined in future studies.
Alternatively, mistimed light exposure may induce atherosclerosis without modulating 
cholesterol metabolism but via inducing a proinflammatory phenotype, since the biological 
clock also influences the immune system. Circulating leukocytes and monocytes display 
a circadian rhythm [72]. Macrophages from mice with ClockΔ19/Δ19,an arrhythmic mouse 
model, were previously shown to be more proinflammatory and to exacerbate metabolic 
syndrome upon high fat feeding [73]. Macrophages from Rev-erbα-/- mice were also shown 
to be more proinflammatory [74]. We infer that inflammatory cells are regulated by the 
biological clock and that its disturbance induces a proinflammatory phenotype. Therefore, 
disturbance of the biological clock via other pathways, such as mistimed light exposure, 
likely also induce a proinflammatory state.
From clock disturbance to metabolic disease: scientific 
challenges and future perspectives
The relationship between the circadian clock and metabolism is steadily being unraveled. 
Animal studies, including those described in this thesis, have convincingly shown that a 
malfunctioning clock causes metabolic disease. Nevertheless, there are some challenges 
ahead. Future research has yet to answer the following questions: 1) What are the timing 
signals for peripheral tissues? 2) What are the intracellular pathways that cause metabolic 
derangements upon circadian rhythm disturbances? 3) Which data from animal experiments 
are translatable to humans and which are not? 4) How can we ‘cure’ our diseased clock, if 
at all? 5) Since timing determines virtually every tissue function, how should we integrate 
this fourth dimension into other research fields? These questions are challenging due to 
the several aspects in the current research on this topic, of which I will discuss the following 
three.
I. The use of knock out models. Many studies on circadian disturbances have been 
performed by studying the effect of knock out or mutant clock genes on metabolism using 
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genetically modified mice. Although very useful to uncover vital functions of genes, the use 
of genetic animal models has drawbacks. Any genetic model has the downside that animals 
develop without the gene of interest. Any phenotype may therefore be a developmental 
problem and compensatory mechanisms may have occurred. This issue may be solved 
by using conditional knock-out mice. To date, these have not been used in the context of 
circadian research. In addition, genetic manipulation of a clock gene always affects both the 
central and peripheral clocks, since they share the same molecular mechanism. This issue 
is slowly being solved by the use of tissue-specific knock-out mice, although the tissue 
specificity is often an issue. For example, in adipose tissue-specific Bmal1 knock-out mice, 
both WAT and BAT are affected, while only WAT was studied [75]. The SCN-specific Bmal1 
knock-out mouse has been developed using a synaptotagmin10-Cre driven mouse strain, 
which is specifically expressed in the SCN [76, 77]. SCN-specific Bmal1 knock-out leads to 
disturbed gene expression rhythm in WAT, showing that SCN specific rhythm is necessary 
for rhythmic gene expression in metabolic tissues [78]. Whether the gene expression 
disturbance translates to disturbed tissue function and whether that results in metabolic 
disease remains to be investigated. Another drawback of genetic manipulation is that the 
translatability of findings in mice to human settings of circadian disruptions is very limited. 
We have shown that, by using artificial light exposure in our studies to manipulate the 
clock, the human exposure to artificial light can be mimicked, making it possible to study 
metabolic consequences in an intact animal model. Therefore, findings obtained by varying 
light exposure regimes are likely more translatable to the human situation compared with 
genetic intervention. Future research in humans should prove whether indeed BAT activity 
is influenced by light exposure regimes.
II. Discovery of intracellular mechanisms. It is becoming increasingly clear which 
metabolic organs mediate the relationship between disturbed clock function and metabolic 
disease. Nevertheless, the intracellular mechanisms involved are still obscure. Gene 
expression analysis is the most widely used method to investigate rhythms. However, gene 
expression analysis alone may be insufficient to predict functional rhythms in organs. We 
demonstrated a clear adaptive rhythm in BAT with respect to its capacity to take up FA from 
TG-rich lipoproteins. Upon examination of gene expression, many canonical BAT ‘activity’ 
genes, such as Ucp1, did not display a clear rhythmicity (chapter 3). In general, regulation 
of gene expression is only one layer of rhythmic regulation within the cell. In an extensive 
paper by Koike et al. [79], immunochromatin precipitation-sequencing of seven core clock 
genes showed thousands of genes with bound clock proteins. They compared intronic and 
exonic RNA expression and concluded that only 22% of cycling transcripts are driven by 
transcriptional regulation, demonstrating that oscillating mRNA levels depend more on 
non-transcriptional regulation, e.g. post-transcriptional regulation. The highly rhythmic 
gene Nocturnin regulates poly-adenylation of mRNA transcripts [80]. This is likely the tip of 
the iceberg of non-transcriptional circadian regulation.
Another challenge in elucidating intracellular mechanisms is to obtain human tissue. 
Gene expression rhythms in humans are often assessed in easily accessible peripheral 
blood mononuclear cells [81-83]. Subcutaneous white adipose tissue was also shown to 
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display rhythmic gene expression [84]. In a recent study, repeated muscle biopsies were 
taken from healthy men under regular feeding and sleep-wake conditions. Oxidative 
capacity of muscle displayed a rhythm with a peak in the afternoon. While mitochondrial 
genes did not show oscillations, protein involved in mitochondrial dynamics did oscillate 
[85]. We also obtained evidence for the involvement of mitochondria in circadian rhythm 
of metabolism in humans. After one night of short sleep, we found an increase in plasma 
of specifically the metabolite class of acylcarnitines, which may indicate a mitochondrial 
dysfunctional (chapter 6). To examine the hypothesis that acylcarnitines derive from 
muscle tissue and are a result of mitochondrial dysfunction, we are currently investigating 
the effect of short sleep energy metabolism, including measuring mitochondrial function 
directly in muscle and white adipose tissue. Although taking human biopsies is invasive, 
these studies will be necessary to advance the knowledge on intracellular mechanisms in 
the context of circadian disturbances of energy metabolism.
III. Microbiome involvement. We are not alone. Humans are a symbiosis of human cells 
and bacteria. The importance of the microbiome for metabolism in general is increasingly 
recognized. Interestingly, circadian rhythms are also present in the function and composition 
of gut microbiota [86]. Disturbance of the circadian clock either by genetic modification 
or by jet-lag resulted in a loss of circadian rhythms of microbiota in mice. Restricting the 
feeding time to the dark period – the natural feeding time – rescued this effect. Thus, 
timed feeding controls the circadian rhythm in microbiome [87]. Interestingly, the same 
group recently reported that the inverse relationship holds true as well. Rhythmicity in the 
microbiota influences the metabolic pathways in the intestine and in the liver, as loss of 
rhythmicity in the microbiota changed rhythmic expression in metabolic pathways in these 
organs [88]. In these studies, rhythms in adipose depots were not established. Since the 
gut microbiome has been shown to influence the function of both brown and white adipose 
tissue, it seems highly likely that these organs are also under control of the microbiome [89, 
90]. Sleep fragmentation in mice was shown to both change the gut microbiome and lead 
to inflammation of visceral WAT [91]. Thus, disturbed circadian rhythms may indeed lead to 
metabolic diseases via changes in gut microbiota, although this relationship needs to be 
investigated in more detail.
Concluding remarks
The data presented in this thesis have added to the growing body of literature 
demonstrating that disturbances of the biological clock can lead to cardiometabolic 
disease. We show that BAT plays a crucial role in mediation of these effects and that this 
is regulated by both the sympathetic nervous system and glucocorticoid rhythms. The 
clinical implications of these observations are that prevention of disturbances to our day-
night rhythms provides additional handles to improve cardiometabolic health of both the 
general population and CVD patients. These can be summarized as follows: 1) diminishing 
(blue) light exposure at dark (inactive) periods, 2) aligning behavior (e.g. food intake, physical 
activity and sleep) to the natural light-dark cycle, 3) aiming to sleep at least 7 hours per 
night, 4) use of chronotherapy in CVD, 5) BAT activating strategies, probably restricted to 
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the early wakeful phase, 6) administration of glucocorticoids aimed to mimic the circadian 
rhythm. Our data showing marked day-night rhythms in metabolism also have diagnostic 
implications. Measuring lipids at multiple daily time points may give better predictive value 
for development of CVD. For other CVD risk factors such as blood pressure, it is already 
common practice to measure multiple times. Blood pressure ‘dips’ during the night, and 
‘non-dippers’ are known to have an increased risk of CVD in absence of hypertension [92]. 
Analogous to the 24h blood pressure monitoring, repeated determination of plasma lipid 
levels may refine risk assessments.
Future research should investigate whether humans display a diurnal rhythm in TG-
derived FA uptake by BAT and whether specific flattening of BAT rhythm contributes to 
cardiometabolic disease. The timing signals and intracellular pathways that synchronize 
peripheral tissues need further elucidation, e.g. with respect to whether the SNS outflow 
towards BAT is rhythmic. If so, this would provide an additional target for pharmacological 
activation. In conclusion, the circadian clock crucially regulates energy metabolism. 
Increasing our understanding of the interplay between clock and energy metabolism will 
provide new avenues to improve cardiometabolic health.
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Cardiovascular diseases (CVD) are the leading cause of death worldwide, and disturbances 
in day-night rhythms have recently been implicated as a novel risk factor for CVD. Chapter 
1 provides an overview of both lipid metabolism and the biological clock system and their 
role in the pathogenesis of CVD is outlined. We introduce the various research question 
that were addressed by a combination of studies in animal models and humans.
Part I of this thesis focuses on the effects of modulating circadian rhythms on energy 
metabolism using animal models. Disruption of circadian rhythmicity in humans, e.g. through 
exposure to light at night, is associated with obesity and related disorders, including type 
2 diabetes and CVD. The underlying mechanism is unclear. Therefore, we investigated the 
effect on the duration of light exposure on the metabolic phenotype in Chapter 2. Mice 
that were exposed to day lengths of 16 h and 24 h light, compared to regular 12 h light, 
showed increased adiposity without food intake or locomotor activity being affected. 
Mechanistically, we demonstrated that prolonged day length decreases sympathetic 
input into brown adipose tissue (BAT) and reduces β3-adrenergic intracellular signaling in 
BAT. As a consequence, prolonging day length decreased the uptake of FAs from TG-rich 
lipoproteins as well as glucose from plasma selectively by BAT. We concluded that impaired 
BAT activity is an important mediator in the association between disturbed circadian 
rhythm and adiposity. Therefore, we anticipate that activation of BAT may overcome the 
adverse metabolic consequences of disturbed circadian rhythmicity.
Since BAT activity is subject to seasonal regulation, we hypothesized that BAT is also 
subjected to a circadian, i.e. 24 h, regulation by the central biological clock. In Chapter 3 
we characterized the 24 h rhythm of BAT activity and its implications for lipid metabolism. 
We observed a high amplitude 24 h rhythm in the TG-derived FA uptake by BAT. The 
highest uptake was observed at the onset of the active period which was explained by 
high Lipoprotein lipase (Lpl) expression and low Angioprotein-like 4 (Angptl4) expression, 
resulting in high LPL protein levels in BAT. Since BAT takes up TG-derived FA to produce 
heat, we examined fasting and postprandial lipid levels at various time points, and observed 
that circadian rhythmicity in BAT activity determined daily fluctuations in plasma lipid 
concentrations as well as lipid clearance. Strikingly, in mice as well as humans we found 
postprandial lipid excursions to be nearly absent at the onset of the active period and high 
before sleep, consistent with the diurnal BAT activity pattern. We hypothesize that diurnal 
rhythm in BAT activity explains previous findings that restriction of food intake to the early 
wakeful period improves metabolic health.
From the previous chapters, we concluded that the biological clock regulates BAT 
activity rhythm. However, the mechanisms underlying the regulation of BAT rhythmicity 
were still unclear. We hypothesized that the circadian rhythm of plasma glucocorticoids, 
referring to cortisol in humans and corticosterone in rodents, plays a crucial role. In 
Chapter 4 we thus addressed this hypothesis by implanting mice with subcutaneous 
pellets containing a low concentration of corticosterone, which markedly dampened the 
endogenous corticosterone rhythm. After one week of corticosterone pellet treatment, 
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the ability of BAT to take up TG-derived FAs from the circulation was determined at AM 
(onset of the light period) and PM (onset of the dark period). In control mice receiving 
vehicle, FA uptake by BAT displayed a large AM-PM fluctuation that was in accordance with 
data shown in Chapter 3. Interestingly, this AM-PM fluctuation was abolished in mice with 
dampened corticosterone rhythms by preventing the rise in FA uptake PM. Examination of 
cellular pathways in BAT revealed that dampened rhythm in FA uptake was accompanied by 
dampened rhythms of the expression of Lpl and phosphorylation of CREB, a downstream 
β3-receptor signaling target. In contrast, known glucocorticoid-responsive element-
controlled genes retained rhythmic expression patterns, suggesting that glucocorticoids 
did not act on brown adipocytes directly. We concluded that short-term dampening of 
corticosterone rhythm flattens the rhythmicity of BAT activity with respect to the uptake 
of TG-derived FAs in mice. Our data imply that the biological clock regulates rhythmicity of 
BAT activity via circadian glucocorticoid levels.
Shift work is a risk factor for atherosclerotic disease, however which aspect(s) of 
shift work causally induce(s) atherosclerosis remains to be elucidated. In Chapter 5 we 
investigated the contribution of mistimed light exposure to atherosclerosis development by 
performing studies in female APOE*3-Leiden.CETP mice fed a Western-type diet, which is 
a well-established model for human-like lipoprotein metabolism and atherosclerosis. In two 
separate experiments, mice were either subjected to constant light (LL) or to three different 
rotating light-dark schedules, compared to control 12h light-dark (LD) schedule, during 
15 weeks of Western-type diet feeding. While LL disturbed the circadian physical activity 
rhythm to some extent, atherosclerotic lesion development was not affected. In contrast, 
a weekly 6 h advance light schedule increased plaque severity. Moreover, weekly reversal 
of LD schedule, which is possibly most effective to disturb circadian rhythmicity, increased 
plaque severity as well as plaque size. Interestingly, increased atherosclerotic development 
could not be attributed to higher plasma cholesterol levels, which may suggest that other 
factors including regulation of immune function by the biological clock may play a role. 
In conclusion, mistimed light exposure aggravates atherosclerotic development in mice, 
which may at least partly explain the association between shift work and CVD in humans. 
Future studies should focus on whether this is mediated via cholesterol metabolism or 
inflammatory pathways.
Part II of this thesis focuses on the effects of altered day night rhythm and longevity 
on human lipid metabolism. In Chapter 6 we investigated the effects of shortened sleep on 
metabolism. We previously showed that acute sleep curtailment induces insulin resistance, 
in healthy individuals as well as in patients with type 1 diabetes. Therefore, disturbances 
in sleep might play a causal role in the pathogenesis of insulin resistance, independent 
of endogenous insulin production. However, the underlying mechanisms remained unclear. 
This study aimed to explore the metabolic pathways affected by sleep loss using targeted 
metabolomics in human fasting plasma samples. Healthy individuals and patients with type 
1 diabetes were studied after a single night of short sleep (4 h) versus normal sleep (8 h) in 
a cross-over design. Remarkably, one night of short sleep specifically increased the plasma 
levels of acylcarnitines, essential intermediates in mitochondrial FA oxidation. Specifically, 
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short sleep increased plasma levels of tetradecenoyl-L-carnitine (C14:1), octadecanoyl-
L-carnitine (C18:1), and octadecadienyl-L-carnitine (C18:2). Since increased plasma 
acylcarnitine levels could be a sign of disturbed FA oxidation, it is possible that sleep 
curtailment acutely induces inefficient mitochondrial function. Inefficient mitochondrial 
function has been associated to insulin resistance. Also, acylcarnitines have been 
shown to have pro-inflammatory properties in vitro that could disturb insulin signaling. 
Our observations provide a basis for further research into the role of acylcarnitines as 
a potential mechanistic pathway by which sleep deprivation – even short term – causes 
adverse metabolic effects, such as insulin resistance.
In Chapter 7 we investigated whether longevity may determine circadian rhythms in 
cholesterol concentrations. The function of the biological clock function deteriorates with 
increasing age, and aging is associated with dampening of circadian rhythms. Therefore, 
we hypothesized that individuals with a familial predisposition for longevity have a higher 
amplitude circadian rhythm in serum cholesterol concentrations. We investigated circadian 
rhythmicity of serum cholesterol concentrations in offspring of nonagenarian siblings and 
their partners. Offspring from nonagenarian siblings and their partners as controls were 
studied in a controlled in-hospital setting over a 24 h period, receiving three isocaloric 
meals. Serum total cholesterol, HDL-cholesterol and non-HDL-cholesterol were determined 
every 30 min over a 24 h period. The serum total cholesterol concentrations were higher 
during day than during night in offspring and in controls. The difference in total cholesterol 
concentrations between day and night tended to be greater in offspring than in controls, 
reaching statistical significance in females. Notably, the day-night serum differences in 
non-HDL-cholesterol were 2-fold greater in offspring than in controls and most explicit in 
females. We conclude that familial longevity is characterized by a high circadian rhythmicity 
of non-HDL- cholesterol in healthy elderly offspring from nonagenarian siblings.
Finally, in Chapter 8, we discuss the clinical implications and future perspectives of the 
research described in this thesis. Using animal studies we observed that BAT is strongly 
regulated by the biological clock, possibly via circadian glucocorticoid rhythms, and 
attenuated BAT activity through prolonged light exposure increases adiposity. Research 
focusing on the rhythm in human BAT, and regulation thereof, is necessary to confirm 
the translational value of our findings. We also observed that mistimed light exposure 
enhances atherosclerosis development, which may provide a mechanistic link between 
the known association between shift work and CVD. We anticipate that living according 
to the natural circadian rhythms presumably contributes to cardiometabolic health. Since 
disturbances in day-night rhythms are inevitable in modern society, in the future we may 
advise individuals at risk for development of CVD refrain from shift work and short sleep 
duration. In addition, data in this thesis may be useful to design strategies to avoid the 




Hart- en vaatziekten vormen gezamenlijk wereldwijd de belangrijkste doodsoorzaak. Deze 
ziekten worden meestal veroorzaakt door slagaderverkalking, ook wel ‘atherosclerose’ 
genoemd. Verhoogde concentraties van vetten in het bloed, voornamelijk cholesterol 
en triglyceriden, vormen de belangrijkste risicofactor voor de ontwikkeling van 
atherosclerose. Hoewel er effectieve cholesterolverlagende medicijnen zijn, kunnen 
we daarmee atherosclerose niet geheel voorkómen. Het is daarom van belang om meer 
factoren te ontdekken die bijdragen aan een verstoorde vetstofwisseling, zodat we die ook 
kunnen moduleren. Het is in de afgelopen jaren aan het licht gekomen dat verstoring van 
de biologische klok van ons lichaam een risico vormt voor hart- en vaatziekten, mogelijk via 
verstoring van de vetstofwisseling. Het exacte werkingsmechanisme is echter onbekend. In 
dit proefschrift is gekeken naar het verband tussen de biologische klok en vetstofwisseling 
en de gevolgen die verstoringen van de biologische klok kunnen hebben op de ontwikkeling 
van hart- en vaatziekten.
In deel 1 van dit proefschrift onderzochten we de relatie tussen de biologische klok en 
vetstofwisseling door gebruik te maken van muismodellen. In Hoofdstuk 1 wordt uitgelegd 
hoe de vetstofwisseling en de biologische klok in elkaar zitten. Daarna wordt de onderlinge 
verhouding tussen de vetstofwisseling en de biologische klok uiteengezet. Elke lichaamscel 
heeft energie nodig om te kunnen functioneren. Deze energie wordt geleverd door suikers 
en vetzuren. Suikers en vetzuren, in de vorm van ‘vrije’ vetzuren dan wel triglyceriden, 
worden via de bloedbaan naar cellen getransporteerd die deze energiebronnen nodig 
hebben. Omdat vet niet oplost in water, worden triglyceriden verpakt in bolletjes omgeven 
door zeepachtige moleculen en eiwitten. Deze zogenaamde ‘lipoproteïnen’ transporteren 
niet alleen triglyceriden, maar ook het vettige molecuul cholesterol, een voor cellen 
essentiële bouwsteen. Energie in de vorm van suiker en vetzuren is afkomstig uit voeding. 
Een overschot aan energie kan worden opgeslagen in met name wit vetweefsel en in 
mindere mate in de lever en in spierweefsel. De lichaamseigen aanmaak van suiker en vet 
vindt met name in de lever plaats. Sinds enkele jaren is het bekend dat er nog een type 
vetweefsel bestaat wat bijdraagt aan de stofwisseling in mensen, namelijk bruin vetweefsel. 
Bruin vet is als het ware de kachel van het lichaam; door de verbranding van suikers en 
vetzuren produceren bruine vetcellen warmte, met als doel de lichaamstemperatuur op peil 
te houden. Dit ‘gratis’ energieverbruik heeft bruin vet tot een aantrekkelijk doelwit gemaakt 
voor het verlagen van een overschot aan opgeslagen en circulerende vetten, waarmee 
stofwisselingsziekten zoals suikerziekte (ofwel type 2 diabetes) en hart- en vaatziekten 
bestreden zouden kunnen worden. Hierom wordt er veel onderzoek gedaan naar medicijnen 
die bruin vet aanzetten tot verbranding van suikers en vetten.
De biologische klok beïnvloedt vrijwel alle aspecten van de stofwisseling en zorgt 
ervoor dat de energiebalans afgestemd is op onze omgeving. Menselijk gedrag, zoals 
eten, bewegen en slapen, volgt een regelmatig dag-nacht patroon. Door ervoor te zorgen 
dat de werking van organen ook een dag-nacht patroon volgt kan het lichaam efficiënt 
omgaan met energie. Licht is het belangrijkste signaal voor de centrale klok in het brein, 
de zogenaamde suprachiasmatische nucleus (SCN), om aan te geven ‘welk tijdstip van de 
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dag’ het is. In de afgelopen eeuw heeft het gebruik van kunstmatige verlichting een enorme 
vlucht genomen. Hierdoor zijn de dag-nacht ritmes in menselijke bezigheden losgekoppeld 
van de natuurlijke 24-uurs licht-donker cyclus en de jaarlijkse seizoensritmes. Dit heeft 
geleid tot de mogelijkheid van werken in ploegendiensten, maar tot het besteden van vrije 
tijd in nachtelijke uren. Deze ontkoppeling van dag-nacht ritmes van de natuurlijke licht-
donker cyclus heeft grote effecten op onze gezondheid. Kortere slaapduur, lichtvervuiling 
en werken in ploegendiensten zijn allemaal in verband gebracht met verstoringen in de 
stofwisseling, en leiden met name tot een verhoogd risico op overgewicht, type 2 diabetes 
en hart- en vaatziekten.
In deel 1 hebben de relatie tussen In hoofdstuk 2 hebben we onderzocht via welke 
organen lichtblootstelling de stofwisseling beïnvloedt. Hiertoe werden muizen blootgesteld 
aan een normale licht-donker cyclus (12 uur licht, 12 uur donker), of aan dagen met 16 
uur of 24 uur licht. Hoe langer de lichtblootstelling, hoe meer vetstapeling in het witte 
vetweefsel, ‘de voorraadkamer’ van het lichaam, plaatsvond. Daarentegen nam het bruine 
vetweefsel, de ‘kachel’ van het lichaam, juist minder vetten op uit bloed. Bruin vet wordt in 
belangrijke mate aangestuurd door het zenuwstelsel. Als het we de zenuwbanen naar het 
bruine vet doorknipten, was er geen effect meer van lichtblootstelling op bruin vetweefsel. 
Lichtblootstelling is dus een belangrijk signaal voor de seizoensgebonden activiteit 
van bruin vetweefsel en voor het doorgeven van dit signaal is het zenuwstelsel blijkbaar 
onmisbaar. In hoofdstuk 3 hebben we het 24-uurs ritme van bruin vet in muizen onderzocht. 
In tegenstelling tot andere organen, vertoonde bruin vetweefsel een opmerkelijk ritme in de 
opname van vetzuren gedurende de dag. De piek in vetzuuropname vond plaats bij de start 
van de wakkere periode, wat in muizen overeenkomt met het begin van de nacht. Bovendien 
paste dit patroon zich aan wanneer muizen aan korte of lange dagen werden blootgesteld: 
de vetzuuropname door bruin vet was steeds het hoogst aan het begin van de donkere 
periode. Vervolgens hebben we gekeken of dit uitgesproken 24-uurs ritme gevolgen had 
voor de vetstofwisseling over de dag. Aangezien activatie van bruin vet vetniveaus in het 
bloed kan verlagen, hebben we in muizen met verhoogde vetten in het bloed het effect 
van de bruin vet ritmiek op bloedvetten onderzocht. We vonden dat de piek in bruin vet 
activiteit altijd samen viel met het laagste niveau van bloedvetten. Ook als we de muizen 
een standaard hoeveelheid vet toedienden in de vorm van olijfolie, waren de vetniveaus in 
het bloed heel laag bij het ontwaken en hoog voor het slapen gaan. Vervolgens hebben we 
onderzocht of bloedvetten eenzelfde dag-nacht ritme vertonen in mensen. In een groep 
van gezonde mensen van middelbare leeftijd zagen we dat de vrije vetzuren in het bloed 
ook een 24-uurs patroon volgden. Ondanks het feit dat de proefpersonen drie identieke 
maaltijden toegediend kregen als ontbijt, lunch en diner, waren na de maaltijd de vetzuren in 
het bloed veel lager na het ontbijt van na de lunch of het diner. We concluderen daarom dat 
consumptie van vetten op het moment dat bruin vet heel actief is leidt tot het snel verbranden 
van deze vetten door bruin vet waardoor de vetten niet in de bloedbaan blijven circuleren 
en de bloedniveaus dus laag blijven. Zowel in muizen als mensen is dit waarschijnlijk rond 
het moment van ontwaken. Ons onderzoek kan verklaren waarom vroege eters gemiddeld 
minder aankomen dan late eters en heeft een wetenschappelijke basis gegeven aan de 
oude volkswijsheid ‘Ontbijt als een keizer, lunch als een koning en dineer als een bedelaar’.
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De centrale biologische klok kan zowel zenuwbanen als hormonen gebruiken om het 
ritme in organen te bepalen. De hormonen die hierbij waarschijnlijk een rol spelen zijn de 
glucocorticoïden. Glucocorticoïden vertonen een opvallend 24-uurs ritme in het bloed 
dat gelijk valt met het hierboven beschreven ritme in de opname van vetzuren door 
bruin vet. Daarom hebben we in hoofdstuk 4 onderzocht in hoeverre het 24-uurs ritme 
in bruin vet door glucocorticoïden worden gereguleerd. Het natuurlijke 24-uurs ritme van 
het glucocorticoïde corticosteron werd afgevlakt door muizen een continue lage dosis 
corticosteron toe te dienen onder de huid. Afvlakking van het corticosteronritme leidde 
ertoe dat bruin vet geen piek meer in vetzuuropname vertoonde. Hierdoor konden we 
concluderen de SCN bruin vet niet alleen door zenuwbanen maar waarschijnlijk ook door 
glucocorticoïden aanstuurt.
Ploegendienst werkers hebben zoals gezegd een verhoogd risico op hart- en 
vaatziekten. Een mogelijke oorzaak zou de verandering in lichtblootstelling kunnen zijn. 
In mensen is dit niet goed te onderzoeken omdat er veel levensstijlveranderingen zijn 
die dit verband beïnvloeden: ploegendienst werkers eten, bewegen en slapen op andere 
tijden dan niet-ploegendienst werkers. Daarom hebben wij in muizen onderzocht of een 
veranderde lichtblootstelling atherosclerose kan veroorzaken. In hoofdstuk 5 laten we 
zien dat verandering in lichtblootstelling inderdaad tot een versnelde ontwikkeling van 
atherosclerose kan leiden. Muizen die gedurende 15 weken aan continu licht werden 
blootgesteld hadden verhoogde cholesterolconcentraties in het bloed in vergelijking met 
dieren die in een regelmatige licht-donker (12 uur licht, 12 uur donker) cyclus leefden, maar 
geen toename in atherosclerosevorming. Een mogelijke verklaring hiervoor is dat de dieren 
gewend raakten aan het regelmatige continue licht, gezien de meeste dieren nog steeds een 
zeer regelmatig bewegingsritme lieten zien. Daarom voerden we een tweede experiment uit 
waarin gedurende 15 weken de licht-donkercyclus wekelijks werd opgeschoven, waarmee 
een ‘jetlag’ werd nagebootst. De vorming van atherosclerose werd niet verergerd als de 
donkerfase wekelijks 6 uur werd verlaat. Echter, wanneer we de donkere periode van muizen 
wekelijks 6 uur vervroegden, wat voor de mens vergelijkbaar is met vliegen naar het oosten, 
zagen we wél een toename in atherosclerosevorming. Wanneer muizen elke week werden 
blootgesteld aan een omgekeerde licht-donkercyclus, wat overeenkomt met een wekelijkse 
jetlag van 12 uur, ontwikkelden zij bijna twee keer zoveel atherosclerose dan onder normale 
licht-donker omstandigheden.
In deel 2 hebben we diverse aspecten van de biologische klok in relatie tot de 
vetstofwisseling onderzocht in mensen. We hebben gekeken naar twee veel voorkomende 
omstandigheden waardoor dag-nachtritmes in mensen veranderd zijn, namelijk korte 
slaapduur en veroudering. Type 2 diabetes kenmerkt zich door ongevoeligheid voor het 
hormoon insuline, waardoor de lever meer suiker en vet produceert en andere organen 
minder suiker en vet opnemen. Hierdoor stijgt de suiker- en vetspiegel in het bloed, wat veel 
schadelijke gevolgen heeft voor de functie van organen en een verhoogd risico voor hart- en 
vaatziekten geeft. Het is onbekend of korte slaapduur een oorzaak is voor het ontstaan van 
suikerziekte. Mocht dit zo zijn, dan zou langdurige slaapbeperking de suikerstofwisseling 
nadelig kunnen beïnvloeden. In een vorige studie hebben we bevestigd dat één nacht van 
4 uur slaap al leidt tot insulineongevoeligheid van organen. In hoofdstuk 6 hebben we de 
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mogelijke mechanismen van deze ongevoeligheid onderzocht door een groep mensen te 
onderzoeken die één nacht ‘normaal’ (8 uur) en één nacht kort (4 uur) hadden geslapen. We 
hebben in het bloed een groot aantal ‘metabolieten’ gemeten. Dat zijn moleculen die worden 
gevormd als resultaat van stofwisselingsprocessen en daarmee informatie geven over deze 
processen. We ontdekten dat na korte slaap één bepaalde klasse metabolieten verhoogd 
was, en wel de acylcarnitines. Dit wijst op een mogelijk probleem in het energieverbruik 
in specifieke organellen binnen cellen, zogenaamde mitochondriën, die vetten en suikers 
omzetten in energie.
Veroudering is geassocieerd met een verminderde werking van de biologische klok, 
wat zich uit in slechtere slaapritmes, maar ook afgevlakte ritmes in hormoonafgifte. Aan de 
andere kant is langlevendheid juist geassocieerd met behoud van ritmiek in bijvoorbeeld 
hormonen in het bloed. Langlevenden hebben daarnaast in het algemeen een gunstigere 
verdeling van vetten in het bloed. In hoofdstuk 7 hebben we onderzocht of langlevendheid 
ook geassocieerd is met een verhoogde dag-nachtritmiek in bloedvetten. Hiervoor 
onderzochten we de cholesterolspiegels in een groep mensen met een genetische 
aanleg voor langlevendheid en hun partners die deze aanleg niet zonder meer hebben als 
controles. Zowel de langlevenden als de controles vertoonden een dag-nachtverschil in 
cholesterolspiegels maar dat verschil was groter in langlevenden. We concluderen hieruit 
dat de cholesterolspiegels meer ritmiek vertonen in mensen van middelbare leeftijd die 
aanleg hebben voor langlevendheid.
In hoofdstuk 8 werden de resultaten van dit proefschrift besproken als ook de 
gevolgen van de nieuwe bevinden voor toekomstig onderzoek en de gezondheid. We 
toonden aan dat langere blootstelling van muizen aan licht tot overgewicht leidde en dat 
deze relatie verklaard kon worden door vermindering van de bruin vetactiviteit. Op basis 
van deze gegevens kan gesteld worden dat het reduceren van licht in nachtelijke uren kan 
bijdragen aan vermindering van overgewicht in mensen. Verder hebben we laten zien dat 
24-uurs ritmes in bruin vet bepalend zijn voor de bloedvetconcentratie. Hoewel nog dient 
te worden aangetoond dat bruin vet een vergelijkbare ritmiek in mensen vertoont en dan 
het meest bijdraagt aan de verbranding van vet aan het begin van de dag, sluiten onze 
bevindingen aan bij studies die laten zien dat afvallen effectiever is wanneer maaltijden met 
name ’s ochtends worden gegeten. Tevens zou dit impliceren dat bruin vet op het goede 
moment geactiveerd kunnen worden met bijvoorbeeld medicijnen. Het maakt dus niet 
alleen uit wát we eten, maar ook wannéér we eten. We lieten ook zien dat verschuivingen 
in licht-donkercycli atherosclerosevorming kunnen verergeren. Deze bevinding vormt een 
wetenschappelijke onderbouwing van de vele observationele studies die laten zien dat 
werken in ploegendiensten een risicofactor voor hart- en vaatziekten is. Op basis hiervan 
zouden wij aanbevelen om mensen met een verhoogd cardiovasculair risicoprofiel uit te 
sluiten van ploegendienst werk. Er blijven nog steeds belangrijke vragen over, bijvoorbeeld 
hoe het brein precies de 24-uurs ritmes in bruin vet reguleert. We hebben laten zien dat 
glucocorticoïden hierbij een rol spelen, maar de exacte rol en relatie tot aansturing door 
zenuwen moet nog verder uitgezocht worden.
199
LIST OF PUBLICATIONS
Rosa van den Berg,*, Sander Kooijman*, Raymond Noordam, Gustavo Abreu-Vieira, Ashna 
Ramkisoensing, Wieneke Dijk, Lauren L. Tambyrajah, Isabel M. Mol, Barbara Kramar, 
Rosanna Caputo, Laura Sardón Puig, Evelien M. de Ruiter, Linda W.M. van Kerkhof, 
Constantinos Christodoulides, Fredrik Karpe, Sander Kersten, Zachary Gerhart-Hines, 
Johanna H. Meijer, Claudia P. Coomans, Diana van Heemst, Nienke R. Biermasz, Patrick 
C.N. Rensen. Circadian rhythmicity of fatty acid uptake by brown fat determines plasma 
lipid metabolism. Submitted. *authors contributed equally
Rosa van den Berg, Raymond Noordam, Sander Kooijman, Steffy W.M. Jansen, Abimbola A. 
Akintola, P. Eline Slagboom, Hanno Pijl, Patrick C.N. Rensen, Nienke R. Biermasz, Diana 
van Heemst. Familial longevity is characterized by high circadian rhythmicity of serum 
cholesterol in healthy elderly individuals. Aging Cell 2017; 16: 237-43.
Rosa van den Berg, Dennis O. Mook-Kanamori, Esther Donga, Marieke van Dijk, J. Gert 
van Dijk, Gert-Jan Lammers, Klaas W. van Kralingen, Cornelia Prehn, Jerzy Adamski, 
Johannes A. Romijn, Ko Willems van Dijk, Eleonora P.M. Corssmit, Patrick C.N. Rensen, 
Nienke R. Biermasz. A single night of sleep curtailment increases plasma acylcarnitines: 
Novel insights in the relationship between sleep and insulin resistance. Arch Biochem 
Biophys 2016; 589: 145-51.
Rosa van den Berg*, Sander Kooijman*, Ashna Ramkisoensing, Mariette R. Boon, Eline N. 
Kuipers, Marieke Loef, Tom C. Zonneveld, Eliane A. Lucassen, Hetty C. Sips, Iliana A. 
Chatzispyrou, Riekelt H. Houtkooper, Johanna H. Meijer, Claudia P. Coomans, Nienke R. 
Biermasz, Patrick C.N. Rensen. Prolonged daily light exposure increases body fat mass 
through attenuation of brown adipose tissue activity. Proc Natl Acad Sci USA 2015; 112: 
6748-53. *authors contributed equally
Sjoerd D. Joustra, Roland D. Thijs, Rosa van den Berg, Marieke van Dijk, Alberto M. Pereira, 
Gert-Jan Lammers, Eus van Someren, Johannes A. Romijn, Nienke R. Biermasz. 
Alterations in diurnal rhythmicity in patients treated for nonfunctioning pituitary 
macroadenoma; a controlled study and literature review. Eur J Endocrinol 2014; 171: 
217-28.
Claudia P. Coomans, Sjoerd A. van den Berg, Thijs Houben, Jan B. van Klinken, Rosa van 
den Berg, Amanda C. Pronk, Louis M. Havekes, Johannes A. Romijn, Ko Willems van Dijk, 
Nienke R. Biermasz, Johanna H. Meijer Detrimental effects of constant light exposure 





Rosa van den Berg werd op 2 april 1985 geboren te Voorburg. In 2003 behaalde zij het 
gymnasium diploma aan het Zandvliet college in Den Haag, waarna zij begon aan de 
studie Biomedische Wetenschappen aan de Universiteit Leiden. In 2006 behaalde zij haar 
bachelor diploma. Hierna maakte zij gedurende één collegejaar deel uit van het bestuur 
van Vereniging te Studerenden te Leiden Catena in de functie van penningmeester 
sociëteit, ondersteund door een beurs van de Universiteit Leiden. Zij solliciteerde voor het 
dubbeltraject programma van de Universiteit, die het mogelijk maakt om zowel de Master 
Biomedische Wetenschappen als de studie Geneeskunde af te ronden. Zij werd hiervoor 
toegelaten en startte in 2007 met de Master Biomedische Wetenschappen. In 2008 startte 
zij in het derde jaar van het doctoraal programma van Geneeskunde. In het kader van de 
Master Biomedische Wetenschappen rondde zij twee stages af binnen het domein van de 
Interne Geneeskunde, te weten bij de afdeling Reumatologie (onder supervisie van prof. 
dr. R.E.M. Toes) en de afdeling Endocrinologie (onder supervisie van prof. dr. J.A. Romijn). 
In 2010 werd zij toegelaten tot de Honours Class ‘Medicine and Literature’, begeleid door 
medisch psycholoog prof. dr. A.A. Kaptein. Op 30 augustus 2012 behaalde Rosa haar 
Master diploma Biomedische Wetenschappen en op 31 augustus 2012 verkreeg zij het 
doctoraal diploma Geneeskunde en het artsexamen, met lof. Zij startte als arts assistent 
interne geneeskunde in het Alrijne Ziekenhuis te Leiderdorp. In mei 2013 begon zij als 
arts-onderzoeker aan haar promotieonderzoek naar de rol van de biologische klok in 
het energiemetabolisme. Per 1 september 2017 zal zij als arts in opleiding tot specialist 





Promoveren is een vierjarig project waar je zelf de regie over hebt. Het is echter alles 
behalve eenzaam en ik zou dan ook dit proefschrift willen afsluiten met een dankwoord aan 
de mensen zonder wiens hulp, steun en advies ik dit resultaat nooit had kunnen bereiken.
Allereerst wil ik mijn promotor, Prof. dr. Rensen noemen. Beste Patrick, bedankt voor 
je benaderbare en enthousiasmerende manier van supervisie. Ik heb geleerd dat de 
combinatie van inhoud en vorm van vitaal belang zijn in het bedrijven van wetenschap.
Van evenveel belang is mijn copromotor dr. Biermasz. Beste Nienke, bedankt voor 
je vertrouwen om mij aan te stellen op je prachtige onderzoekslijn naar de invloed van 
circadiaan ritme op gezondheid. Dankzij jouw genuanceerde advies hielden we de relevantie 
voor de mens in het vizier en leerde ik tegelijkertijd dat er niet zoiets bestaat als ‘dé patiënt’.
Voordat ik mijn collega’s ga noemen, wil ik benadrukken dat helpen bij experimenten 
van mij een bijzondere opgave was, aangezien dit meestal betekende dat mensen op de 
meest barre tijdstippen aan mochten treden. Dank aan allen voor de vroege en late uurtjes. 
Sander, nog voordat mijn aanstelling inging had je me al op sleeptouw genomen, hetgeen 
uitmondde in een prachtige onderzoekslijn naar bruin vet ritmiek. Bedankt voor het mij leren 
delegeren. Edwin, bedankt voor je onverstoorbaarheid. Jan; je laat zien dat er zoiets bestaat 
als ontspannen promoveren. Yanan, a conversation with you resulted invariably in good 
advice, be it scientific, private or fashion. Gustavo, thanks for being my guinea pig. Padmini 
en Jimmy voor de praktische en theoretische inleiding in het atherosclerose onderzoek.
Endomeiden van het eerste uur: Andrea, Geerte, José, Lisa vW, Mariëtte, en endomeiden 
van het ‘tweede uur’ Eline, Kimberly, Laura, Lisanne, Lisa K, Maaike en natuurlijk de 
endo‘heren’ Huub, Enchen, Zhuang. Bedankt voor de hoognodige pauzepraat, comic relief 
en congresbezoekplezier. De goede sfeer zorgde ervoor dat ik met plezier naar werk ging.
Graag wil ik van het endolab Chris, Trea, Hetty en Janny bedanken voor praktische 
ondersteuning en koffiepauze ontspanning. Isabel, bedankt voor je eindeloze inzet, dag en 
nacht, bij kamertemperatuur en bij ‘thermoneutraal’, in licht en donker.
Alle studenten die stage hebben gelopen bij mij: Rosanna, Julia, Laura, Tom, Karina, 
Evelien, Eveline, Nikki, Sebas. Ik leerde altijd ook iets van jullie. Thank you for all your 
enthusiasm and efforts.
Er waren verder veel andere afdelingen waarmee ik zeer prettig heb samenwerkt. Van de 
afdeling Humane genetica: Ko, Vanessa, Jan, Lisa H, Amanda, Sam, Saeed, Mattijs, Lianne. 
Dennis, voor een inleiding in grote data-analyse. Van de afdeling ouderengeneeskunde: 
Diana, Steffy, Abi en Raymond, ik heb erg veel plezier gehad in ons gezamenlijk project. Het 
RIVM; Harry, Linda, Martijn en Conny, dank voor de samenwerking met het jet-lag project. 
Ten slotte was de samenwerking met de afdeling neurofysiologie (MCB) onontbeerlijk voor 
alle ritme studies. Joke, Claudia, Ashna, Erno en Eliane, ik heb ontzettend veel van jullie 
geleerd.
Dan wil ik nog een aantal mensen noemen die op één of andere manier belangrijk zijn 
geweest. Jolanda, bedankt dat je me ooit het dubbeltraject in loodste. Alberto, bedankt dat 
je je over mij ontfermde ten aanzien van mijn verdere loopbaan. Onno, gesprekken met jou 
kunnen gaan over muziek, studenten, zombies of cortisol, altijd met hetzelfde enthousiasme 
en inzet. Je aandacht voor studenten en onderwijs is een voorbeeld voor me.
Het avontuur van het opzetten en (deels) uitvoeren van een klinische slaapstudie had 
heel wat voeten in de aarde. Van het klinisch onderzoekscentrum wil ik Bep en Sabrina 
bedanken voor de praktische hulp. Van de afdeling dermatologie wil ik Sjan en Abdoel 
bedanken voor het meedenken en van Unilever wil ik Harry, Timo en Louise bedanken voor 
de input. Iris, zonder jou had mijn laatste promotiejaar er heel anders uitgezien, bedankt 
voor alle slapeloze nachten.
Promoveren was alleen mogelijk geweest met morele steun van vrienden en familieleden. 
Hierbij wil ik in het bijzonder de volgende mensen noemen. Soraia, voor je eerlijke mening. 
Fransje, voor onze stimulerende discussies over het wetenschappelijk bedrijf (en life, 
the universe and everything). Joke, voor hulp in barre tijden. Karin, voor het voorbeeld 
dat geneeskunde en een bruisend sociaal leven prima te combineren zijn. Petra, voor je 
energie. Annemarie en Martijn, voor een luisterend oor. Marina, voor je volste vertrouwen 
in mijn wetenschappelijke kwaliteiten, ook als ik het zelf niet zo zeker wist. Chiara, voor het 
inzicht van het belang van een goede werk-privé balans, voor durven te dromen. Floris, 
bedankt dat ik altijd op je kan rekenen. Alberto, le distanze non si misurano in kilometri; 
grazie per tenermi presente nei tuoi pensieri. Quirien, Didi, Job; jullie hebben mij mijn 
hele promotietraject bijgestaan. Bedankt voor jullie geduld als ik weekenden, avonden en 
vakanties doorwerkte, voor het ophalen en brengen naar het lab met mijn gebroken enkel en 
nog veel meer. Aurora, cara mamma, grazie per il sostegno morale tramite telefonate, pranzi 
e cene. Martin, paps, discussies over slaap brachten onze werk/hobby’s onverwachts en tot 
mijn grote vreugd bij elkaar. Bedankt voor jullie onvoorwaardelijke steun.

implications of circadian lipid metabolism 
for cardiometabolic health














Rosa van den Berg
